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Nitrile oxide-isoxazoline chemistry has been utilised in a convergent 
approach towards the synthesis of a series of undecose monosaccharides. 
The sequence involves three stages. The cycloaddition of a five-carbon 
nitrile oxide to a hex-5-enofuranose derivative provides an eleven carbon 
framework incorporating a 2-isoxazoline. Reductive hydrolytic cleavage of 
the heterocycle to a -hydroxyketone followed by reduction affords the target 
6-deoxy-higher sugar. 
Two co-unsaturated monosaccharide derivatives, 3-O-benzyl-5,6-
dideoxy- O-isopropy lid ene-a-D-xy/o- hex-5-enofu ranose and methyl 5,6-
dideoxy-2,3-Q-isopropylidene-a-D-/yxo-hex-5-enofuranoside, were selected 
for this purpose. 2,3:4,5-Di-0-isopropylidene-D- and Larabinononitrile 
oxides were generated from the corresponding oximes by a chlorination-
dehydrochiorination protocol. Cycloaddition to both alkenes proceeded with 
good it-facial selectivity (64-78% de). In each instance the major adduct 
possessed the R-configuration at the new asymmetric centre, corresponding 
to an erythro relationship between it and the adjacent 0-4 position of the 
attached furanose unit. The observed selectivities are rationalised in terms 
of the 'inside alkoxy effect' and the 'homoallylic' modification proposed by 
Houk and De Micheli. The configuration of the carbon adjacent to the nitrile 
oxide was found to have negligible effect on the observed erythro:threo 
ratios. 
Reductive hydrolytic cleavage of the 2-isoxazolines provided the 
desired 3-hydroxyketones, accompanied by formation of a diastereoisomeric 
mixture of -y-amino alcohols. Subsequent reduction of the carbonyl of the 
former afforded the corresponding 1 ,3-diols, which were converted to their 
ketals in order to aid in structure determination. Finally isopropylidene 
Vii 
deprotection and peracetylation provided the corresponding 6-deoxy-octa-
acetyl undecofuranoses. 
Similarly the application of nitrile oxide-isoxazoline chemistry for the 
synthesis of azasugars has been investigated. Cycloaddition of (S)-serine 
derived (4R)-3-(N-t-butoxycarbony1)-2 ,2-dimethy1-4-vinyloxazolidine to 
ethoxycarbonylformonitrile oxide and, secondly, (4R)-3-(N-t-butoxycarbonyl)-
2,2-dimethyloxadiazOle-4-CarbOnitrile oxide to p-toluenesulphonic acid allyl 
ester afforded precursors suitable for conversion to such target molecules. 
Problems encountered at the N—O bond cleavage stage led to a brief study 
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This thesis describes the application of nitrile oxide-isoxazoline 
chemistry to the synthesis of higher monosaccharides and preliminary 
studies into its use for the preparation of azasugars. 
In the introduction three topics are discussed. First a short section 
provides background information concerning 1,3-dipoles and their 
cycloaddition products; particular emphasis is paid to nitrile oxides and their 
reaction with alkenes to give 2-isoxazolines. In the second part a review of 
higher sugars and approaches to their construction is presented. Finally the 
role of glycosidases and the syntheses of azasugar-type inhibitors of these 
enzymes are discussed. 
1.2 	1,3-Dipolar Cycloaddition Chemistry 
The field of 1,3-dipolar cycloaddition chemistry is too extensive to be 
reviewed in depth in this introduction and only a brief overview will be 
presented, with particular attention given to the properties of nitrile oxides 
and their reactions. For further detail the reader is referred to Padwa's 
comprehensive monograph entitled '1,3-Dipolar Cycloaddition Chemistry', 1 
to Grundmann and Grunanger's text 'The Nitrile Oxides', 2 to Torssell's more 
recent book 'Nitrile Oxides, Nitrones and Nitronates in Organic Synthesis' 3 
and to a recent review article by Kanemasa and Tsuge entitled 'Recent 
Advances in Synthetic Applications of Nitrile Oxide Cycloaddition'.4 
2 
1.2.1 	1,3-Dipoles 
The concept of 1,3-dipolar cycloaddition was developed by Huisgen 
in the 1960's and has since evolved into a well-established method for the 
construction of five-membered ring heterocycles. 1 
The 1,3-dipole is defined as a three atom four it-electron system 
isoelectronic with heteroallyl anions but with neutral overall charge. 5 They 
are divided into two structural types, the linear propargyl-allenyl type (1) and 
the bent allyl type (2), differing only in the presence or absence respectively 
of an additional orthogonal it-bond. 
ab—c 	 ac 
(1) 	 (2) 
Each type is further divided and subdivided according to the elements 
occupying the a, b and c positions and this is illustrated, 6 together with some 
representative members of each group, in Table 1. Nitrile oxides are thus 
members of the nitrilium betaine class of 1,3-dipoles. Although their most 
usual representation is in terms of the zwitterionic octet structure used in the 
formulae so far, as with the other 1,3-dipoles, they are more accurately 
described as a hybrid of resonance forms (3)-(8) (Scheme 1). The most 
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C=0—NR Carbonyl Imides 
+ 	- 
R2C=0—O 	Carbonyl Oxides• 
Table 1: Common 1,3-Dipoles 
RCN-0 - RC=N=-O RCN-0 
(3) (4)  
RCN— Re—NO RC=N-0 
(8)   
Scheme 1 
rd 
1.2.2 1,3-Dipolar Cycloaddition 
The most important reaction undertaken by 1,3-dipoles, from a 
synthetic point of view, is a [3+2] cycloaddition to a multiple-bond-containing 
system, the dipolarophile, to form a five membered heterocycle (Scheme 2). 





Although the mechanism of such 1,3-dipolar cycloadditions has been 
an area of controversy, and the conclusions drawn from theoretical 
calculations have tended to conflict, it is now 7 generally accepted that, under 
normal conditions, 1,3-dipoles react via a concerted, but not necessarily 
synchronous, one-step process. Huisgen 89 proposed that the reaction 
proceeds via a parallel-plane orientation complex which permits it-orbital 
overlap of reactants and subsequent formation of the two new G-bonds of the 
product (Figure 1). 
Figure 1 
5 
Stepwise diradical 10,11  and stepwise zwitterionic mechanisms have also 
been considered. 12 However, the observed retention of reactant 
stereochemistry, the negligible solvent effect and the large negative entropy 
of activation of such reactions provide strong evidence in favour of the 
concerted process- 12,13  
1.2.3 Frontier Molecular Orbital Theory of 1,3-Dipolar 
Cycloadditions 14 
The development of Frontier Molecular Orbital (FMO) theory has 
provided an explanation for observed reactivities and regioselectivities in 
1,3-dipolar cycloadditions. 
The interactions of the dipole and dipolarophile FMOs have been 
classified by Sustmann 5 into three limiting cases : Types I, II and III (Figure 
2). For a given system the HOMO-LUMO interaction which gives the greater 
stabilisation energy represents the dominant interaction (characterised by 
smaller HOMO-LUMO separation). Hence Type I systems are dipole HOMO 
controlled, Type II are dipole HOMO and LUMO controlled, whereas Type III 
are dipole LUMO controlled. From the knowledge that donating substituents 
raise FMO energies and withdrawing substituents lower FMO energies, while 
conjugating substituents raise the HOMO and lower the LUMO, the effect of 
varying functionalities can be predicted. 
For instance the 'normal' nitrile oxide FMO interaction is LUMO 
(dipole) controlled (Type III). This tends to Type II with increasing strength 
of electron-withdrawal by substituents on the dipolarophile and/or increasing 
strength of electron-donation by dipole substituents. For Type III, donating 
and conjugating groups on the dipolarophile, or withdrawing groups on the 
dipole, increase the stabilisation energy and hence result in increased 
reaction rates. Similar predictions may be made for Type I and II systems 

























Regioselectivity phenomena have also been interpreted by FMO 
theory. The magnitude of the orbital coefficients in 1,3-dipoles and 
dipolarophiles vary with substituent. As a consequence of the principle of 
maximal orbital overlap 16 the major regioisomer results from the interaction 
of orbitals of matched size, i.e. large-to-large and small-to-small (Figure 3) 
(see also Section 1.2.6.2). Steric factors can also play an important role, 
and orbital control may be over-ridden in intramolecular cycloadditions 








The addition of 1,3-dipoles to dipolarophiles is a concerted process 
and proceeds with the retention of dipolarophile stereochemistry. When the 
two faces of the dipolarophile are open to attack, two stereoisomers for each 
regioisomer are produced (Scheme 3). The relative abundance of each is 
usually governed by steric factors. 
R 1 —ab—C 	 R l _ a b ••% c 
+ 	 + 
R2 	R3 	
R( 	R3 	 R 	'R3 
Scheme 3 
1.2.5 Generation of Nitrite Oxides 
The reactive nature of most nitrile oxides, in particular their tendency 
to dimerise (Section 1.2.6.1), has necessitated their generation in situ for 
synthetic purposes. The general procedure involves slow generation of the 
nitrite oxide in the presence of excess dipolarophile. The principle routes 
are summarised in Scheme 4. 
Hydroximoyl halides (9) are frequently employed as nitrite oxide 
precursors, undergoing dehydrohalogenation with base (usually 
[;] 
triethylamine, 7 or more recently potassium fluoride 18) or thermally. 19 ' 20 
These halides may be prepared from the corresponding aldoxime (10) by 
direct halogenation 2l or by the milder in situ method with N-
bromosuccinimide or N-chlorosuccinimide. 23 Alternatively, alkaline 
sodium hypochlorite 24 or hypobromite, 25 and chloramine-T26 have been 
used for the one-pot conversion of aldoxime to nitrile oxide via the 
hydroximoyl halide. Direct dehydrogenation of syn aldoximes27 (10) using 
lead tetraacetate has also been reported. 
The dehydration 28 of primary nitro compounds (11), using 
isocyanates in conjunction with a catalytic amount of triethylamine 
(Mukaiyama method), is the most common alternative to the approach from 
hydroximoyl halides. 
Finally the thermal cycloreversion 2931 of 1 ,2,5-oxadiazole-2-oxides 
(furazan N-oxides/furoxans) (12) also provides access to nitrile oxides. 
RCXNOH 	 RCH2NO2 







1.2.6 Reactions of Nitrile Oxides(Scheme 5) 
1.2.6.1 Absence of Dipolarophile 32 ' 33 
Once generated nitrile oxides have a tendency to dimerise to 
furazan N-oxides (12). The susceptibility of a particular nitrile oxide to 
undergo such a process is mainly governed by the steric bulk of the A 
substituent; however electronic factors may also have an influence. Thus 
the half-life of a neat sample of an aliphatic nitrile oxide at room temperature 
varies from seconds to minutes, while that of a substituted aromatic nitrile 
oxide may be hours, days or even longer. Dimerisation to 1 ,2,4-oxadiazole-
4-oxide (13) and 1 ,4,2,5-dioxadiazine (14) may also take place, often under 
the influence of Lewis acids. 
The more stable nitrile oxides have been observed to undergo 
thermal (110-140°C) rearrangement to isocyanates (15), while nucleophilic 
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X Y 	 0 1  (17) 
R 	 + 	 (18)x=Y=cR2 - 
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1.2.6.2 Presence of Dipolarophile 
As previously noted the most synthetically appealing reactions of 
nitrile oxides are their 1,3-dipolar cycloadditions to dipolarophiles affording 
5-membered heterocycles incorporating the C=N-O unit (17) and (19) 
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(Scheme 5). 	For instance with alkenes 2-isoxazolines (4,5- 
dihydroisoxazoles) (18) are obtained, whereas addition to alkynes affords 
isoxazoles (20). The reaction with alkenes, the focus of this work, will be 
discussed further. 
Cycloaddition to monosubstituted (Scheme 6) or 1,1 -disubstituted 
alkenes is highly regioselective affording 5-substituted- (21) and 5,5-
disubstituted-2-isoxazolines respectively. For ethene bearing electron-
donating or conjugating substituents e.g. hex-1 -ene or styrene the reaction is 
regiospecific. Introduction of a strongly electron-withdrawing group into the 
alkene increases the amount of the 4- (22) and 4,4-disubstituted 
regioisomers. 1 ,2-Disubstituted alkenes, in contrast, are much less 






(21) 	 (22) 
Ratio34 
R1 R2 (21):(22) 
Ph Bu 100:0 
Ph Ph 100:0 
Ph CO2CH3 95 : 5 
Scheme 6 
The origin of the regioselectivity effects can be rationalised using 
FMO theory (Section 1.2.3). 	The relative MO energies and sizes of the 
coefficients for nitrile oxide addition to monosubstituted alkenes are shown 
in Figure 4. The LUMO (dipole) controlled reaction of alkenes substituted by 
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donating or conjugating groups can been seen to favour 5-substituted 
products. The presence of a withdrawing group in the dipolarophile lowers 
its FMO energies thereby increasing the contribution from the HOMO 
(dipole) interaction which leads to the 4-substituted regioisomer. The LUMO 
(dipole) interaction is still dominant, and the overall result is decreased 
regioselectivity. This effect is increased by the presence of donating groups 












C = Conjugating Group 
D = Electron Donating Group 
W = Electron Withdrawing Group 
Figure 4 
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1.2.7 Synthetic Utility of Nitrile Oxide-lsoxazoline Chemistry 
The nitrile oxide cycloaddition reaction which produces 2-
isoxazolines is important, not only from the point of view of heterocycle 
synthesis, but also as a result of the functionalities which may be revealed 
upon subsequent ring cleavage. The stability of the 2-isoxazoline nucleus to 
a variety of reaction conditions, which allow side chain manipulation and/or 
ring substitution, coupled with the improved procedures for ring opening to 
specific target functionalities, 35  has resulted in the development of the Nitrile 
Oxide Cycloaddition (NOC) route for the syntheses of natural products and 
their analogues. The key reactions of the isoxazoline nucleus will be briefly 
outlined. 
Deprotonation at the 4-position of a 3,5-substituted isoxazoline may 
be effected using lithium di-isopropylamide (LDA) or butyllithium at -78°C. 
The 	resulting carbanion 	may 	then be 	trapped with 	an 	appropriate 
electrophile to give the corresponding 4-substituted derivative. 36 '37 	The 
stereochemistry of this new substituent is directed by the steric influence of 
the existing 5-substituent. At elevated temperatures the carbanion 
undergoes ring opening to an a,13-unsaturated  oxime (Scheme 7). 
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Cleavage of the isoxazoline N-O bond releases a variety of latent 
functionalities dependent upon the conditions employed (Scheme 8). For 
instance, reductive hydrolytic cleavage 38 of the N-O bond affords the highly 
important -hydroxyketone functionality in an alternative fashion to the 
classical aldol reaction. Viewed retrosynthetically these two methods involve 
the formation of complementary C-C bonds (Figure 5). Various procedures 
have been employed for such isoxazoline ring openings including catalytic 
hydrogenation 38 with a palladium-on-charcoal or Raney-nickel catalyst in 
aqueous methanol, or alternatively reduction with titanium trichloride, 39 
molybdenum hexacarbonyl 40 or ozone.41 The -hydroxyketone itself 
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Reductive non-hydrolytic cleavage, using lithium aluminium hydride 
(LAH)42  or non-aqueous catalytic hydrogenation,43 releases the y-
aminoalcohol moiety. The stereoselectivity of the former process is 
generally higher than the latter due to LAH complexing with the isoxazoline 
ring. 
The 3-hydroxynitrile functionality may also be unmasked from 3-
unsubstituted isoxazolinesW in the presence of base or via thermal 
decarboxylation of isoxazoline-3-carboxylic acids. 45 
Finally, oxidation of 2-isoxazolines to isoxazoles followed by 
manipulation and/or ring cleavage (e.g. to a 1 ,3-diketone) is also available. 46 
The synthetic potential of 2-isoxazolines, as outlined above, has 
been exploited in the synthesis of a wide range of natural products and 
analogues: examples4247 include alkaloids, amino acids, carbocycles, 
carbohydrates and prostaglandins. 
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1.3 Higher Carbon Sugars 
1.3.1 Introduction 
Monosaccharides consisting of a backbone of seven or more 
consecutive carbon atoms, i.e. heptoses, octoses, nonoses, etc, are 
collectively referred to as higher carbon sugars. Compared to the pentoses 
and hexoses which, as well as existing in the free form, are components of 
numerous bio-oligomers and biopolymers, these chain-extended 
monosaccharides are less abundant in nature and are usually found as sub-
units of natural products of varied biological function. 
Examples include, in order of increasing chain length, various 
heptose components of some bacterial cell wall polysaccharides e.g. D- and 
L-gIycero--D-manno-heptopyranoses. The broad spectrum aminocyclitol 
antibiotic apramycin" (23) contains an amino-octodialdose unit and the 
Gram-positive antibiotic lincomycin (24) contains an amino-octose derivative, 
lincosamine. 49 KD050 (3-deoxy-D-manno-2-octulosonic acid) (25), a lipid-
polysaccharide linker in Gram-negative bacterial membranes, and the 
octosyl acid component of the corresponding nucleoside antibiotics, e.g. 
octosyl acid A51 (26), are further representatives of eight-carbon 
monosaccharides. N-Acetylneuraminic acid 52 (27), a nine carbon analogue 
of KDO, is an important glycoconjugate constituent, while the nucleoside 
sinefungin53 (28) contains a decose unit. 
Undecose monosaccharides have been identified in a variety of 
nucleoside antibiotics. For instance, the tunicamycin 54 family (29) of 
antibiotics which exhibit antimicrobial, antifungal, antiviral and/or antitumour 
activities through inhibition of glycoconjugate synthesis, contain an amino-
undecose tunicamine. The anthelminthic agent hikizimycin 55 (30) also 
contains an amino-undecose, hikosamine, attached to cytosine and a 
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glucosamine sugar. It acts by inhibition of protein biosynthesis. A final 
example is that of the herbidicins 56 (31). These compounds have been 
shown to possess both antibiotic and herbicidal properties and contain a 
tricyclic eleven carbon uronic acid ester. 
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The identification of such long chain carbohydrates and the 
recognition of their multi-functional roles when incorporated in larger 
structures has stimulated interest in the development of efficient methods for 
their construction. The structural complexity of these polyhydroxylated 
compounds represents a significant synthetic challenge, particularly in terms 
of stereochemical control which has been the focus of much attention in 
recent investigations. 
The classical Kiliani-Fischer cyanohydrin route 57 for one carbon 
chain extension of monosaccharides is the forerunner of many modern 
approaches, all of which aim to form the new carbon-carbon bonds in a more 
stereoselective and stereopredictable manner. Several elegant and efficient 
routes have been exploited including iterative one, two and three carbon 
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atom extensions of aldoses or appropriate precursors, convergent 
carbohydrate couplings and highly stereoselective syntheses from non-
carbohydrate precursors. A recent review 58 by Casiraghi and Rassu, 
entitled 'Aspects of Modern Higher Carbon Sugar Synthesis', details many of 
these approaches, covering work published up to 1991. C-Disaccharides 
and branched chain sugars have been included in several of their cited 
examples. Several accounts59-62 outling specific approaches to this topic 
are also available. The following survey will outline the main routes 
employed for higher sugar synthesis, updating the previous review and 
including additional material. Routes leading solely to C-disaccharides and 
branched chain sugars have not been included. Since the focus of this thesis 
is concerned with the preparation of undecose monosaccharides the 
illustrations will, where applicable, highlight the synthesis of such 
compounds. The overall account has been divided into two main sections. 
The first deals with syntheses based on carbohydrate starting materials, 
while the second covers their construction from non-sugar compounds. 
1.3.2 Syntheses of Higher Sugars From Carbohydrates 
1.3.2.1 Thiazole Route 
Dondoni et a/61 ,63  have developed a highly stereoselective iterative, 
one-carbon extension of chiral alkoxy-aldehydes and dialdoses which results 
in long chain polyhydroxylated aldehydes with an anti relationship of vicinal 
hydroxyl groups. This 'Thiazole Route' employs two key steps - A : the anti 
addition of 2-(trimethylsilyl)thiazole (2-TST) to a chiral a-hydroxylated 
aldehyde, and B : conversion of the thiazole ring to the aldehyde function 
(Scheme 9). The observed anti selectivity has been explained 63 in terms of 
a non-chelation controlled Felkin-Anh transition state in which interaction of 
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silicon with the carbonyl oxygen, producing a tight transition state, promotes 
high selectivity (eg. Figure 6). 
S 	B 	* * 
	Reiterate A+B * * * 	 A ____ 	____ RCHCHO RCH=O 	RCH—( I .... R(CH)CH=O 
OH 	N 	
OH 	(n-i) times 	OH 
Scheme 9 




The thiazole group is important in the success of this approach, being stable 
to a wide variety of conditions and yet undergoing efficient conversion to the 
formyl group under neutral conditions. This formyl unmasking involves a 
one-pot sequence of N-methylation to a thiazolium salt, sodium borohydride 
reduction, and mercury (II) assisted hydrolysis of the resulting thiazolidine. 
The overall route is illustrated 63 in the four carbon extension of the 
dialdogalactopy ran oside (32) to afford the thiazole-decose (34) (Scheme 10; 
the ratio of anti:syn product is given for each sequence). In this way, 2,3-di-
O-isopropylidene-D-glyceraldehyde was converted to a thiazole-nonose 
using six cycles of the above procedure with diasteroeselectivities for the 2-
TST additions in the range 90-95%. 63 Access to the syn adduct through an 
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oxidation-highly stereoselective reduction sequence' 65  is possible at each 
stage in the iteration thereby increasing the scope of this approach. 
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(Th = 2-Thiazolyl) 
(i) 2-TST, CH2Cl2 ; (ii) (Bu)4NF, THF; (iii) NaH, BnBr, (Bu) 4N1, THF; 
(i) Mel, acetonitrile, ref lux; (ii) NaBH 4 , MeOH, -10°C; (iii) HgCl 2 , acetonitrile/H20 
Scheme 10 
Dondoni has also investigated the use of 2-TST and other 2-
substituted thiazoles in further applications of the thiazole route. For 
instance, Wittig reaction of 2-thiazolylmethylenetriphenylphOsphOrane (2-
TMP) with aldehyde (33) afforded almost exclusively (>95:5) the trans 
alkene (35) which, after formyl unmasking and reduction afforded a dideoxy 
undecitol (36)66 (Scheme 11). 
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An improved procedure 67 for release of the formyl group, using 
methyl triflate in the methylation step and CuC1 2 and CuO for the metal 
assisted hydrolysis, has been recently reported. This further increases the 

























(36) R= CH 20H 
(Th = 2-Thiazolyl) 
(a) Wittig using 2-TMP; (b) (i) Mel, acetonitrile; (ii) NaBH 4, MeOH; (iii) HgCl 2 , H20; 
(c) NaBH4 , EtOH 
Scheme 11 
1.3.2.2 The Butenolide Route 
Casiraghi et al have developed a versatile reiterative four-carbon 
chain extension of chiral aldehydes applicable for the synthesis of higher 
sugars. 58 ' 68 This procedure (Scheme 12) involves the highly stereoselective 
addition of a four carbon nucleophile, 2-(trimethylsiloxy)furan (TMSOF), to a 
homochiral Cn  aldehyde affording a C.1 4 butenolide. The butenolide double 
bond is functionalised as appropriate (for higher sugars X=Y=OH) and the 
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HIGHER 	repeat 
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OZ ~ 
Scheme 12 
This process is illustrated 69 in the synthesis of an enantiomerically 
pure undecose from 2,3-O-isopropylidene-D-glyceraldehyde (37) (Scheme 
13). Boron trifluoride etherate promoted , addition of TMSOF to the aldehyde 
afforded a mixture of butenolides (38) and (39) with the latter 4,5-threo:5,6-
erythro isomer predominating (>95:5). The 5,6-erythro relationship is 
consistent with that predicted on the basis of a Felkin-selective nucleophilic 
attack on an unchelated aldehyde. 70 ' 71 The 4,5-threo stereochemistry is 
predicted on the basis of the sign of the optical rotation which is related to 
the absolute configuration at C-4 through an empirical rule applicable to 4-
substituted 2,3-unsaturated-'y-butyrolactones. 72 This rule is supported by 
the threo preference observed in the Lewis acid promoted attack of TMSOF 
on aldehydes. 7374 The overall 4,5-threo:5,6-erythro structure was 
confirmed by X-ray analysis of the compound resulting from complete 
deprotection of butenolide (39). Anti-selective cis-hydroxylation of the 
butenolide double bond 75 , followed by an established procedure of lactone 
ring cleavage, desilylation and protection gave ester (40). Subsequent 
DIBAL reduction yielded aldehyde (41), which was subjected to a further 
highly selective (94:6) TMSOF addition and manipulation as above to afford 
23 
the target undecose (42) in a 5.1% overall yield. A similar strategy has been 
used to generate branched chain deoxy sugars 76 and cyclic imino sugars 
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(a) TMSOF, BF3.OEt2, -90°C then TMSCI, pyridine; (b) KMn04, DCH-18-crown-6, 
CH2Cl2 ; (C) DMP, TsOH; (d) DIBAL, CH 2Cl2, -90°C 
Scheme 13 
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1.3.2.3 Olefination-Functionalisation Approaches 
Several of the approaches reported for the synthesis of higher 
carbon sugars involve the olefination of an aldehydo sugar via Wittig 
reaction (or equivalent) or carbanion attack, followed by functionalisation of 
the resulting double bond by, for example, catalytic osmylation or Sharpless 
epoxidation. 
Among the first to explore such a route were Kochetkov and 
Dmitriev (Scheme 14). Knoevenagel-Doebner condensation or Wittig 
olefiriation extended the chain by two carbons resulting in a trans 
unsaturated aldonic acid or ester respectively. Bishydroxylation of the 
double bond using osmium tetroxide followed by reduction of the acid or 
ester gave the higher aldose with moderate selectivity. 
Knoevenagel-  
Doebner 	RCHO + CH2 (CO H) 22 
Wittig RCH=O + Ph3P=CHCO2Et 
CO2Et 
OH OH OH 
A--~ 	CO2H 57% 
OH OH 	 Os04 	OH OH OH OH 
KCIO3 	 + 
OH OH OH 	 OH OH OH 
26% 
OH OH OH OH 
Scheme 14 
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The stereoselectivity of the osmylation of allylic alcohols and 
derivatives has been extensively studied by Kishi and co-workers. 78 It was 
found that the stoichiometric process resulted in better selectivity than the 
catalytic process - however the increased price coupled with the higher 
toxicity levels of the former rules it out for large scale processes. The 
stereoselectivity of cis alkene osmylation was in general higher than that for 
the corresponding trans alkene. Kishi also formulated a highly useful 
empirical rule to predict the major product of osmylation of chiral allylic 
alcohols and derivatives. He states that the relative stereochemistry 
between the new OH and the existing OH or OR at an adjacent stereocentre 
in the major product is erythro. The explanation is based on the attack of 
osmium tetroxide from the face of the double bond anti to the existing OH or 
OR when the alkene adopts the sterically least crowded eclipsed form 
(Figure 7). A further point noted by Kishi is that if a chiral centre bearing an 
OH or OR is present at both ends of the double bond the selectivity 






1.3.2.4 Wittig-olefination-osmylation and/or Wittig-olefi nation-
epoxidation 
Prompted by these observations Brimacombe and co-workers 59 
have carried out extensive studies on the Wittig olefination-osmylation route 
to heptose, octose, nonose and decose sugars. The results of their 
osmylation reactions79 were in the main consistent with Kishi's empirical rule 
(except where steric factors interfered with the preferred direction of 0s0 4 
attack). A pyranose or furanose ring oxygen at a stereocentre adjacent to 
the double bond was found to direct the stereochemistry of the osmylation in 
the same manner as an exocyclic OH or OR, i.e. the major product was due 
to osmylation anti to the endocyclic oxygen. For instance the 
dialdogalactopy ran oside (32) was converted through Wittig olefination and 
subsequent anti-selective cis-hydroxylation to a mixture of isomeric octoses 
(43) and (44) with the latter predominating (7:1) (Scheme 15). 80 
o 	 o 	 o 










YO 	 OR 
OH 
(44) 
(a) Ph 3PCHCHO, benzene, ref lux; (b) DIBAL, CH 2Cl2 ; ( C) 0s04, NMO, acetone/H 20 
Scheme 15 
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Cis-aj-unsaturated esters provide a major exception 59 '79 to Kishi's 
empirical rule, often giving the anti-Kishi product with high selectivity 
(Scheme 16). The corresponding trans isomers tend to give mainly the Kishi 
product but with widely varying selectivities. The proposed explanation is 
that a,1-unsaturated esters often adopt a different preferred conformation to 
that of isolated alkenes. 
0 -\- 
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0 CHO 










0 Me I 
OH 
Kish 
(a) Ph 3PCHCO2Me, MeOH; (b) OsO4, NMO, acetone/H20 
Scheme 16 
Use of the appropriate 'matching' chiral ligand (either 
dihydroquinidine p-chlo robe nzoate or dihydroquinine p-chlo robe nzoate) in 
the osmylating agent was found to increase the diastereofacial selectivity for 
trans-conjugated esters81  (Scheme 17) but was not successful for promoting 
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0s04 7.4 :1 
0s04 + 'non- 3.5 :1 
matching' ligand  
0s04 + 'matching' 15.9 :1 
ligand  
Scheme 17 
In principle this Wittig olefination-osmylation route could be 
repeated, but the octose to decose conversion met with varied success in 
the osmylation step and in such cases Brimacombe 59 resorted to an 
epoxidation to functionalise the new double bond. Use of a chiral 
epoxidising agent controlled the stereochemistry of the epoxide formed 
which could be predicted using the Sharpless model 82 (Figure 8). The 
chiral auxiliary D-(-)- or L-(+)-diisopropyl tartrate [(+)- or (-)-DIPTJ determines 
from which face the oxygen will be delivered. 






Furthermore, the base catalysed opening of the epoxide (Payne 
rearrange ment83 ) leads to predictable stereochemistry for the resulting triol. 
Since overall cis-hydroxylation of a trans alkene has the same result as the 
trans opening of a cis epoxide, by choice of appropriate starting alkenes the 
same hydroxylated products may be formed from either osmylation or 
epoxidation, but often with greatly varying stereoselectivities as is shown for 
the bis-hydroxylation of some decoses (Scheme 18). The epoxide route thus 
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Stutz et 04 ' 85 have studied the two carbon extension of 
5-0-tert-butyldimethylsilyl-1 ,2-0-isopropylidene-a-D-gluco- 	and -0-L-ido- 
hexodialdoses, (47) and (48) respectively. 	Initial extension84 using 
vinylmagnesium bromide resulted, in the case of the gluco isomer, in a 1:1 
mixture of the expected diastereomers, contrasting with a 10:1 mixture for 
the corresponding ido isomer (Scheme 19). Further functionalisation of the 
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Scheme 19 
More recently these hexodialdoses (47) and (48) have been 
converted85  into octoses utilising the Wittig olefination-osmylation strategy. 
Two Wittig reagents were employed, namely ethoxycarbonylmethylene-
triphenylphosphorane (49) and triethyl phosphonoacetate (50). The results 
are summarised in Table 2. The resulting a43-unsaturated uronic esters 
were reduced to the corresponding allylic alcohols, which underwent 
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catalytic osmylation to afford the octose sugars. In each case the major 
osmylation product corresponded to that predicted by Kishi's empirical rule, 
with the L-ido derived product showing the greatest selectivity. 
CO2Et 
- CO Et02CCH=PPh 3 (49) 	 Et 
or + 	or 	
_____ 





(EtO)2 PCH2CO2Et (50) 	 R 	 A 
x V 
From (47) R 1 = OTBDMS, R2= H 
From (48) R 1 = H, R2= OTBDMS 
(R = As in Scheme 19) 
















1.3.2.5 Convergent olefination approaches 
Secrist et ai60 have employed unstabilised carbohydrate 
phosphoranes in a convergent application of the Wittig olefination-
osmylation strategy. This method offers access to decose, undecose and 
dodecose sugars in which the respective stereochemistries of seven, eight 
and nine chiral centres are defined by the initial carbohydrate units, whilst 
that of the remaining two are dependent upon the double bond hydroxylation 
process. 
A protected form of the hikosamine fragment of hikizimycin has been 
synthesised in this way 86 (Scheme 20). 
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AcHN)I0Me 	 AcHNi' 'I0Me 
AcO 	OAc 	 BnO 	OBn 
(55) 	 (54) 
(a) BuLl, THF, HMPA, -65°C to -10°C; (b) (i) LiAIH 4 , (ii) by, Ph2S2 ; (iii) Ac20,pyridine; 
(iv) 0s04, NMO, THF/H20; (C) 10% Pd/C, MeOH, H20, HCI then Ac20, pyridine 
Scheme 20 
An arabi nose-de rived phosphorane (51) was coupled with a galactose-
derived aldehyde (52) to afford the alkene (53) solely in the cis form. 
Photochemical isomerisation, after azide reduction, gave access to the 
required trans isomer. Stereospecific catalytic osmylation afforded the 
hikosamine precursor (54), which underwent deprotection and acetylation to 
methyl peracetyl-a-hikosaminide (55). It should be noted that unstabilised 
carbohydrate phosphoranes have the potential for b-elimination to vinyl 
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phosphonium salts. However, Secrist reasoned that if the 3-oxygen is 
attached through a second bond to the same molecule this process may be 
intramolecularly reversible - resulting in possible epimerisation about the cx-
carbon. In the work carried out by Secrist only one example of this 
epimerisation problem was noted. 87 
In order to avoid even the possibility of n-elimination Jarosz' 89 and 
Fraser-Reid88 have employed stabilised carbohydrate phosphoranes in 
Wittig coupling to carbohydrate aldehydes. The resultant major trans 
enones are reduced to either the R or S trans allylic alcohols, dependent on 
the reducing agent employed 90 , and finally the double bond bishydroxylated 
via catalytic osmylation. The alternative epoxidation of the double bond was 
found to be harder to control in this instance. 91 An example90 ' 92 of this 
route is illustrated in the highly stereoselective synthesis of a dodecose 
sugar (58) (Scheme 21). Enone (56) was reduced to allylic alcohol (57) with 
excellent selectivity (98:2) using zinc borohydride, while the osmylation 
produced a 9:1 mixture of dodecoses (58) and (59) respectively. The high 
selectivity in the osmylation step is a result of the stereocentres at both ends 
of the double bond directing the attack of osmium tetroxide from the same 
face in compliance with Kishi's model. 
Alternatively these trans allylic alcohols were synthesised directly by 
the addition of a sugar vinyltin derivative to a sugar aldehyde 93 (Scheme 
22). Treatment of the acetylene (60) with tributyltin hydride afforded a 2:1 
mixture of cis:trans vinyltin alkenes which underwent complete isomerisation 
to the trans form on heating in the presence of catalytic amounts of tributyltin 
hydride and azobis(isobutyronitrile). Addition of butyllithium afforded the 
vinyl anion which reacted with the sugar aldehyde (61) to produce a 3:1 
mixture of the allylic alcohols (62) and (63). 
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(a) Benzene, reflux; (b) Zn(BH 4 ) 2 , Et20; (C) 0s04 , NMO, THF, H20 
Scheme 21 
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1.3.2.6 Wittig approach to tunicamine 
Tunicamine has been synthesised by Zamojski and co-workers. 94 '95 
The key coupling step in the production of the eleven-carbon unit is the 
Wittig-Horner olefination of the D-galacto-dialdose (65) with diethyl (2-furyl)-
methoxymethylphosphonate (64) (Scheme 23). The E/Z mixture of adducts 
(66) was hydrolysed to a ketone which on reduction with K-Selectride gave a 
3.3:1 mixture in favour of the required alcohol (67). Known conversion 96 of 
the furfuryl alcohol to a ribose unit, with trapping of the -anomer 
(BzBr/Ag 20) of (68) (required to direct the subsequent catalytic osmylation) 
led, after isopropylidene protection, to ketone (69). Stereospecific sodium 
borohydride reduction, spontaneous pyranose to furanose rearrangement on 
debenzylation and azide to amine reduction gave partially protected 
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(70) 
(a) LDA, -78°C ; (b) (i) pyrdinium-p-toIuenesuIphonate; (ii) K-Selectride; (C) Br2 , acetonitrile, 
H 20; (d) (i) BnBr, A9 20; (ii) 0s04, AgCI03 ; (iii) DMP, TsOH; (e) (i) NaBH 4, -78°C; 
(ii) 5% Pd/C, EtOH 
Scheme 23 
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1.3.2.7 Convergent Nitroaldol Approach 
The first application of the coupling of nitro sugars to sugar 
aldehydes for the construction of long chain sugars was reported by Suami 
et a!,97 and is exemplified in the synthesis of protected tunicamine 98 
(Scheme 24). Potassium fluoride mediated addition of the 5-nitroribose 
derivative (72) to the amino dialdose (71) afforded a single diastereomer 
(73), the absolute stereochemistry of which was not determined. 
Dehydration and reduction removed the C-6 hydroxyl, and nitro to hydroxyl 
conversion was achieved using permanganate oxidation followed by sodium 
borohydride reduction and hydrolysis, to give a 2:3 mixture of diastereomers 
in favour of required product (74). Deprotection and acetylation gave a fully 
protected tunicamine derivative (75). Later conversion 99 to tunicamycin was 
also demonstrated. Similar approaches have been used by Rapoport et 


























(a) KF, acetonitrile; (b) (i) Ac 20, pyridine, CHCI 3 then NaBH4 ; (ii) KMn04 , N aOtBu , 
NaBH4 then NaOMe; (c) aq. acetic acid, reflux then acetylation 
Scheme 24 
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1.3.2.8 Enzymatic Approaches 
The use of enzymes in carbohydrate synthesis overcomes both 
regio- and stereospecificity problems and also the need for protection and 
deprotection steps. 102 Fructose- 1,6-di phosphate  aldolase (FDP) isolated 
from rabbit muscle, which in nature catalyses the stereospecific aldol 
reaction between dihydroxyacetone phosphate (DHAP) and D-
glyceraldehyde-3-phosphate, has been well explored. The studies show that 
FDP is quite specific for DHAP, but will accept a variety of aldehydes 
enabling potential syntheses of various carbohydrate analogs. Whitesides 
et aI 03 demonstrated the use of aldehydo pentose and hexose 
monophosphate substrates to furnish octose and nonose sugars 
stereospecifically. This is exemplified in the conversion of mannose-6-
























1.3.2.9 Radical Coupling Approach 
Carbohydrates have been chain extended with varying degrees of 
success via tributyltin hydride induced radical coupling of terminal iodo-
sugars to alkenes. 104  A convergent radical coupling between a sugar based 
allylic alcohol and an aldehydo nucleoside formed the basis of a further 
39 
approach to tunicamycins. Myers 105 prepared the silicon bridged adduct 
(78) which was suitably disposed for radical coupling between the 0-5 and 
C-i' carbons (Scheme 26). Tributyltinhydride promoted cyclisation and 
subsequent siloxane hydrolysis afforded the 0-5 epimers of the 
tunicaminyluracil in a ratio of, at best, 4:1 with the required 5R isomer (79) 
predominating. The subsequent conversion to a N-deacylated tunicamycin 
has also been reported. 106 
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1.3.2.10 Miscellaneous Approaches 
Other chain extension routes which have been explored for higher 
carbon sugar synthesis include a diastereoselective three carbon extension 
of unprotected sugar aldehydes effected by indium (or tin) promoted addition 
of allyl bromide. 107 Ozonolysis of the resulting terminal double bond 
provides 2-deoxyaldoses. Matsumoto et aP°8 have demonstrated the 
conversion of an aldopentose to the corresponding 2-ketohexose by addition 
of formaldehyde and a catalytic amount of 3-ethylbenzothiazolium bromide in 
the presence of base. Extension of this route to the addition of aldehydes 
other than formaldehyde would provide a useful synthesis of higher sugars. 
In addition the formation of 3-hydroxysulphonyl sugars 109 from dialdoses 
provides the potential for their extension by generation of the carbanion, and 
attack on an appropriate aldehyde. The stereoselectivity of this latter 
process has not been reported. 
A convergent approach using allyl tin derivatives 110 and a directed 
a1do1 111 coupling of two sugar units have also been reported. 
Gallagher et al have reported 112 the condensation of a 
carbohydrate-based enolate precursor (80) to a dialdose (61) to build a C-li 
unit (81) which upon manipulation, including oxidative cleavage of the ether 
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(a) KOtBu,  THF, -78°C 	 (82) 
Scheme 27 
Paton et 0 13 have reported the synthesis of octose, nonose and 
decose monosaccharides using a nitrile-oxide cycloaddition to chain extend 
sugar-derived alkenes. The route is illustrated by the synthesis of octoses 
(90) and (91) (Scheme 28). Addition of ethoxycarbonylformonitrile oxide (83) 
to the six-carbon D-glucose-derived alkene (84) gave an 86:14 mixture of 
isoxazolines (85) and (86) respectively. The major isomer was converted 
through the sequence of ester reduction, catalytic hydrogenolytic isoxazoline 
ring cleavage and borohydride reduction of the resulting ketone (87) to the 
triols (88) and (89). Deprotection and acetylation of each triol provided the 
corresponding D-gluco-octopyranoses (90) and (91). 
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(I) NaBH 4, EtOH, THF; (ii) 10% Pd/C, H 2 , B(OH)3 , MeOH, H20; 
NaBH4, EtOH, H2O; (C) (i) TFA, H2O; (ii) Ac20, ZnCl2 
Scheme 28 
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1.3.3 Syntheses of Higher Sugars From Non-Carbohydrates 
1.3.3.1 Homologation of Tartrate-Derived Compounds 
Schreiber et al have reported 14 the first total synthesis of 
hikizimycin. Their procedure involves preparation of a protected form of 
hikosamine by a two-directional chain synthesis strategy, followed by 
attachment of the cytosyl and kanosamine units. The route to the eleven 
carbon portion involves the simultaneous addition of a two-carbon unit to 
both ends of a four-carbon unit, differentiation of one end of the resulting 
eight carbon fragment to which one-carbon is added while a two carbon unit 
is attached to the opposite end. The key repeating step in this sequence is 
a stereoselective olefination-osmylation (see Section 1.3.2.3) to yield a diol 
with predictable stereochemistry. 78 
L-(+)-diisoprOpyl tartrate, with the same stereochemistry as the C6-
C7 centres in hikosamine, was selected as the starting four carbon unit for 
double ended extension (Scheme 29). The protected tartrate (92) 
underwent a one pot reduction/Horner-Emmons olefination to afford an a,13-
unsaturated ester which was hydroxylated to a protected hexitol (93) with 
high diastereofacial selectivity (12.9:1 at each double bond). A selective 
DIBAL reduction followed by a Swern oxidation to an aldehyde at one of the 
terminal ester groups differentiated the terminii thus enabling their 
sequential extension. A Tebbe olefination introduced a vinyl group at the 
aldehyde end, then subsequent reduction, oxidation and Horner-Emmons 
olefination at the ester terminus established the eleven carbon framework 
(94). Catalytic osmylation in the presence of a chiral amine catalyst 
afforded, after suitable protecting group manipulation (to increase the anti 
diastereoselectivity of the osmylation), the tetraol (95) as 75% of a 
diastereomeric mixture. A further series of protection, deprotection and 
44 
reduction steps enabled the introduction of an azide group at 0-4 (via triflate 
displacement with inversion) and formation of the pyranose ring to give the 
differentially protected hikosamine precursor (96). Subsequent addition of 
the cytosyl and kanosamine units, azide reduction and deprotections 
afforded hikizimycin. 
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(95) 
(a) (i) NaH, BnBr; (ii) DIBAL, Horner-Emmons reagent; (b) (I) 0s0 4 , NMO; (ii) TBSOTf, 
2,6-dimethylpyridine; (c) DIBAL; (d) Swern oxidation; (e) (i) Tebbe reagent; (ii) DIBAL; 
(iii) Swern oxidation; (iv) Horner-Emmons reagent;(f) (i) Bu 4 1NIF (ii) H2SO4,  acetone; 
(iii) Os04 , NMO, chiral catalyst 
Scheme 29 
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A related homologation of tartrate-derived enals affording long-chain 
polyols in a highly stereoselective manner has been investigated recently by 
Marshall et al. 115 The methodology is illustrated in Scheme 30. (S)-Silyloxy 
allylic stannane (98) added stereospecifically to the tartrate-derived enal 
(97), in the presence of boron trifluoride diethyletherate to afford diene (99) 
in 93% yield. Stereospecific catalytic osmylation (0s0 4/NMO) in the anti 
sense 116 yielded a tetraol which after deprotection and acetylation resulted 
in the nonaacetate (100). This procedure was also applied 115 in a 
bidirectional sense using (R)-silyloxy allylic stannane to afford a polyol, 
comprising sixteen carbons, as the major product. 
TBSO SnBu3 
TBSO—" ° + 
(97) 	 (98) 	
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1.3.3.2 Total Synthesis from 'Naked Sugars' 
Vogel et a!117 have employed 7-oxabicyclo[2.2.1]hept-5-en-2-yl (7-
oxanorbornenyl) derivatives in their 'naked sugar' approach to higher sugars. 
These enantiomerically pure bicyclic compounds are readily accessible 118 
from Diels-Alder cycloaddition of furan with camphonyl-substituted 
M. 
dienophiles; the camphanic acid is recoverable and re-usable. The naked-
sugars can be stereoselectively functionalised and modified 119 to provide a 
variety of versatile derivatives suitable for manipulation to carbohydrates and 
other natural products. Vogel has successfully utilised these 'naked sugar' 
derivatives in several varied routes to higher sugars. 
One route 117 involves the stereospecific titanium tetrachloride 
promoted cross-aldolization of derivative (101) with 2,3-0-isopropylidene-D-
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(105) 	 (106) 
(a) TiCI4 ,CH2Cl2 , -78°C; (b) MCPBA; (C) (i) LiAIH 4, THF; (ii) acetic acid, H 2O, 60°C 
Scheme 31 
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The exo facial attack is typical of such bicyclic systems and the 
stereochemistry at the new C-i' centre is consistent with that predicted by a 
Felkin-Cram transition 	state 	modeL 120 This highly functionalised aldol 
product was readily converted via the lactone (103) to the ketone (104) 
which could be reduced with varying degrees of selectivity to afford, after 
deprotection, a mixture of the isomeric octoses (105) and (106). 
An alternative route 121 to octose (105) involved a highly 
chemoselective Wittig-Horner olefination of a hemiacetal derived from the 
'naked sugar' derivative (107) (Scheme 32). The resulting major alkene 
(108) underwent stereoselective allylic bromination, intramolecular bromine 
displacement, dihydroxylation and deprotection en route to the desired 
octose (105). 
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(107) 










(a) - (e) 
CO2Me 
(108) 
(a) (I) NBS, CCI4 , hv; (ii) A9 20, DMF; (b) Os04, NMO; (C) DMP, TsOH; 
(d) LiBH4 , THF; (e) TFA, H 20, 2000 
Scheme 32 
A further variation of the 'naked sugar' approach is illustrated in the 
recently reported 122 synthesis of an undecose unit related to the 6,10- 
anhydro-5-deoxy-undeculofuranosiduronic acid found in the herbicidins. 
The 7-oxanorbornenyl derived lactone (109) underwent a condensation 
reaction with the sugar aldehyde (110) to afford the branched dodecose 
(111) as the major product (no isomer ratio quoted) (Scheme 33). A multi-
step conversion to the undecose (112) was then performed. 
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1.3.3.3 Diets-Alder Cycloaddition Approach 
The total synthesis of higher sugars has been carried out effectively 
by Danishefsky and co-workers. The approach 62 involves two parts - A: the 
stereoselective and regiospecific formation of functionalised dihydro--y -
pyrones through the Lewis Acid catalysed cyclocondensation of substituted 
siloxydienes with chiral aldehydes; and B: stereoselective functionalisation 
49 
in the pyranoid ring using established procedures and/or stereoselective 
side chain extension (Scheme 34). Almost any pattern of functionalisation 
and associated stereochemistry may be built up using the appropriate 
starting dienes and aldehydes together with subsequent transformations. 
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Scheme 34 
This strategy has been used 123 in the total synthesis of a protected 
hikosamine which is now outlined (Scheme 35). The D-galactose-derived 
dialdose (32) (which has also been totally synthesised using this 
methodology 123) was converted to a mixture of epimeric nine carbon 
alcohols (15:1) using a modified 124 (BF3.Et20 catalysed) Sakurai reaction 
(ally ltri met hylsilane addition). A series of reactions cleaved the major isomer 
of this nine carbon system to the desired seven carbon aldehyde (113). 
Stereospecific cyclocondensation of compound (113) with the substituted 
siloxy diene (114) in the presence of magnesium bromide as Lewis acid 
afforded the adduct (115). Luche reduction (NaBH 4/CeCl3) of the carbonyl to 
an equatorial hydroxyl, followed by double bond hydroxylation using MCPBA 
and deacylation afforded the fully functionalised undecose (116). The new 
pyranose ring was unravelled by reduction and the free hydroxyls 
benzylated. Deprotection of the original pyranose and benzoylation of all 
except the 0-4 hydroxyl (a consequence of its axial orientation) was 
subsequently achieved. The C-4 hydroxyl was then replaced, with inversion, 
by an amino group via mesylation and azide displacement. Finally, complete 
HO OH 
OBn 








deprotection and acetylation afforded methyl a-peracetylhikosaminide (117). 
Lincosamine, 125 KDO, 126 NANA127 and the tunicaminyluracil unit 128 have 
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1.4 	Azasugar Glycosidase Inhibitors 
1.4.1 Glycosidases 
Glycosidases (glycoside hydrolases) are one of the most important 
classes of carbohydrate processing enzymes, catalysing the hydrolysis of 
glycoside linkages in oligosaccharides, polysaccharides and 
glycoconjugates. As a result of their widespread involvement in extracellular 
and intracellular metabolic processes of most organisms they have 
warranted considerable biochemical study. The enzymes have been 
classified 129 according to the pyranosidic or furanosidic nature of the 
substrate and its anomeric configuration relative to that of the product 
('retaining' or 'inverting' glycosidases). In each instance the overall catalytic 
process is a nucleophilic substitution at the saturated anomeric carbon 
centre resulting in replacement of an aglycone residue by a hydroxyl group. 
1.4.2 Mechanism of Glycosidase Action 129 ' 130 
Some forty years ago Koshland proposed mechanisms to explain the 
action of retaining and inverting hydrolases and to this day they form the 
basis of the generally accepted pathways for glycoside hydrolysis. 
Retaining glycosidases are believed to act via a double 
displacement mechanism (Scheme 36) in which the glycosyl cation-like 
transition state (118) proceeds to a covalent glycosyl-enzyme intermediate 
(119). This in turn undergoes nucleophilic attack by water en route to the 
product. 
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An alternative to the covalent intermediate was proposed by Phillips and co-
workers. They postulated the existence of an ion-pair (Figure 9), formed 
between the glycosyl cation and enzyme-bound carboxylate, which was long 
enough lived to proceed to product without formation of the covalent 




Although there is less mechanistic data on inverting glycosidases they are 







An alternative pathway involving endocyclic C-O bond 
cleavage,  131,132  to produce an acyclic cationic intermediate, has also been 
OH 
A 
suggested (Scheme 38) based on theoretical considerations. However, it is 
54 
found to be at variance with many biochemical observations 133 and has not 
been generally accepted. 
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1.4.3 Role of Glycosidases in Glycoprotein Processing 134 
The oligosaccharides attached to proteins influence their 
conformation, solubility and functional properties, as well as being implicated 
in cell-to-cell recognition events. Glycosidases are involved in the 
processing of these oligosaccharides (together with those of other 
glycoconjugates). In the particular case of Winked (through asparagine) 
glycoproteins their role is to modify their Glc 3Man9(GIcNAc) 2 precursor once 
it has been transferred from the lipid carrier, dolichol pyrophosphate, to 
specific asparagine residues of the growing polypeptide chain. Both 
glycosidases and glycosyltransferases are involved in this processing: cx-
glucosidases I and II and various a-mannosidases 'trim' the precursor in 
specific ways (Scheme 39), while glycosyltransf erases add fructose, 
galactose, N-acetylglucosamine and sialic acid as appropriate. The 
resulting oligosaccharide structure depends on the polypeptide as well as 
the enzymes expressed in the cell in which it is synthesised. Despite the 
diversity of possible structures the same pentasaccharide core, 
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Scheme 39 
1.4.4 Glycosidase Inhibitors 
One particular class of compounds that has shown potent and 
reversible glycosidase inhibitory activity is the azasugars. 135137 These are 
derivatives of pyranose or furanose sugars in which the ring oxygen atom is 
replaced by an imino group and include the monocyclic polyhydroxylated 
piperidines and pyrrolidines, together with the bicyclic polyhydroxylated 
indolizidines and pyrrolizidi nes. Approximately twenty-five naturally 
occurring azasugar glycosidase inhibitors have been isolated 138 and many 
analogues have been synthesised. 
Nojirimycin 139 (120), the azasugar analogue of D-glucose, was the 
first azahexose to be isolated and it was subsequently found to be a general 
glucosidase inhibitor. Its 1 -deoxy derivative, 1 -deoxynojirimycin (1 -DNJ) 
56 
(121), was not only more stable but also a potent inhibitor. Similarly other 1-
deoxyazasugar analogues of the pyranose monosaccharides were found, in 
general, to inhibit the corresponding glycosidase (an exception 140 is 
deoxyrhamnojirimycin which exhibits no inhibition of a-L-rhamnosidases). In 
contrast the structural resemblance of the pyrrolidine and bicyclic azasugars 
to the glycosidase inhibited is not so obvious.. For representative examples 
of glucosidase and mannosidase inhibitors see structures (121)-(127). For 
further examples of azasugars and other types of glycosidase inhibitors the 
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1.4.5 Applications of Glycosidase Inhibitors 137 
1.4.5.1 Digestive Glycosidases 
Intestinal glycosidases are involved in the breakdown of dietary 
carbohydrates allowing absorption and utilisation by the organism in 
question. It has been demonstrated 142 that the controlled inhibition of 
intestinal cx-glucosidases reduces the rate of monosaccharide uptake and 
hence aids the regulation of blood glucose levels. Acarbose, 13 a pseudo-
tetrasaccharide, incorporating an amino linkage, is an effective inhibitor of 
such enzymes (e.g. sucrase and maltase). Its use, and that of other 
disaccharidase inhibitors, has been suggested in the treatment of diabetes 
mellitus. 
In the agrochemical industry the differential inhibition, by azasugars, 
of intestinal glycosidases between different insect species offers the 
potential for their development as selective insecticides. 144  
1.4.5.2 Affinity Chromatography 
Attachment of selective but reversible binding inhibitors to a 
chromatographic support offers the possibility for the separation and hence 
purification of glycosidases. Indeed N-carboxypentyl-1-nojinmycin has been 
successfully used as a chromatographic ligand for the purification of 
glucosidase 1.145 
1.4.5.3 Anti-HIV 
Although all viruses possess envelope glycoproteins those of the 
HIV virus are found to be especially heavily N-glycosylated. For example 
gpl 20, found on the surface of the AIDS virus, possesses 20-25 potential N-
glycosylation sites per molecule. These oligosaccharide chains are 
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implicated in the binding of the gpl 20 with the CD-4 target cell of the host, a 
process which initiates an infectious cycle. 146 ' 147 A number148 ' 149 of imino 
sugars including 1 -deoxynojirimycin (121), castanospermine (123) and 
(2R,5R)-dihydroxymethyl-(3R,4R)-dihydroxypyrrolidine (124) have been 
shown to possess anti-HIV activity. This action is believed to be a 
consequence of their ct-glucosidase inhibitory properties resulting in an 
interruption 150 ' 151 of the glycoprotein processing pathways and, as a 
consequence, production of abnormal glycans and in particular changes to 
gp120. The altered oligosaccharide chains on gp120 may interfere with 
recognition processes or at least lead to the incorrect conformation of the 
gpl 20/CD-4 complex. In this way, it is postulated, viral infectivity is reduced. 
Current interest is focused on N-butyldeoxynojirimycin (122) which 
has shown exceptional 148 anti-HIV activity in vitro and is at present 
undergoing Phase-IT clinical trials. Interestingly, it has only recently been 
shown that its known glucosidase I inhibition occurs at anti-viral 
concentrations. 152  This observation supports the above mode of action or at 
least suggests that it may be a contributing factor towards its activity. 
Furthermore, it is thought that the host cell proteins may be able to engage 
alternative glycosidases to counteract the effect of such inhibition thereby 
remaining unaffected. 
1.4.5.4 Anti-cancer 
Glycosidase inhibitors have also been demonstrated to possess 
potential chemotherapeutic benefit in the treatment of cancer; e.g. 
swainsonine 1 (126) and castanospermine 154 alter tumour properties in 
vitro and in vivo. Again this action is presumed to result from interference of 
N-glycoprotein processing. 
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Tumour cells possess abnormal oligosaccharide structures with 
increased branching and larger chains, due to altered endocellular 
glycosyltransferase activity. These altered glycans are associated with the 
metastatic 55 capability of a cell, i.e. the process whereby malignant cells 
migrate from their site of origin, via the circulatory or lymphatic systems, to 
set up tumour colonies at secondary sites. Glycosidase inhibitors may be 
able to prevent the formation of large complex N-linked glycans and 
therefore interfere with the tumour/target cell recognition processes. As 
such they have potential as anti-cancer agents. 
1.4.6 Mode of Action of Glycosidase Inhibitors 
It is postulated 129 ' 130 that azasugar inhibitors act by imitating the 
glycosyl cation-like transition state invoked in the mechanistic pathway of 
glycosidase action (Section 1.4.2). Structure-activity relationship 
studies141 ' 156 coupled with molecular modelling 157,158  have been used to 
probe the structural and electronic properties required for particular 
inhibitory activities. To date most work has focused on the characteristics of 
glucosidase inhibitors. Some general observations will be noted. 
For six-membered ring azasugars, which exist in a chair 
conformation, the hydroxyl group topography strongly dictates the enzyme 
inhibited. Often epimerisation at only one centre can completely alter the 
inhibitory action, e.g. 1-deoxynojirimycin (1-DNJ) is a glucosidase inhibitor 
whereas its C-2 epimer 1-deoxymannojirimycin (1-DMJ) inhibits 
mannosidases. However, for the 5-membered ring azasugars, which 
resemble the flattened half-chair conformation of the glycopyranosyl cation, 
the hydroxyl group topography required to inhibit a particular glycosidase is 
more relaxed, e.g. a-L-fucosidase is inhibited by several isomeric 5- 
9 
membered ring azasugars. Presumably the greater resemblance to the ring 
conformation of the glycopyranosyl cation overrides any lack of correct 
hydroxyl group topography in the binding of these azasugars to the enzyme. 
A fuller understanding of the mechanism of action and active site 
topography of the various glycosidase enzymes is still required before 
specific new inhibitors can be designed reliably. 
1.4.7 Syntheses of Azasugars 
The potential therapeutic benefits of azasugar glycosidase inhibitors, 
coupled with their role in further probing the effects of modified glycoprotein 
processing (e.g. understanding recognition processes), has resulted in 
significant efforts to develop efficient and stereoselective routes to such 
compounds and their analogues. Indeed, more potent and specific inhibitors 
are still sought. Since Paulsen's early repo rt 159 concerning 
monosaccharides possessing a ring nitrogen atom, many mono- and bicyclic 
analogues have been prepared. Fleet has produced a short account 160 
highlighting some aspects of his strategy, while an in-depth review of the 
enzymatic approach 142 to azasugars is also available. However, no general 
review of the methods employed for their synthesis has been published. The 
following account will therefore present, in some detail, the recent 
procedures used for the formation of monocyclic azasugars. The first 
section deals with their preparation via the modification of carbohydrates, 
while the second covers the many varied non-carbohydrate based 
approaches. A short summary of the chemoenzymatic route follows and 
finally a miscellaneous section, covering work not categorised elsewhere, is 
presented. 
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1.4.7.1 Syntheses from Carbohydrates 
1.4.7.1.1 Approaches via sugar azides 
Fleet and co-workers have carried out an extensive study into the 
synthesis and glycosidase inhibition of both monocyclic and bicyclic imino 
sugars with the aim of building up a picture of structure-activity relationships 
for such systems. In the monocyclic series they have successfully 
synthesised various iminopentitols, 161 iminohexitols 162 and iminoheptitols 163 
from suitably protected sugars and sugar lactones. The strategy involves 
reduction of a suitably substituted azido sugar. The resulting amino group 
then intramolecularly displaces a suitably positioned leaving group (e.g. 
mesylate, tosylate or trif late) with inversion of configuration, or undertakes 
an intramolecular reductive amination to afford, in both cases, the new 
nitrogen containing heterocyclic ring. The following examples illustrate 
many of the features of Fleet's approach. 
1-DMJ was synthesised 164 from L-gulonolactone in an overall yield 
of 25% (Scheme 40). Selective hydrolysis of the 5,6-0-isopropylidene 
group of 2,3:5,6-di-Q-isopropylidene-L-gulonolactone (128) afforded the diol 
(129), the primary hydroxyl of which was protected as the tert-
butyldimethylsilyl ether while the secondary hydroxyl was converted to the 
trif late. Displacement of the triflate by azide gave compound (130) which 
upon hydrogenation rearranged to the &lactam (131). Reduction and 


























(131) 	 (130) 
(a) aq. acetic acid, 30°C; (b) TBDMSCI, imidazole, DMF, -40°C; (C) Tt20, pyridine, -30°C; 
(d) NaN3 , DMF; (e) H2 , 10% Pd-C, MeOH; (f) Borane/Me2S; (g) TFA/H 20 then HCI 
Scheme 40 
An alternative synthesis 165 from diacetone-D-glucose afforded 1-DMJ in an 
overall 35% yield (Scheme 41). The azido compound (133), formed from 
diacetone-D-glucose by a series of standard transformations, was converted 
to the wo mixture of furanosides (134) separation of which was not 
necessary for the subsequent reaction sequence. Introduction of the trif late 
group at 0-2 followed by azide reduction with triphenylphosphine enabled 
intramolecular cyclisation to the bicyclic amine (135). Cleavage of the 
original furanoside ring via hydrolysis to the lactol and subsequent reduction 
gave the diol (136) which on deprotection gave 1-DMJ. 
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(a) HCI, MeOH; (b) Tf20, pyridine; (c) Ph 3 P then aq. K2CO3;  (d) CbzCl, Na2CO3 ; 
(e) TFA/H 20; (f) NaBH 4, aq. EtOH 
Scheme 41 
The iminoheptitol, 6-epi-a-L-homofuconojirimycin (139), has also 
been synthesised 166 by Fleet et a!, with the C-N ring closure brought about 
by an intramolecular reductive amination. The route is outlined in Scheme 
42. The azidolactone (137) is chain extended to the heptulose (138) by 
addition of methyllithium. Reduction of the azide, subsequent intramolecular 
reductive amination, the stereochemistry of which is directed by the steric 
bulk of the tert-butyldimethylsilyl protecting group, and deprotection affords 
the iminoheptitol (139). 
Similar azide reduction and in situ intramolecular reductive amination 
has been employed by Furneaux et al in the synthesis of 1 ,5-dideoxy-1 ,5-
imino-D-galactitol 167 and 1 ,5-dideoxy-1 ,5-imino-D-mannitol (1-DMJ) 168 from 
carbohydrate starting materials. 
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(a) MeLi; (b) H2, Pt02 ; ( C) aq. TFA 
Scheme 42 
1.4.7.1.2 Other intramolecular cyclisations via mesylate displacement 
Buchanan, Wightman et al have synthesised 169 a number of 1,4-
dideoxy-1,4-imino-pentitols and -hexitols via the intramolecular displacement 
of mesylate by nitrogen introduced via an oxime. The sequence of 
transformations involves (a) oximation at C-i of an appropriate sugar, (b) 
one step dehydration of oxime and mesylation at C-4 affording a nitrile 
mesylate, (c) intramolecular reductive cyclisation and (d) deprotection. Each 
of these steps is illustrated in the synthesis 169 of 1 ,4-dideoxy-1 ,4-imino-L-
talitol (141) from commercially available L-mannonolactone (140) (Scheme 
43). 
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(a) DIBAL, -78°C, 88%; (b) NH 20H, pyridine, 94%; (C) MsCI, pyridine, 63% 
(d) LiAIH4, ether, 45%; (e) TFA, H 20, 49% 
Scheme 43 
Wig htman 170 has also reported the syntheses of 1 ,4-imino-hexitols 
and -octitols through a different sequence of transformations: (a) Wittig 
extension at C-i to afford an a,3-unsaturated ester, (b) mesylation of a free 
hydroxyl at the original C-4, (C) stereoselective conjugate addition of 
ammonia followed by intramolecular cyclisation, (d) ester reduction and (e) 
deprotection. Each of these steps is illustrated 170 in the synthesis of 1,4,5-  
trideoxy-1 ,4-imino-L-/yxo-hexitol hydrochloride(143) (Scheme 44). The 
pyrrolidine (142) was accompanied by a smaller quantity of its C-3 epimer 
(9:1 mixture) due to incomplete stereospecificity in the conjugate ammonia 
addition. The major product of ammonia addition, for both Z- and E-isomers, 
has a threo relationship with the vicinal OR group, which was rationalised by 
Buchanan and Wightman 170 in terms of the Cornforth-model (Figure 10). 
The formation of a 1 ,4-iminoheptitol en route to a hydroxylated 
pyrrolizidine via a route incorporating a nitrone cycloaddition has also been 
reported by Wightman. 171 
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1.4.7.1.3 Synthesis from dibromolactones 
	
A 	number 	of 	1 ,4-dideoxy-1 ,4-iminohexitols 	have 	been 
synthesised 72 ' 173  in two steps from 2,6-dibromo-2,6-dideoxyhexono-1 ,4-
lactones without the need for hydroxyl protection. These 
bromodeoxylactones, obtained by the action of hydrogen bromide in acetic 
acid on aldonolactones, are reduced to the corresponding 2,6-
dibromohexitols which on addition of aqueous ammonia undergo ring closure 
via epoxides resulting in iminohexitols. The details of this sequence are 
exemplified in the synthesis 172 of 1 ,4-dideoxy-1 ,4-imino-L-allitol which was 
isolated as its hydrochloride salt (144) (Scheme 45). 












1.4.7.1.4 One step nitrogen introduction and cyclisation 
The nitrogen containing ring has also been formed by 
stereospecific formation of both N-C bonds in one step. Shing 174 ' 175 was 
the first to report such an approach. The D-mannitol-derived 2,5-ditriflate 
(145) underwent nucleophilic substitution with hydrazine or ammonia to 
afford the cyclised products (146) and (147) respectively. On deprotection 
of each the 2,5-iminohexitol (148) was obtained (Scheme 46). Fleet 176 et al 
have reported a parallel approach to a 1 ,4-iminohexitol using a 1,4-
dimesylate derived from D-mannitol, with benzylamine as the nucleophilic 
reagent. The method is further exemplified 177 in the cyclisation of protected 
TFA/ H20 




1 ,5-dimesyl-D-glucitol (149) to the six-membered ring azacycle (150) 
(Scheme 47) and in the formation of 1 ,4-dideoxy-1 ,4-imino-L-lyxitoL 70 
0— 


















BnO 	Bn 	 HO 	H.HCI 







OBn 	 BnO 	OBn 	 HO 	OH 
(149) (150) 
Scheme 47 
A similar one step cyclisation of a diketo sugar, by a double reductive 
amination, gives access to polyhydroxylated azacycles 178 ' 179 with the 
advantage that protecting groups are not required, and indeed were found to 
be undesirable if high stereoselectivities were to be obtained. Commercially 
available 5-keto-D-fructose (151), in the presence of benzhydrylamine and 
sodium cyanoborohyd ride, afforded 179 the pyrrolidine (152) together with 
smaller quantities of the other possible isomers (86:14) (Scheme 48). The 
high selectivity was attributed to neighbouring hydroxyl group assistance in 
the cyclic imine precursor. It should be noted that this latter series of 
reactions enables formation of N-substituted azacycles directly by use of the 
appropriate amine nucleophile. 
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1.4.7.2 Syntheses from Non-Carbohydrates 
1.4.7.2.1 Thiazole Route 
A number of azahexoses (gatactostatin 180 , (-)- 3-deoxynojirimycin 
and 	(-)-3-deoxymannojirimycin , 181 1 82 	(-)-nojirimycin 	and 
mannojirimycin 182 ) have been synthesised by application of the 'Thiazole 
Route' developed by Dondoni 61 (for 'Thiazole Route' to higher sugars see 
Section 1.3.2.1). The key feature of this approach involves an overall three 
carbon elongation of a D- or L-serine derivative by stereoselective addition of 
one or more 2-substituted thiazoles. 	Available reactions include: 
nucleophilic substitution by 2-lithiothiazole or 2-tri met hylsilylthiazole (2-TST) 
(both result in 1 C extension), aldol condensation with 2-acetylthiazole 
(2-AU) 	(3 	C 	extension), 	Wittig 	reaction 	with 	2- 
thiazolylmethylenetriphenyiphosphorane (2-TMP) (2 C extension) or 2- 
Boc 











thiazolylcarbonylmethylenetriphenylphosphorane (2-TCMP) (3 C extension). 
The final step involves, in each instance, thiazole to formyl deblocking and 
nitrogen deprotection resulting in ring closure to establish a 
polyhydroxylated piperidine. 
The use of 2-ATT in a stereodivergent application  181,182  of the 
'Thiazole Route' will serve as an illustration of this approach (Scheme 49). 
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(a) t-BuOLi, THF, -40°C; (b) NaBH 4, Et2BOMe, THF, MeOH, -78°C; 
(C) Me4NBH(OAc)3 , MeCN, AcOH, -35°C; (d) NaH, PhBr, DMF; (e) Mel, 




Anti-selective addition of 2-AU (154) to the L-serine derived aldehyde (153) 
gave a 4:1 mixture of f-hydroxyketones with (155) predominating. 
Stereospecific reduction (2 95:5) of the major adduct to the syn 1 ,3-diol 
(156) using sodium borohydride and diethylmethoxyborane, followed by the 
sequence of hydroxyl protection, thiazole to formyl conversion and 
isopropylidene deprotection afforded the protected (-)-3-deoxynojirimycin 
(157). Stereospecific reduction (2t 95:5) of the major adduct (155) with 
tetraethylammonium triacetoxyborohydride afforded the anti 1 ,3-diol (158) 
which by the same sequence of transformations furnished the protected (-)-
3-deoxymannojirimycin (159). 
1.4,7.2.2 Butenolide approach 
Casiraghi et al have applied their 'Butenolide Route' (see Section 
1.3.2.2) to the preparation of an iminoheptitol 183 (Scheme 50). In this 
instance, boron trifluoride etherate promoted addition of 2-
(trimethylsiloxy)furan (TMSOF) to an imine (160), which provides the 
nitrogen source, afforded a 1:1 mixture of butenolides. This contrasts with 
the equivalent addition of TMSOF to the corresponding aldehyde which 
proceeded with high diaste reose lectivity (>95:5). 69  Base-catalysed 
benzyloxycarbonyl nitrogen protection resulted in equilibration to the D-ribo-
isomer (161) which was converted by cis-hydroxylation and protection to the 
lactone (162). Subsequent nitrogen deprotection was accompanied by 
rearrangement to the S-lactam. Further reduction using borane 
dimethylsulphide complex afforded the protected iminoheptitol (163). 
Deprotection gave the free base in 9% yield overall. For the application of 
this route to the synthesis of poly hydroxyindolizidines 184 and the use of a 
nitrogen analogue of TMSOF, 2-(tert-butoxycarbonyl)-2-(tert- 
72 
butyldimethylsiloxy)-pyrrole ,185 for the synthesis of polyhydroxypyrrolidine 
derivatives the reader is referred to the relevant literature. 
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(a) BF3 .OEt2 ; (b) CbzCI, aq. NaHCO 3 ; (c) KMn04 , DCH-crown-6, then DMP, TsOH; 
(d) H 2 , Pd(OH)2 ; (e) BH3 .Me2S 
Scheme 50 
1.4.7.2.3 Nitroaldol and nitrile oxide-furan approaches 
Jager et al have demo nstrated 186187 the use of the nitroaldol 
(Henry) reaction for the construction of iminopolyols. 
Addition of the nitro compound (165) to the diethyl tartrate derived 
aldehyde (164) in the presence of tetrabutylammonium fluoride trihydrate 
afforded an 88:12 mixture of diastereomers (166) (Scheme 51). Nitro to 
amino conversion followed by intramolecular displacement of a tosylate, 
introduced previously at the primary hydroxyl, afforded an 88:12 mixture of 
hydrotosylates (167). Separation was achieved after N-benzoylation and the 
73 
major diastereoisomer converted through aldehyde deprotection and 



































(a) Bu4NF.3H20, THF, -78°C to -5°C; (b) H 2 , Pd/C, MeOH; (c) CbzCI, NaHCO 3 , H2O; 
(d) TsCI, pyridine /ether; (e) (i)HCI, THF (ii) NaBH 4, EtOH (iii) H 2 , Pd/C, MeOH 
Scheme 51 
A recent communication 187  of particular relevance to the present 
work outlines the nitrile oxide-furan route to iminopolyols. Addition of the 
nitrile oxides derived from hydroximoyl chlorides (169) or (170) to furan 
afforded, in each instance, a 1:1 mixture of isoxazolines, from which either 
five- or six- membered ring azasugars could be obtained (Scheme 52). For 
example, hydroxylation of the remaining furan double bond, followed by 
periodate cleavage and selective tosylation of the primary hydroxyl, gave 
isoxazoline (171). Deprotection and stereoselective non-hydrolytic 
isoxazoline ring cleavage with subsequent intramolecular cyclisation 
afforded the 1 ,4-iminoheptitol (172). 	The other diastereoisomer was 
74 
similarly transformed with excellent stereoselectivity (>95:5) to an isomeric 
(at C-2, C-3 and C-4) iminoheptitol. 
Alternatively, direct isoxazoline cleavage to the amino alcohol after 
double bond hydroxylation gave access to the six membered ring azasugar 
(173) via in situ intramolecular reductive amination. The stereoselectivity 
was excellent (>95:5) in the case illustrated, but lower (70:30) in the case of 
the other diastereoisomeric adduct. The absolute configuration at C-5 was 
not reported in these latter cases. 
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Scheme 52 
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1.4.7.2.4 Diels-Alder cycloaddition approach 
A Diels-Alder cycloaddition has also been utilised for the 
construction of racemic polyhydroxylated piperidines. 188  
Cycloaddition of an (E,E)- and (E,Z)-diene mixture (174) (4:1 
respectively) with the acylnitroso dienophile (175), obtained in situ from the 
corresponding hydroxamic acid, afforded the major adduct (176) as expected 
from reglo- and stereoselective addition to the major (E,E)-diene (Scheme 
53). The piperidine ring was obtained after stereospecific cis-hydroxylation, 
hydrogenolytic N-O bond cleavage and aldehyde deprotection. The initially 






















1.4.7.2.5 Total synthesis from tartrate-derived chiral allylic alcohols 
Access to both monocyclic and bicyclic 189 azasugars by 
elaboration of the chiral allylic alcohol (178) has been achieved by Kibayashi 
et al. This non-carbohydrate precursor unit is readily obtained from diethyl 
L-tartrate in six steps 190  (Scheme 54). Its subsequent transformation 
involves, as the key steps, stereoselective epoxidation followed by regio-
and stereoselective epoxide opening. The syn epoxide 90 (179) may be 
obtained by Sharpless' epoxidation (with diethyl L-tartrate) and the anti 
76 
epoxide 191 (180) by use of meta-chloroperbenzoic acid (70:30 mixture). 
Introduction of nitrogen is achieved directly or indirectly via epoxide opening 
for which three routes have been described (Scheme 54). Manipulation of 
the terminii (with possible chain extension 192) to incorporate an aldehyde or 
mesylate group establishes the correct functionalities for ring closure on 
amino release as illustrated 193 in the synthesis of (+)-galactostatin (182) and 
(+)-1-deoxygalactostatin (183) from (181) (Scheme 55). 
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Scheme 55 
1.4.7.2.6 Total synthesis from 'Naked Sugars' 
The elaboration of 'naked sugar' derivatives (see Section 1.3.3.2) 
has been implemented by Vogel eta/in the construction of mono- 194195 and 
bicyclic- 195 ' 196 azasugars. An outline of the synthesis of an imino-octitol 195 
illustrates the strategy involved (Scheme 56). 
The uronolactone (184) was obtained 117 by a highly stereoselective 
cross-aldolisation and subsequent Baeyer-Villager oxidation in a route 
analogous to that in Scheme 31 (Section 1.3.3.2). Lactone ring cleavage 
under conditions favouring epimerisation gave a 0-5 epimeric mixture (10:1) 
in favour of (185). The silylated derivative underwent debenzylation and 
78 
azide introduction followed by Curtius rearrangement to an isocyanate 
which, on addition of benzyl alcohol, gave the carbamate (186). The 
protected imino octitol (187) was then obtained by desilylation followed by 
intramolecular reductive amination. 
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(d) N3PO(OPh) 2 , Et3N; (d) BnOH, 100°C; (e) Bu 4NF, THF 
Scheme 56 
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1.4.7.3 Chemoenzymatic Approach 
1.4.7.3.1 Aldolases 
For a recent account which outlines the use of aldolases in a 
combined chemical-enzymatic approach to the synthesis of azasugars, and 
which includes key references to the synthesis of specific five and six 
membered ring analogues by this strategy, the reader is directed to a review 
by Wong et al. 142 
The major input to this area has been from the groups of Wong 142 
and Effenberger. 197 They independently developed similar strategies based 
on the aldolase-catalysed construction of an azido sugar which subsequently 
undergoes intramolecular reductive amination to the azasugar. The 
approach, involving DHAP dependent aldolases, is summarised 198 in 
Scheme 57. The main features will be outlined briefly; specific examples are 
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The role of the aldolase is to produce an azido keto sugar by 
stereospecific aldol coupling of DHAP to the appropriate azido aldehyde. 
The stereochemistry of the new C-3/C-4 bond is wholly dependent on the 
aldolase used; e.g. fructose-i ,6-diphosphate always gives the (3S,4R) 
stereochemistry, whereas the other stereochemical combinations can be 
achieved by use of the appropriate aldolase: fucu lose- 1-phosphate, 
rhamnose-i-phosphate or tagatose-1-phosphate. A racemic mixture of 
aldehyde acceptors was usually employed. Since the enzyme reacts more 
rapidly with one enantiomer the reaction, when run under kinetic control, 
affords only one diastereomer (or at least predominantly one). The use of 3-
azido-2-hydroxyaldehydes results in six membered ring azasugars, while 
use of 2-azido-3-hydroxyaldehydes affords the five membered ring analogs 
after reduction. Intramolecular reductive amination, using Pd-C (Wong) or 
Pt-C (Effenberger) as catalysts, if carried out on the phosphate containing 
compound gives a dideoxyazasugar; however if carried out after phosphate 
removal affords the corresponding deoxyazasugar. The stereoselectivity of 
the latter process (especially in the six membered ring cases) is high. 
Hydrogen approach is deemed to be from the face of the intermediate imine 
opposite to any axial hydroxyls. Whitesides et aP 99 and Honek et ai200 have 
also reported use of the aldolase approach, the former employing a resolved 
aldehyde substrate, while the latter paid particular attention to purification of 
the rhamu lose- 1 -phosphate aldolase. 
Use of a four carbon aldehyde (3-azido-2-hydroxybutanal) rather 
than a three carbon aldehyde has also been demonstrated producing 
iminoheptitol products. 197 Finally a number of novel azasugars have been 
obtained by use of the non-DHAP dependent 2-deoxyribose-5-phosphate 
aldolase.20 
[;1 
1.4.7.3.2 Combined microbial oxidation and chemical synthesis 
The stereocontrolled functionalisation of halocyclohexadiene-cis-
diols coupled with their ready availability (now commercially) via microbial 
oxidation of halobenzenes by Pseudomonas putida 39D (Scheme 58) has 
led to their recent use in enantioselective syntheses. Isopropylidene 
protection of the diol affording (188) enables facial as well as double bond 
differentiation and hence a planned order of functional group introduction 
offers the potential for stereo- and regio-isomeric compound syntheses. 202 
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Hudlicky et a 03 have exploited the divergency of such a strategy in 
the synthesis of azasugars (Scheme 59). Regio- and stereo-selective 
epoxidation or cis-hydroxylation of (188), followed by azide introduction 
enabled the synthesis of three isomeric azido alcohols (189), (191) and 
(193). Controlled ozonolysis cleaved the remaining double bond, enabling 
ring closure to the lactams (190), (192) and (194) on azide hydrogenation. 
The lactams could then be transformed to the corresponding azasugars by 
carbonyl reduction as demonstrated by Fleet eta/(Section 1.4.7.1.1). 
Kinast and Schedel also report204 a combined microbial oxidation-
chemical transformation route to 1 -DNJ. 
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1.4.7.4 Miscellaneous Approaches 
Ganem et a!205 have converted naturally occurring hexoses to the 
corresponding azacycles via intramolecular aminomercuration of an 
intermediate amino alkene. A similar ring closure procedure has been 
employed by Liu et a!206 in the synthesis of an iminoheptitol. 
Vasella et a!207 prepared 1 -DNJ via intramolecular 1,3-dipolar 
cycloaddition of a sugar-derived azidonitrile followed by reductive cleavage 
of the resulting tetrazole. 
An intermolecular 1,3-dipolar cycloaddition between an azomethine 
ylide (generated thermally from an aziridene) and vinylene carbonate forms 
the key ring forming reaction in Takano's 208 route to iminopentitols. 
Myo-inositol has been converted 209 in a multi-step route to (+)- or 
(-)-nojirimycin, and pyroglutamic acid has been used as the nitrogen 
containing starting material for the syntheses 210 of 1-DNJ and 1-DMJ. 
2 	RESULTS AND DISCUSSION 
2.1 	Higher Carbon Sugars 
2.1.1 	Introduction 
Higher carbon monosaccharides containing seven or more 
consecutive carbon atoms provide the organic chemist with an interesting 
synthetic target. The potential biological activity of these compounds, 
especially when incorporated within larger structures, coupled with the 
challenge of developing stereoselective routes to such polyhydroxylated 
frameworks, has indeed attracted much attention. A variety of approaches, 
including iterative procedures, convergent and non-convergent Wittig 
reactions together with various total syntheses, have been utilised (see 
Section 1.3 for survey). Previous studies within our research group have 
illustrated the applicability of nitrile oxide cycloaddition (NOC) methodology 
for the construction of higher sugars 113 '211 (Section 1.3.2.10). The NOC 
route which is now widely used in natural product synthesis, 47 involves three 
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Firstly the cycloaddition of a nitrile oxide to an alkene provides a 2-
isoxazoline with predictable regio- and stereochemistry. In the second 
stage, if required, the side chains R 1 and R2 can be modified and additional 
substituents introduced at the 4-position of the heterocycle. Finally the 
isoxazoline nucleus itself is cleaved to unmask the functionality required. 
This strategy has been employed by Paton et 0 13 . 211 for the 
convergent syntheses of octose, nonose and decose monosaccharides. 
Coupling of a sugar-derived nitrile oxide to a terminal sugar alkene provides 
isoxazoline-bridged carbohydrate units which, by the correct choice of 
starting materials, would incorporate much of the stereochemistry of the 
target compound (Scheme 61). Subsequent manipulation of the isoxazoline 
ring, including ring cleavage affords the higher sugar. 
Sugar' 
HIGHER SUGAR 	> 
Sugar 	Sugar' 	
+ 
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Scheme 61 
The naturally occurring undecoses hikosamine and tunicamine, 
which are key subunits of the antibiotics hikizimycin 55 and tunicamycin 54 
respectively, have received much attention from the synthetic point of view. 
It was therefore proposed that the above methodology could be further 
applied to the target of eleven carbon monosaccharides. 
Construction of the eleven-carbon isoxazoline-bridged unit could be 
achieved through the cycloaddition of various combinations of nitrile oxides 
and alkenes, e.g. five-carbon nitrile oxides and six-carbon alkenes or six- 
carbon nitrile oxides and five-carbon alkenes, etc. However, a key factor 
MM 
which determines the particular choice, besides that of availability of the 
starting materials, is the attainment of selectivity in the cycloaddition step. 
The six-carbon D-xylo alkene (84) has been previously shown 113 '212 to fulfil 
this requirement in its addition to a variety of nitrile oxides (de - 70%) and 
was therefore selected for this purpose. The suitability of similar hex-5-
enofuranose derivatives (198) and (199), possessing the D-ribo and D-Iyxo 
configurations respectively, was also investigated by determination of the it-
facial selectivity obtained in their additions with benzonitrile oxide (195). 
The five-carbon D- and L-arabino se-de rived nitrile oxides (196) and (197) 
respectively, were chosen as the dipole components in our proposed route 
to 6-deoxyundecose derivatives, including that of the hikosamine framework, 
as outlined in Scheme 62. 
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2.1.2 Syntheses of Nitrile Oxide Precursors 
The nitrile oxides were generated in situ by dehydrohalogenation of 
the corresponding hydroximoyl chlorides with base. Benzohydroximoyl 
chloride was prepared in 70% yield by treatment 213 of benzaldoxime with 
chlorine. The D- and L-arabinose derived hydroximoyl chlorides were formed 
by in situ chlorination of their precursor oximes using N-chlorosuccinimide. 
2.1.2.1 2,3:4,5-Di-O-isoprOpylidefle-D-arabinose oxime (203) 
The title compound was prepared in four steps from D-arabinose 
(Scheme 63). The D-arabi nose-de rived thioaceta1 24 (200) was treated with 
acetone containing 1.5% sulphuric acid, followed by anhydrous copper 
sulphate in acetone, to afford the thermodynamically favoured 2,3:4,5-di-O-
isopropylidene derivative 215 (201). The aldehyde function was unmasked 215 
by treatment with mercury II chloride and mercury II oxide. The role of the 
latter was to neutralise the hydrochloric acid generated during the reaction 
thus preventing the formation of acid-catalysed rearranged products. 
Cadmium carbonate has been used as an alternative in similar systems and, 
indeed, its use has been reported in a synthesis of the L-arabinose 
analogue. 216  The aldehyde hydrate obtained initially provided the pure 
compound (202) on distillation. As this compound was found to degrade on 
standing, possibly by polymerisation, freshly distilled aldehyde was preferred 
in the subsequent oximation. Reaction of the aldehyde with hydroxylamine 
hydrochloride and sodium carbonate provided the oxime (203) in near 
quantitative yield; a lower yield (- 60%) was obtained using pyridine as 
base. 1 H NMR analysis revealed the presence of an approximately 5:1 
mixture of the E/Z isomers. This mixture was used without separation for 
subsequent conversion to the nitrile oxide (196). 
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(a) C2H5SH, HCI; (b) acetone, H 2SO4 ; (c) HgO, HgCl 2 ; (d) NH 20H.HCI, Na2003 . 
Scheme 63 
2.1.2.2 2,3:4,5-Di- O-isopropylidene-L-arabi nose oxi me (204) 
The title compound was prepared in an analogous manner to the D-
arabinose derivative (203). As in that case the oxime was obtained as an 
approximately 5:1 mixture of E/Z isomers, and used as such for conversion 
to the corresponding nitrile oxide (197). 
CH NOH 
(204) 
2.1.3 Syntheses of Alkenes 
Three six-carbon alkenes, (84), (198) and (199), were selected for 
study. Each is a known compound and readily prepared by literature 
methods or by modifications thereof. 
2.1.3.1 3- O-Benzyl-5,6-dideoxy-1 ,2- O-isopropylidene-a-D-xyIo-hex-5-
enofuranose (84) 
Commercially available diacetone-D-glucose (205) was converted in 
four steps to the title alkene 27 in an overall yield of 50% (Scheme 64). 
Benzylation28  of the free 3-hydroxyl, followed by selective hydrolysis 219 of 
the 5,6-isopropylidene group yielded the 5,6-diol (207). Subsequent 
treatment with methanesulphonyl chloride and pyridine afforded the 
dimesylate220 (208) as a white crystalline solid without the need for 
purification of the intermediate compounds (206) and (207). The alkene (84) 
tended to decompose on prolonged storage, whereas the crystalline 
dimesylate was readily storable. The conversion to the alkene (84) using a 
zinc/copper couple, in a modification 211  of the Tipson-Cohen221 reaction, 
was therefore carried out as required. 
HO 
YO 	 10 	(a) (  b) HOIVO ..'10 , 
	 BnO 	03( 
(205) 	 (206) 
 . 11 0 









(a) NaH, BnCI; (b) AcOH, H 20, 40°C; (C) MsCI, pyridine; (d) Zn/Cu couple, Nal, 133°C. 
Scheme 64 
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2.1.3.2 3-0-Benzyl-5,6-dideoxy-1 ,2- O-isopropyl idene-a-D-ribo-hex-5-
enofuranose (198) 
The title compound222 was prepared in six steps also from 
diacetone-D-glucose as outlined in Scheme 65. After epimerisation at 0-3 
the alkene was obtained by the same sequence of reactions as for the D-
xy/o-alkene (84). 
The epimerisation was achieved by an oxidation-reduction 
sequence. Oxidation of the free hydroxyl of diacetone-D-glucose, using 
acetic anhydride in DMS02 afforded the ketone (209). Stereospecific 
reduction using sodium borohydride followed by benzylation of the product 
gave the crystalline allose derivative (210). Subsequent selective hydrolysis 
of the 5,6-isopropylidene group to yield compound (211), dimesylation 220 
and zinc/copper couple mediated reduction afforded the required ,ibo-alkene 
(198). As in the case of the xy/o-isomer, the alkene was prepared as 
required from the readily storable crystalline dimesylate 220 (212). 
> 0TjhbO 	
(a) 	: " 3.iio 	(b) 
 X 1 1, 	 0 
•II 
HO 	0 \ 0 	0 \ 	 BnO' 
(205) 	 (209) 	 (210) 
1(d)  
IVISO 	 HO 
jo,




'0 	 BnO 	 BnO" 	0)(  
(198) (212) 	 (211) 
(a) Ac20, DMSO; (b) NaBH 4 , EtOH; (C) NaH, BnCI; (d) AcOH, H 20, 40°C; 
(e) MsCI, pyridine; (f) Zn/Cu couple, Nal, 133°C. 
Scheme 65 
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2.1.3.3 Methyl 5,6-dideoxy-2,3- O-isopropylidene-a-D-!yxo-hex-5-
enofuranoside (199) 
Alkene224 (199), a 0-2 epimeric analogue of the xy/o-alkene (84), 
was prepared from D-mannose in four steps (Scheme 66) in an overall yield 
of 68%. 
The fully protected glycoside (213) was obtained from D-mannose by 
acid catalysed reaction with acetone and methanol. 225 Selective hydrolysis 
of the 5,6-isopropylidene group and subsequent mesylation of the diol 
afforded the crystalline, readily storable, dimesylate 225 (215), without need 
for purification of the intermediate compounds (213) and (214). As with the 
two previous alkenes, the zinc/copper couple mediated reduction of the 
dimesylate was carried out just before use; the resulting Iyxo-alkene (199) 
being found to decompose on prolonged storage. 
HO 
(a) 	 (b) 	HO"' 
D-Mannose 
(213) 	 (214) 
I(C) 
MsO 
OhAe (d) 	MSOL.,pIOMe 
(199) 	 (215) 
(a) Acetone, MeOH, conc. HCI, ref lux; (b) Conc. HCI,H 20, 23°C; (C) MsCI, pyridine; 
(d) Zn/Cu couple, Nal, 133°C. 
Scheme 66 
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2.1.4 Investigation of it-Facial Selectivity in Nitrile Oxide 
Cycloadditions to Hex-5-enofuranoses 
A preliminary investigation into the stereoselectivity of nitrile oxide 
cycloadditions to the three six-carbon alkenes (84), (198) and (199) was 
carried out in conjunction with other members of this research group. 
Cycloadditions to the D-xylo-alkefle (84), and derivatives thereof, have been 
reported previously both by our group 113211 and by others. 226228 In the 
case of the D-xylo-alkene (84) the reactions are reported to proceed with 
moderate to good selectivity with adducts possessing an erythro relationship 
between C-4 and the new chiral centre C-5 predominating (Scheme 67). 
The erythro:threo ratios quoted for such additions to this alkene are 
presented in Table 3. 
+ - 
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Scheme 67 
Nitrile Oxide erythro:threo 
2,4,6-Me3C6H2CNO 96.8 : 3.2a 
PhCNO 94.2 	5.8a 
PhCNO 90 : 10b 
Et02CCNO 85.5 :14.5a 
Et02CCNO 86 :14b 
a:Ref. 228; b:Ref. 211 
Table 3: Isomer Ratios for Cycloaddition of Nitrile Oxides to Alkene (84) 
In order to probe the influence of the stereochemical configurations 
at C-2 and C-3 in such hex-5-enofuranoses, additions of both benzonitrile 
oxide (195) and ethoxycarbonylformonitrile oxide (83) to the D-ribo-alkene 
(198) and the D-/yxo-alkene (199) were undertaken. Cycloadditions to either 
of these alkenes had not been previously reported. 
In the present work229 benzonitrile oxide was cycloadded to the D-
ribo- and D-Iyxo-alkenes. The nitrile oxide was generated in situ by the slow 
addition, via motorised syringe pump, of triethylamine to a chilled solution of 
benzohydroximoyl chloride and the appropriate alkene. These conditions 
were chosen in order to minimise the competing dimerisation of the nitrile 
oxide to unwanted by-products. The cycloadducts were separated from such 
dimeric products and, if applicable, excess alkene by chromatography. The 
ratios of diastereoisomers were determined by comparison of the integrals 
for corresponding protons in the 1 H NMR spectra of the cycloadduct 
mixtures. The excess alkenes recovered could be used again for 
subsequent reactions. The adducts were characterised by 1 H and 13C-NMR 
spectroscopy, FAB mass spectrometry, optical rotation and, in the cases of 
(216) and (220), by X-ray crystallography. Chemical formulae were verified 
by high resolution FAB mass spectrometry and/or elemental analysis. The 
results of this study have been published. 212,230 
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2.1.4.1 Cycloaddition to 3-0-Benzyl-5,6-dideoxy-1 ,2-O-isopropylidene-
a-D-ribO-hex-5-eflOfUraflOSe (198) 
The cycloaddition of benzonitrile oxide (195) to the title alkene (198) 
(Scheme 68) was carried oUt229  as outlined above. After chromatography to 
remove diphenylfurazan N-oxide (224) (nitrile oxide dimer) a mixture of 
diastereoisomeric isoxazolines (216) and (217) in a ratio of 42:58 and a 
combined yield of 70% was obtained. 
RC N -0 
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(216) A = Ph 
(218) R = CO2 Et 
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BnO' 
(217) R = Ph 
(219) R = CO 2Et 
Scheme 68 
The ratio was determined by comparison of the integrals for the anomeric 
proton signals at 5.77 and 5.72 ppm in the 1 H NMR spectrum of the mixture. 
Although the isoxazolines were chromatographically inseparable the 1 H 
NMR of the mixture was readily interpreted on the basis of the differing 
signal intensities. Repeated recrystallisation from chloroform provided a 
small quantity of the pure minor isomer. Subsequent X-ray analysis of this 
sample showed that the new chiral centre at 0-5 possessed the R-
configuration, corresponding to an erythro relationship about the C-4/C-5 
bond. (Full details of the crystal structure have been published. 212) Thus 
the minor isomer was identified as (216) and the major isomer as the threo 
adduct (217). 
The corresponding cycloaddition of ethoxycarbonylformonitrile oxide 
(83) to the same alkene (Scheme 68) was carried out similarly by A. 
Young. 113 	Again an inseparable mixture of isoxazolines (218) and (219) 
was 	obtained together 	with the nitrile 	oxide 	dimer 3,4- 
diethoxycarbonylfurazan N-oxide (225). The isomer ratio was determined as 
51:49 in favour of erythro adduct (218). In this instance the assignment of 
configuration for the major isomer was made by comparison of its spectral 
parameters with those for the benzonitrile oxide adducts (216) and (217). 
2.1.4.2 Cycloaddition to Methyl 5,6-dideoxy-2,3-0-isopropylidene-a-D-
Iyxo-hex-5-enofuranoside (199) 
Cycloaddition of benzonitrile oxide (195) to the title alkene (199) 
(Scheme 69) was carried out in the manner described above. Removal of 
excess alkene and 3,4-diphenylfurazan N-oxide (224) afforded a mixture of 
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Scheme 69 
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The ratio was determined by comparison of the integrals for the methoxy 
signals in the 1 H NMR. In this case the individual adducts were separable 
by chromatography. The major isoxazoline provided crystals suitable for X-
ray analysis230 which established the R-configuration for the new chiral 
centre at C-5, indicating the preferential formation of the erythro adduct 
(220). 
The corresponding cycloaddition using ethoxycarbonylformonitrile 
oxide (195) was carried out by K. Penman 230231 and G. Kirkpatrick230 ' 232 
(Scheme 69). The isoxazolines (222) and (223) were obtained in a ratio of 
82:18 and a combined yield of 76%. The structures of the products were 
assigned by comparison of their spectral properties with those of the major 
benzonitrile oxide-derived adduct (220), for which the stereochemistry had 










The lack of it-facial selectivity offered by the D-ribo-alkene, together 
with the difficulty in achieving separation of the resulting cycloadducts, 
marked it as unsuitable for further study towards our aim of higher sugar 
synthesis. Instead the D-xylo- and D-/yxo-alkenes were selected as six-
carbon units suitable for extension to the target undecose monosaccharides. 
A rationalisation for the selectivities observed in the nitrile oxide 
cycloadditions discussed above will be presented in section 2.1.7. 
2.1.5 Nitrile Oxide Cycloadditions: Undecose Precursors 
To provide access to the eleven-carbon undecose frameworks, and 
to test the selectivities obtained, two hex-5-enofuranoses (84) and (199), 
with the D-xylo and D-Iyxo configurations respectively, and two five-carbon 
nitrile oxides (196) and (197) were selected for investigation. 
The cycloadditions were carried out by chlorination of the D- or L-
arabinose derived oximes, (203) and (204) respectively, followed by direct 
dehydrochiorination with base in the presence of excess alkene. The 
procedure, developed by Torssell, 23 was employed. N-Chlorosuccinimide 
together with a catalytic amount of pyridine was added to a chloroform 
solution of the oxime (1 eq). The resulting hydroximoyl chloride was not 
isolated, instead the alkene (1.5 eq) was added and the mixture cooled to 
0°C before a chloroform solution of triethylamine (1.1 eq) was added via 
syringe pump over 10-11 hours. Such conditions were chosen in order to 
minimise the formation of dimeric nitrile oxide by-products, by the generation 
of a low concentration of the nitrile oxide in the presence of excess 
dipolarophile. 
The D-arabi nose-de rived hydroximoyl chloride has been prepared 
previously by Tronchet et ai 33 via direct chlorination. Its conversion to a 
furoxan dimer in the presence of base and to an isoxazole derivative in the 
presence of phenylacetylene was then demonstrated. 234 However, the 
addition of this nitrile oxide, and the corresponding L-arabinose-derived 
nitrile oxide (197), to alkenes has not been reported. 
Each cycloaddition was accompanied by formation of a mixture of 
nitrile oxide-derived dimeric by-products. The major component of these 
mixtures was identified as the corresponding furazan N-oxide: (226) in 
reactions with D-arabino se-de rived nitrile oxide (196), and (228) in reactions 
with L-arabi nose-de rived nitrile oxide (197). The presence of additional 
satellite peaks in the 1 C NMR of these mixtures (specifically the quaternary 
signal at 161.7 ppm, for additions involving the D-arabino se-de rived nitrile 
oxide, and at 161.6 ppm for additions involving the L-arabi nose-de rived 
nitrile oxide) were assigned to the oxadiazoles (227) and (229). The 
formation of 1 ,2,4-oxadiazoles in NOC reactions has been observed 235 
previously and has been attributed to alternative base-catalysed nitrile oxide 
dimerisation pathways. The chemical formulae of each of these compounds 
was confirmed by high resolution FAB mass spectrometry. 
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The diastereoisomeric cycloadducts were separated from the excess 
alkene and dimeric by-products by chromatography. A small quantity of the 
adduct mixture was used for isomer ratio determination, while the remainder 
was subjected to further flash chromatography to afford the pure 
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isoxazolines. The diastereoisomeric ratios were obtained by comparison of 
corresponding integrals in the 1 H NMR of the mixtures and the individual 
adducts were characterised by 1 H and 130  NMR spectroscopy, optical 
rotation and FAB mass spectrometry. Chemical formulae were verified by 
high resolution FAB mass spectrometry and, where possible, elemental 
analysis. An X-ray crystal structure of adduct .(236) was also obtained. 
2.1.5.1 Cycloadditions of Nitrile Oxides (196) and (197) to 3-0-Benzyl- 
5,6-dideoxy-1 ,2- O-isopropyl idene-a-D-xylo-hex-5-enofuranose 
2,3:4,5-Di-0-isopropylidene-D-arabinononitrile oxide (196) cyclo-
added to the title xylo-alkene (84) to afford, after chromatography, the 
diastereoisomeric 2-isoxazolines (230) and (231) in a ratio of 89:11 and a 
combined yield of 56% (Scheme 70). 
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Figure 11: COSY Spectrum of Adduct (231) 
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Similarly 2,3:4,5-di-O-isopropylidene-L-arabinono nit rile oxide (197) yielded 
the adducts (232) and (233) in a ratio of 88:12 and a combined yield of 65% 
(Scheme 71). The isomer ratios were determined in both cases by 
















The 1 H NMR spectra which, in each instance, showed considerable 
overlap of the protons on C-4, 9, 10 and 11 were interpreted with the aid of 
decouplings and COSY spectra. The analysis of the COSY spectrum of 
adduct (231) is shown in Figure 11. The 130 NMR spectrum of adduct (230) 
was assigned with the help of a 1 1-1- 13C correlation spectrum (Figure 12). 
Although the 0-4 and 0-10 signals could not be differentiated on this basis, 
C-4 was assigned to the signal at 80.2 ppm by comparison of 1 C spectra for 







Figure 12: 1 H- 13C NMR Spectrum of Adduct (230) 
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Although crystalline solids were obtained for at least one of the 
adducts in both reactions, X-ray analysis was deemed unnecessary. 
Instead, the configuration at the new chiral centre in each was confidently 
assigned by comparison of their spectral and tIc properties with those for 
similar isoxazolines prepared from the same alkene and for which the 
stereochemistries had been unambiguously determined. The major adducts 
(230) and (232) were thereby assigned the R-configuration at C-5, 
corresponding to an erythro relationship about the 0-4/0-5 bond. 
2.1.5.2 Cycloadditions of Nitrite Oxides (196) and (197) to Methyl 5,6- 
dideoxy-2,3-0-isopropyl idene-a-D-Iyxo-hex-5-enofu ran oside 
Cycloaddition of 2,3:4,5-di- O-isopropylidene-D-arabi nono nit rile oxide 
(196) to the title alkene (199) afforded, after chromatography, a 61% 
combined yield of the diastereoisomeric 2-isoxazolines (234) and (235) in a 
ratio of 82:18 (Scheme 72). Similarly, the enantiomeric 2,3:4,5-di-O-
isopropylidene-L-arabinononitrile oxide (197) yielded the corresponding 
adducts (236) and (237) in the ratio of 83:17 and a combined yield of 60% 
(Scheme 73). Determination of the isomer ratios was carried out by 
comparison of the 1 H NMR integral intensities for the OCH3 signals in the 
case of adducts (234) and (235), and of the signals for the 0-6 protons in the 
case of adducts (236) and (237). 
As for the adducts derived from the D-xylo-alkene there is 
considerable overlapping of signals in the 1 H NMR spectra. The relative 
positions of the 4-, 9-, 10-, 11 a- and 11 b- protons, which lie within the region 
3.9-4.2 ppm in each of the four adducts, were assigned as far as possible 
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The major adduct (236), obtained from the addition to the L-
arabi nose-de rived nitrile oxide, was isolated as a crystalline solid suitable for 
X-ray analysis. The crystal structure (Figure 13) showed that the new 
asymmetric centre at C-5 possessed the R-configuration thus indicating an 
erythro relationship between C-4 and C-5. This assignment was consistent 
with that for the major adduct (220) obtained from addition of benzonitrile 
oxide to the same alkene (Section 2.1.4.2), which was also established by X-
ray crystallography. The corresponding major adduct derived from the D-
arabinononitrile oxide (196) was assigned the 5R-configuration, i.e. structure 
(234), on the basis of comparison of its spectral and tIc properties with those 
of the above major adducts (236) and (220). 
Figure 13 
107 
The X-ray data for (236) indicated that each asymmetric unit was 
composed of two crystal types. Using the Haasnoot parameterisation 236 of 
the Karplus equation the proton-proton coupling constants were calculated 
from the torsion angles obtained for each structure and compared to those 
observed in solution (Table 4). Although satisfactory correlation is found for 
some of the data, e.g. J1,2, J2,3, J89 there are significant deviations 
elsewhere. As previously observed 231 ' 237 the relationship between the 
observed and calculated J-values for the isoxazoline ring protons is poor 
Other significant deviations are associated with the couplings between 
hydrogens at the ring junctions, i.e. 4-H/5-H and 9-1-1/1-1-1, indicating a 




H-C-C-H Torsion Angle (0)a 
JCa lca JCa l ca SObs 0Obs 0Obs 
1,2 -89.4 -89.6 1.4 1.4 <1 
2,3 -12.0 -11.4 7.7 7.8 5.9 
3,4 -15.7 -18.3 7.5 7.4 3.7 
4,5 178.1 176.9 10.3 10.2 6.2 
5,6a 121.4 113.7 4.1 3.1 8.1 
5,6b -1.0 -8.6 8.1 7.9 10.7 
8,9 155.1 151.1 8.8 8.3 6.6 
9,10 -177.0 175.7 10.2 10.2 6.8 
10,11a -3.4 -26.2 8.0 6.7 6.1 
10,11b -124.3 -147.8
1 1 
4.5 7.9 4.8 
a: 0 and Jealc  represent the torsion angles and coupling constants respectively for 
one crystal type, Wand 'GaIc  are the corresponding values for the alternative. 
3CaIc 7.76C0s29-1.1Cos0+1 .4 
Table 4: Calculated and observed coupling constants for the two crystal 
types of adduct (236) 
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2.1.5.3 General Observations 
Comparison of the properties of each of the D-xylo and D-Iyxo 
adducts obtained here, together with those previously reported, indicated a 
number of distinctive features upon which the prediction of the 
stereochemistry at the new chiral centre in other closely related adducts may 
be based. In the case of the major D-/yxo-derived adducts (220) and (236) 
these assignments were confirmed by X-ray structure determination. The 
characteristic properties of the major and minor isomers obtained in this 
work will now be summarised. 
Tic 
In each case the major adduct, derived from either the D-xylo or D-Iyxo 
alkene, had the larger Rf value on silica for all solvent systems used. 
However, the polarity difference between the C-5 epimeric D-Iyxo-adducts 
was smaller than that for the corresponding 0-5 epimeric D-xylo adducts. 
1 H NMR 
D-xylo-derived isoxazolines: The chemical shift of the anomeric proton 
occurs at a lower 6-value for the major adduct compared to that for the minor 
(A6 0.09, 0.08 ppm) despite the distance from the centre of asymmetry. The 
signals for the methylene protons of the isoxazoline ring, 6a-H and 6b-H, are 
closer together in the major adducts. Indeed, in the case of the major adduct 
(230) they are coincident, while in the minor diastereoisomer (231) they are 
separated by 0.28 ppm. Similarly the methylene protons of the benzyl group 
show a marked separation in the minor adducts (6 0.3 ppm), but are 
closer together in the major isomers. 
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The above patterns have been noted for other cycloadducts 
involving the same alkene, despite the distance of these protons from the 
epimeric C-5 centre. However, less strictly adhered to is the relative 
positioning of the signals for the hydrogen attached to this new asymmetric 
centre. It is observed here that the 5-H signal occurs at higher 8-value for 
the major isomer than for the minor (A8 0.14, 0.06 ppm). But this has not 
always been reflected in the previously noted examples. 
The above differences are summarised in Table 5. 
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Table 5: Trends in 1 H NMR of D-xylo-alkene cycloadducts 
D-Iyxo-derived isoxazolines: As for the D-xy/o-derived adducts the 
anomeric proton resonates at lower chemical shift in the major isomer ( 
>0.07 ppm). However, unlike the D-xylo cases, the 1-H signals occur close 
to or overlapping with the 5-H signals and could therefore not be used for 
isomer ratio determination. Again, as for the D-xy/o-adducts, the isoxazoline 
methylene proton signals (6a-H and 6b-H) are closer together in the major 
adducts and are coincident in the D-arabinose adduct (234) and in the 
phenyl analogue (220). Also observed are larger chemical shift values for 
the -OMe signal of the minor isomers and for the 5-H signal of the major 









































Table 6: Trends in 1 H NMR of D-/yxo-alkene cycloadducts 
13c NMR 
The 130 NMR for the pairs of isomers from both the D-xylo- and D-Iyxo- 
alkenes are very similar. The major difference is associated with the signal 
for the epimeric centre at C-5: in each pair of isomers the major adduct has a 
lower 6-value than the minor (A6 1 .5-2.5ppm). 
Optical Rotation 
The major isomer in the additions to both the D-xylo and D-Iyxo alkenes was 
found to have the lower, usually negative (exception (234)), [cx] 0 value. It is 
also noteworthy that the difference between the values for both pairs of 
major and minor isomers incorporating the D-xylo substituent was -80 0. For 
the D-Iyxo derived isoxazolines the difference in these values was again very 
similar for both pairs, amounting to -50 0 in these instances. This information 
is summarised in Table 7. 
D-Xy/oAdducts D-Lyxo Adducts 
Major (230) -60.50 (234) +15.1° 
Minor (231) +20.4° (235) +64.4° 
Major (232) -99.9° (236) -45.80 
Minor (233) -20.30 (237) +11.1 0  
Table 7: Optical rotation values for D-xylo- and D-Iyxo-alkene cycloadducts 
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2.1.6 Stereoselectivity of Nitrile Oxide Cycloadditions 
Asymmetric induction within nitrile oxide cycloaddition (NOC) 
reactions has been, and continues to be, an area of considerable intereSt. 238  
The attainment of pronounced it-facial selectivity levels would further 
enhance the attractiveness of this route to polyfunctional acyclic compounds. 
Recently attention has been drawn to the use 239 of 'Hydrogen-Bond Directed 
NOC', and there is renewed interest in the use of chiral auxiIiaries 240241 and 
in Lewis acids242 to promote higher levels of selectivity. 
Of more relevance to the work presented in this thesis is the 
attainment of useful diastereoselectivities in NOC to chiral alkenes bearing 
an allylic alkoxy group. A considerable amount of work, both experimental 
and theoretical, has been devoted towards understanding the nature of such 
selectivities. In particular, chiral allyl ethers of the type (238) have been 
studied243245 in some depth and a number of general observations have 
been noted (Scheme 74). In each instance the major product of such an 
addition (R' 4 H) was the erythro isomer. Variation of the alkoxy substituent, 
R', was found to have negligible influence on the selectivity levels. However, 
in the special case of allyl alcohols where R' = H, the selectivity was 
markedly lower with a slight preference for the threo product sometimes 
being observed. Changing the nitrile oxide substituent was also found to 
have only marginal influence. In contrast, increasing the bulkiness of the A 
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Scheme 74 
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The rationale for such observed it-facial discrimination has 
traditionally been in terms of the 'inside alkoxy effect' proposed by Houk. 243  
Houk evaluated the relative energies of the six possible staggered transition 
state structures for the reaction of a nitrile oxide with a chiral allyl ether using 
a combination of ab initio and MM2 calculations (Figure 14): in ascending 
order of energy, A<A'<B<B'<C'<C. Transition states A, B and C afford the 







On this basis the major isomer, produced via the lowest energy transition 
state A, in which the R group occupies the anti position, the H is outside and 
the OR' group is located inside (Figure 15), would be correctly predicted as 
having the erythro stereochemistry. This model also successfully explains 
the aforementioned variations in selectivity. As the R group increases in 
size the C=CCR dihedral angle, 8, increases forcing the allylic oxygen 







The unfavourable lone pair repulsion between the two oxygens therefore 
destabilises A' relative to A with consequential increase in erythro selectivity 
as noted. The low selectivities observed with chiral allyl alcohols are 
explained in terms of a stabilising hydrogen bond interaction with the nitrile 
oxide oxygen. This effect is most pronounced when the OH is in the outside 
position. In this instance A' is now stabilised relative to A and lower erythro 
selectivity would be predicted. It should be noted that isomer ratios 
calculated on the grounds of this model correlated well with the 
experimentally determined values. 
Houk243 simultaneously offered an explanation for the preferred 
inside position of the alkoxy group as found in A. The outside position is 
disfavoured due to the unfavourable oxygen lone pair interactions which 
would result, whereas the argument for inside vs anti is based on secondary 
orbital interactions. The mildly electrophilic nature of nitrile oxide 
cycloadditions means that in the dipolarophile maximisation of electron 
donation or minimisation of electron withdrawal for a particular transition 
state is preferred. With the OR' group inside the electron withdrawal as a 
result of poor and it-orbital overlap is minimised. In contrast with the 
OR' group anti this overlap is at a maximum and the associated transition 
state is destabilised. 
Kozikowski244 has proposed an alternative, non-theoretically based 
model, in which the major adduct is deemed to result from addition of the 
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nitrile oxide anti to the alkoxy group (equivalent of transition state B in 
Houk's analysis). This anti-periplanar addition is argued in terms of the 
minimisation of secondary antibonding orbital interactions, which directly 
contradicts Houk's assessment. Houk's rationale has received more wide 
acceptance. 
Houk246 has extended his model to incorporate chiral alkenes with a 
non-heteroatom substituted allylic centre. The lowest and next lowest 
energy transition states were calculated as A and A' respectively (Figure 
16). The major product arises from A in which the largest group occupies 
the sterically least demanding anti position and the smallest group the 
sterically most demanding outside position. However, compared with allyl 
ethers much lower levels of selectivity are observed. 











Recently improved ab initio calculations have reinforced the 
importance of electrostatic interactions 247 between the nitrile oxide oxygen 
and an allylic oxygen in determining the stereochemical outcome of the 
reaction. They have also shown that 1,3-dipole charge distribution 248  
differences are responsible for fine tuning of selectivities. 
With regard to our current results, De Micheli's study 228 into the 
selectivity of nitrile oxide cycloadditions to the D-xylo-alkene (239) is of 
particular interest. In each instance the erythro adduct was found to 
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predominate, with the erythro:threo ratio greatest when X = OR. Indeed 
such selectivity was significantly higher than that calculated on the basis of 
Houk's theoretical model. By contrast the lower selectivity observed when 
X = H was more readily comparable with its calculated value (Table 8). 
X = H, OH, We, OBn, 
IV 
1.110 	 0CH2-(2,6-C1 2C6H3), 
x












Table 8: Calculated and experimental isomer ratios for addition of HCNO to 
alkene (239) 
De Micheli et al concluded that the lone pair on the homoallylic 
oxygen, i.e. 3-OR, which is not taken into account in Houk's model, plays an 
important role in altering the relative transition state energies. They 
postulated that in A and A' the homoallylic lone pair is located in such an 
orientation that it can exert a destabilising through space interaction with the 
double bond (Figure 17). However, in the next lowest transition state B, the 
lone pair/it-bond interaction is minimised with the consequence that the 









2.1.7 Selectivity of Nitrile Oxide Cycloadditions to D-xylo, D-ribo and 
D-Iyxo-Alkenes 
The it-facial selectivities obtained in the cycloadditions to the D-xylo-, 
D-nbo- and D-Iyxo-alkenes are summarised in Table 9. Both the xylo- and 
lyxo-alkenes which differ in stereochemistry only about the C-2 position 
undergo cycloadditions with comparable selectivities and, indeed, virtually 
independent of the nitrile oxide employed. The 5R isomer, i.e. that having 
an erythro relationship about the C-4/C-5 bond, was formed predominantly in 
each case. This preference, coupled with the observed isomer ratios, is in 
accord with both the 'inside alkoxy effect' and its 'homoallylic' modification 
(Section 2.1.6). In contrast, the cycloadditions to the ribo-alkene which 
differs from the xylo-alkene only in its 0-3 configuration proceed with low 
selectivity. Furthermore, its reaction with benzonitrile oxide resulted in a 
slight preference for the threo adduct. 
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Erythro : Threo Ratios 
D-Xy/o-Alkene D-Ribo-Alkene D-Lyxo-Alkene Nitrile Oxide 
(84)   
PhCNO (195) 90 : ioa 42 : 58 82 :18 
94.2 :_5.8b  
Et0200NO 86 :14a 51: 49C 82 :18 
(83) 85.5: 145b  
D-Ara derived 89 :11 - 82 :18 
 
L-Ara derived 88:12 - 83:17 
 
a: Ret 211: b: Het 225; C: Ret 212 
Table 9: Diastereoselectivities in cycloadditions to alkenes (84), (198) 
and (199) 
These results show that the configuration at the C-2 position in such 
5,6-dideoxyhex-5-enofu ran ose alkenes has negligible effect on the it-facial 
selectivity of nitrile oxide cycloadditions to these compounds. This may be 
rationalised on the basis that it is located too far away from the newly 
forming chiral centre to exert any significant influence. 
The dramatic loss, and even reversal, of selectivity brought about by 
epimerisation at 0-3 (xylo converted to ribo) is more difficult to explain. It 
should be noted that for the alkene (239) unsubstituted at 0-3 an 
erythro:threo ratio of 73:27 was reported. 228 Thus the erythro preference is 
significantly reduced in the ribo-derived adducts. De Micheli 228 has 
previously remarked upon the influence of the homoallylic alkoxy 
substituents in enhancing the good erythro selectivity promoted by an allylic 
alkoxy group (Section 2.1.6). His arguments are based on the differing 
influence of the homoallylic lone pair/it-bond interaction within the three 
lowest energy transitions states. The erythro relationship between the allylic 
and homoallylic substituents in the D-ribo-alkene contrasts with the threo 
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relationship in both the D-xylo- and D-/yxo-alkenes. This difference in 
relative configurations may lead to loss of the above interaction and the 
introduction of an alternative which destabilises one or more of the erythro 
producing transition states, or stabilises one or more of the alternative threo 
forming pathways. Despite no firm explanation for this latter result the study 
has served to highlight the significance of the homoallylic substituent in 
influencing it-facial selectivity. 
These reactions also illustrate that the introduction of a chiral centre, 
of either configuration, adjacent to the nitrile oxide group in the dipole 
component does not interfere with the it-facial selectivity. Changing from the 
achiral nitrile oxides (83) or (195) to either enantiomer of the arabinose-
derived nitrile oxides (196) or (197) does not significantly alter the 
erythro:threo ratio observed. This lack of stereocontrol offered by use of a 
chiral nitrile oxide has been previously reported 249 in the additions to achiral 
alkenes. For instance, additions of nitrile oxides (240) 23 , (241)250 and 
(242)251 to styrene gave -1:1 mixtures of diastereoisomeric isoxazolines in 
each case. The explanation offered for this absence of stereocontrol is that 
the existing chiral centre, adjacent to the nitrile oxide group, is located too 
















It is therefore concluded that the observed it-facial selectivities 
are promoted by the presence of allylic and homoallylic oxygen substituents 
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in the alkene component, with the nature of the nitrile oxide component 
showing negligible influence. Houk's arguments on the 'inside alkoxy 
effects' together with De Micheli's modification to incorporate the 'homoallylic 
group influence' offer a satisfactory explanation for the selectivity results in 
each of the above examples. However, it should be noted that the overall 
picture is more complex as evidenced by the lack of selectivity on switching 
to the D-ribo alkene. Further rationalisations of such anomalous results are 
still to be sought. 
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2.1.8 Reductive Hydrolytic Cleavage of 2-Isoxazolines to 
-Hydroxyketones 
The next step en route to higher sugars is the cleavage of the N-O 
bond of the 2-isoxazoline which bridges the two sugar units. Conversion of 
this heterocycle to a -hydroxyketone followed by carbonyl reduction would 
provide partially protected 6-deoxyu ndecoses. 
Although a number of procedures for such -hydroxyketone 
unmasking have been developed (Section 1.2.7), the most common is a 
modification of that first reported by Torssell. 252 The method253 involves 
hydrogenation in the presence of a palladium-on-charcoal or Raney-nickel 
catalyst using aqueous methanol, containing boric acid, as the solvent. The 
specific incorporation of boric acid, introduced by Curran 38 after a thorough 
investigation into the optimum reaction conditions, was deemed as crucial to 
the overall success of this process. 
The mechanism proposed for this transformation involves the 
addition of hydrogen across the isoxazoline N-O bond to produce a. 1-
hydroxyimine intermediate (243) (Scheme 75). The subsequent hydrolysis 
of this intermediate to the target f-hydroxyketone (245) competes with its 
reduction to -y-amino alcohols (244). 
R 1 (N111 R3 	 R. 	A3 












Curran observed that an acid additive was important for the former process 
and offered some explanations as to why this may be the case: it would 
serve to promote imine hydrolysis, neutralise the ammonia generated in the 
reaction and, when Raney-nickel is used, would neutralise excess hydroxide 
present in this catalyst. Acetate or phosphate buffers were also initially 
used. However, when 4,5-disubstituted isoxazolines were subjected to the 
reaction conditions employing these additives, although the y-amino alcohols 
were not observed, other undesired products were often obtained, 
sometimes even as major products. These compounds were identified as 
retro-aldol products and/or diastereoisomeric mixtures of ketones (245) and 
(246). The latter were shown to arise from a reaction intermediate, 





RI -Ir R2  + 
R2 	 R2 
- 	[R l R3] 
NH2 OH 	 NH OH 
Ir R3 	
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The rapid rate of imine hydrolysis under the typical reaction conditions 
means that these intermediates are not usually detected. 	However, 
evidence for their formation has been obtained in cases where steric 
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hindrance increases their stability to hydrolysis, e.g. 3-hydroxyimines 
(247) 254 and (248)255 have been isolated on hydrogenolysis of the 
corresponding isoxazolines. 











When boric acid was used as the acid additive the formation of the above 
unwanted products (retro-aldol compounds and diastereolsomeric ketones) 
was not observed or in the worst instances minimised. It has been 
proposed,38 yet not proved, that the success of this additive is a 
consequence of its ability to form cyclic borate esters (Figure 18) which 





Despite reports of the use of other additives, e.g. concentrated 
HCI,41 aluminium trichloride 41 and boron trichloride, 256 boric acid has 
tended to remain the reagent of choice in such reductive hydrolytic ring 
opening reactions. 
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2.1.8.1 Palladium-on-Carbon Catalysed Hydrogenotysis of 
2-Isoxazoline (230) 
The reductive hydrolytic cleavage of 2-isoxazoline adducts (249)-
(251) formed from the D-xy/o-alkene (84) has been previously 
reported 113 '211 by Paton and Young. 
R 
BnO 	0)( 
R= HOCH2— R= O\_ 
(249) 	(250) 
A-q- 0 N 
R= oil. (O 
(251) 
Their procedure, based on the optimised conditions developed by Curran, 38 
utilised 10% palladium-on-charcoal (Pd/C) as the catalyst. The possible 
debenzylation at C-3 associated with the use of this catalyst, was not 
observed: a result attributed to partial catalyst poisoning by the boric acid 
additive. The reaction involved vigorous stirring of the isoxazoline (1 eq), 
boric acid (6 eq) and catalyst in a 5:1 mixture of methanol/water under an 
atmosphere of hydrogen, typically for 18 hours. These conditions were 
therefore initially employed for the proposed N-O bond cleavage of the 
isoxazoline (230) (Scheme 77). 
BnO 	0 	 BnO 	0)( 
(230) 	 (252) 
Scheme 77 
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TIc analysis of the reaction mixture after the normal reaction time 
indicated the presence of unreacted starting material together with a new 
more polar material. This new spot gave a positive stain with Brady's 
reagent and was therefore believed to be the desired -hydroxyketone (252). 
Continuing the reaction for a further 20 hours provided, after preparative tic, 
unreacted isoxazoline (51%) plus the more polar component, which was 
indeed identified as the i3-hydroxyketone (252) (19%). Repetition of the 
experiment with a total reaction time of 63 hours yielded, in this instance, 
unreacted starting material (9%), the 6-deoxy-7-undecosuiose derivative 
(252) (37%), together with a significant quantity of a mixture of debenzylated 
compounds. The major component of the latter mixture is tentatively 
assigned the hemiketal structure (253b) based on the available 1 H and 130 
NMR data. Such a compound could be formed by debenzylation at 0-3 in 
(252) and subsequent intramolecular ring closure of the resulting 3-OH 
group onto the keto-group at C-7 in (253a) (Scheme 78). The quaternary 
signal at 5-97.3 ppm in the 13C NMR of this mixture attributed to C-7 is 

















The debenzylation observed here may be explained by the extended 
reaction time required to achieve ring opening. The reduced reactivity of the 
isoxazoline nucleus towards cleavage may in turn be due to increased steric 
hindrance about the reaction site. Indeed Young 211 noted the incomplete 
consumption of isoxazoline (251), in which the substituent at the C-3 position 
of the isoxazoline is the bulky diisopropylidenepyranosyl group, upon 
subjection to the above reaction conditions for 24 hours. Again this effect 
may be attributable to increased steric bulk compared to systems (249) and 
(250). Furthermore Penman 231 has observed debenzylation of similar 
systems when extended exposure to the Pd/C catalyst was found necessary. 
2.1.8.2 Raney-Nickel Induced Hydrogenolysis of 2-Isoxazolines 
In an attempt to overcome the problems of increased reaction times 
and the resulting debenzylation found for the Pd/C induced ring opening, the 
alternative Raney-nickel (Ra-Ni) catalysed process was pursued. 
lsoxazoiine (230) was subjected to the same set of standard 
conditions given above, with Ra-Ni substituted for the Pd/C catalyst. 
Complete consumption of the starting material was now achieved after only 7 
hours. This reaction provided, after preparative tic, the desired 3-
hydroxyketone (252) with properties identical to that obtained from the 
former Pd/C process, together with an inseparable mixture of y-amino 
alcohols (254) (Scheme 79). 
Each of the other major isoxazolines (232), (234) and (236) were 
treated in the same manner. The reactions, which were monitored by tic, 
were complete within 3-7 hours. Again, after preparative tic the appropriate 
6-deoxy-7-undecosulose derivative was obtained along with a more polar 
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inseparable mixture of -y-amino alcohols. These reactions are illustrated 
together with the associated yields in Scheme 79. 




10 "0 + 	HO 
BnO 	0 \ 	 BnO 	 BriO 	0 \ 
R = 	 (230) 	 (252) 66% 	 (254) 25% 
R = 	 (232) 	 (255) 54% 	 (256) 27% 
RN ) ,IIOMe 
R 
0%HO~ "' , OMe  + A 
H2N%H
CO)  
R = ...}\ (234) 	 (257) 55% 	 (258) 34% 
R = 	 (236) 	 (259) 52% 	 (260) 18% 
Scheme 79 
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The 3-hydroxyketones were identified by l.A., 1 H and 1 C NMR 
spectroscopy and FAB mass spectrometry. Their chemical formulae were 
verified by high resolution FAB mass spectrometry. 
The mixtures of y-amino alcohols provided complex 1 H NMR spectra. 
However, the 1 C NMR spectra showed charactenstic signals within the 
region 849-54 ppm as expected 257 for the CHNH2 (C-7) resonance. 
Further evidence for these compounds is given by their positive ninhydrin 
stain on tic, together with the high resolution FAB mass spectrometry 
analysis obtained for each. Further verification of these structures was not 
obtained due to the general instability of these compounds. 
In accord with the mechanism for 2-isoxazoline ring cleavage given 
previously, these -y-amino alcohols are formed by reduction of the 
intermediate 3-hydroximine. Their formation indicates that, in these cases, 
the rate of this process is comparable to that of the desired hydrolysis to the 
-hydroxyketone. In an attempt to increase the rate of this latter process 
relative to that of the reduction, and thereby improve the yields of ketones 
obtained, we repeated the reactions using isoxazolines (230) and (236) with 
9 and 12 equivalents of boric acid respectively. No significant improvement 
was observed and, indeed, the overriding influence in the consistency of the 
yields obtained was the quality of the Ra-Ni employed. The best results 
were achieved when the Ra-Ni which had been previously washed with 
water (- x20), as suggested by Curran, 38 was stored under methanol in a 
freezer for 3-4 weeks prior to use, and used within 6 weeks of this initial 
storage. No further approaches to minimise production of the ?-amino 
alcohol fraction were carried out. 
No evidence for debenzylation was observed in any of the above 
systems. Others258' 259 have achieved similar success in this respect, while 
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the need to use deactivated Ra-Ni to limit such debenzylation has also been 
reported. 244  
2.1.8.3 Characteristics of -Hydroxyketones 
Hydrogenolysis of the sugar substituted 2-isoxazolines provided the 
Corresponding 6-deoxy-7-u ndecosu loses in moderate yields (52-66%). The 
notable features of these f3-hydroxyketones are summarised below. 
i.R.: 	Each shows a characteristic carbonyl absorption in the region 1719- 
1727 cm-1 and an associated broad hydroxy absorption with vmax  in the 
range 3490-3516 cm -1 . 
Tic: 	Each has a smaller R f value on silica than the parent 2-isoxazoline 
and is stained by Brady's Reagent which aids in the identification. 
13C NMR: 	The major differences between the spectra for the - 
hydroxyketones and those of the respective isoxazolines are, as expected, 
for carbons 5-8 (Figure 19). The chemical shifts assigned to these carbons 
in isoxazoline adducts (230) and (234) are compared with those for their ring 
cleaved products (252) and (257) in Table 10. Similar differences are noted 
in the corresponding L-arabinose derived compounds. Furthermore the 
chemical shifts for 0-8 increased by -5-10 ppm from the isoxazolines to the 
corresponding 3-hydroxyketones. However, unambiguous assignment for 
this carbon in the spectra of the latter was not obtained due to the similarity 
of their values with those for C-2, 0-3 and C-4. 
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1 H NMR: 	The 1 H NMR spectra similarly reflect the conversion from 2- 
isoxazolines to 3-hydroxyketones by displaying the major differences for 
protons attached to the reaction site (4-H to 8-H) (Figure 20). Tables 11 and 
12 compare the chemical shifts and coupling constants for the D-arabinose 
derived isoxazolines (230) and (234) with those for their ring cleaved ketone 
products (252) and (257). Again the same pattern is observed in the L-
arabinose series. 
H8 	 4 
	 H H6b H6 H 



















































The existence of the 3-hydroxyketone unit in a hydrogen-bonded half-chair 
conformation (Figure 21) is supported by the large diaxial and smaller axial- 
equatorial type couplings measured for J5,6a  and  J5,6b  respectively in each 
6-deoxy-7-undecosulose. Such a conformation permits the bulky furanose 
















 ri( 0 
Figure 21 
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2.1.9 Reduction of -Hydroxyketones to 1 ,3-Diols 
The previous section detailed the formation of a series of 6-deoxy-7-
undecosuloses via Raney-nickel catalysed hydrogenolysis of 2-isoxazolines 
to -hydroxyketones. The next step en route to the target higher sugars is 
reduction of the carbonyl functions to provide the corresponding series of 6-
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This conversion is of particular interest from the stereochemical point of view 
as a new asymmetric centre is created at C-7. The D- and L-arabinose 
containing undecosuloses have opposite configuration at the carbon 
adjacent to the carbonyl, and it would therefore be of interest to observe the 
extent to which this may influence the ratio of products obtained. 
Two reducing agents, sodium borohydride and L-selectride, were 
selected. Paton and Young have previously reported 113 ' 211 their use for the 
reduction of the -hydroxyketone system of the 6-deoxynonosulose (261). 
O 0 




The latter reagent was found to give a high level of selectivity (6:94) in the 
reduction of this ketone and it was therefore hoped that the chain extended 
systems dealt with in the present work would provide similar degrees of 
selectivity. 
2.1.9.1 Reduction of 6-Deoxy-7-undecosuloses 
The reduction of each 6-deoxy-7-undecosulose was carried out 
using both sodium borohydride in an ethanol-water solvent system 
(combined yields of diols 72-82%) and L-selectride in THF (combined yields 
76-98%). These reactions are illustrated in Scheme 81, and the respective 
isomer ratios of the 1,3-diols obtained are noted in Table 13. The ratios 
were determined by comparison of the integrals (anomeric proton signals for 
D- and L-arabino-a- D-gluco-de rived diols and 6-H2 signals for D- and L- 
arabino-a-D-manno-derived diols) in the 1 H-NMR spectra of the mixtures. 
D- and L-arabino-cx-D-gluco-undecosuloses (252) and (255) afforded 
chromatographically separable diastereoisomeric 1 ,3-diols, each of which 
was characterised by 1 H and 13C NMR spectroscopy, optical rotation and 
FAB mass spectrometry. The chemical formulae were verified by high 
resolution FAB mass spectrometry. In contrast the diols obtained from D-
and L-arabino-a-D- manno-u ndecosu loses (257) and (259) could not be 
separated. However L-selectride reduction of each gave essentially one 
isomer in both cases. This allowed characterisation of one diol of each pair. 
Partial 1 H and 13C NMR analyses of the minor isomers from the spectra of 
the mixtures was also obtained. 
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Scheme 81 
Reducing Agent 
Isomer Ratios for 1 ,3-Diols  
(262):(263)  1 	(264):(265) 1 	(266):(267) (268): (269) 
NaBH4 62 : 38 40 : 60 62 : 38 37: 63 
L-Selectride >97:3 88 --
] 
 >95:5 <3:97 
Table 13 
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It should be noted that the major product of both sodium borohydride 
and L-selectride reductions was the same for a particular undecosulose. 
The borohydride reductions provided access to both isomers with ratios 
approximately 2:3, whereas the L-selectride reductions were highly 
stereoselective. Indeed, except in the case of ketone (255), the signals 
attributable to the minor diols were just on the limits of NMR detection (d.e. z 
90%). 
2.1.9.2 General Comparisons 
Comparison of the corresponding 3-hydroxyketone and 1 ,3-diol 1 H 
NMR spectra reveals two main chemical shift changes associated with the 
protons attached to 0-6 and C-8, i.e. those adjacent to the new chiral centre 
at C-7. The H-8 signal is found to move to lower 8-value by >0.4 ppm, 
whereas a similar shift for the 0-6 methylene protons is even more 
pronounced. This is illustrated for -hydroxyketone (252) and the resulting 
diols (262) and (263) in Table 14. 
H HGbH6 	 H HGbH6 
0 OH 	 OH OH 
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Such differences are a direct consequence of the increased shielding 
brought about by this functional group interconversion, and are reflected 
also in the 13C  NMR spectra where 0-6 is found to move to lower chemical 
shift in the diols (i5-5-6 ppm). Obvious additional differences in the 1 H 
NMR spectra are the presence of an extra multiplet due to 7-H and the 
associated extra couplings for 6-H and 8-H. 
Of greater significance are the differences in the patterns observed 
in the 1 H NMR for the C-6 methylene protons for any pair of 
diastereoisomenc diols; indeed these enable prediction of the 
stereochemistry at the new asymmetric centre in each isomer. For instance, 
consider analysis of the spectrum for the mixture of diols (268) and (269) in 
this region (Figure 22). In the major isomer (269) the signals for 6a-H and 
6b-H appear as two sets of clearly defined doublet-of-doublet-of-doublets 
(ddd), each with two large and one small couplings. In contrast the minor 
isomer (268) exhibits two sets of more widely spaced doublet-of-triplets (dt), 
with a small triplet coupling for 6b-H and a large triplet coupling for 6a-H. 
The adoption of a hydrogen-bonded chair type conformation A or B (Figure 
23) in which the bulky furanose unit and the L-arabino-chain occupy the 
sterically least crowded equatorial positions fits the data for (268). 
Conformer A incorporates the hydrogen of the 5-OH group in hydrogen-
bonding, whereas B represents the alternative use of the hydrogen of 7-OH 
in formation of the chair unit. In these structures 6ax-H would be expected 
to have two large axial-axial couplings (10-13 Hz), with 6eq-H having two 
small axial-equatorial couplings (2-5 Hz). The minor isomer is therefore 
























The equivalent hydrogen-bonded chair-type conformations (both 
"5C2" and the "2C5" types) for the 7R isomer would require one of the bulky 
groups (furanose unit or L-arabino-chain) to occupy an unfavourable axial 
orientation as illustrated by C and D in Figure 24. (The 1 ,3-diol unit of both 
of these confomers could alternatively incorporate the hydrogen of the 7-OH 
group in formation of these chair forms.) Distortion from these arrangements 
would therefore be expected, and is consistent with the coupling constants 
observed for the major diol (269). This compound was therefore assigned 













R 1 and R2 as in Figure 23 
Figure 24 
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Similar characteristic patterns are observed for the C-6 methylene 
protons of the other pairs of diols, with the assignment of configuration at C-
7 for each isomer based on the arguments outlined above. For one isomer 
of each pair these signals appear as two sets of 'dt' with couplings typical of 
those obtained in a hydrogen-bonded chair-type structure. The hydrogen 
assigned as axial, 6a-H, occurs at the lower 6-value, with the separation 
between these signals greater in the L-arabino se-de rived series (i6 0.70, 
0.58) than in the corresponding D-arabinose analogues (6 0.36, 0.32). 
Diols displaying such features were assigned the 7S configuration. 
The epimeric 7R compounds in the L-arabinose series display two 
sets of 'ddd' each with one small and two large J-values associated with 6a-
H and 6b-H. These signals are closer (6 0.24, 0.14) than the 
corresponding displacements for the 'dt' signals shown by the 7S isomers. 
In the D-arabinosederived compounds this separation is reduced even 
further such that the resonances overlap resulting in complex patterns. 
The coupling constants and 6-values for the protons in question in 
each of the 1,3-diols prepared are summarised in Table 15. The major 
reduction product in the D-arabi no se-de rived series was thereby assigned 
the 5R,7S stereochemistry, whereas the predominant isomer in the 
corresponding L-arabinose series was assigned the 5R,7R structure. 
A further point of interest is the difference in polarity between 
isomers for either pair of D-gluco-derived diols. For the D- and L-arabinose-
derived diols the 7S epimers (262) and (264) (hydrogen-bonded chair 
structures) had the higher Rt value on silica. The corresponding epimeric D-
manno-derived compounds had the same Rf values. 
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H/ppm  J/Hz  
6a-H I 	6b-H 5,6a 5,6b
__ 
6a,7 6b,7 6a,6b 1,3-Diol 
Major (262) 1.72 2.08 10.2 2.1 10.4 2.4 14.7 
Minor (263) 1.93 1.93 a a b b nd 
Major (266) 1.71 2.03 10.1 2.4 10.1 2.4 14.5 
Minor (267) 1.91 1.91 nd nd nd nd nd 
Major (265) 1.92 1.68 2.7 9.2 10.1 2.6 14.5 
Minor (264 1.59 2.29 10.1 1.7 10.1 1.7 14.5 
Major (269) 1.93 1.79 2.8 9.1 9.9 2.8 14.5 
-
Minor (268) 1.64 2.22 10.1 1 	2.2 1 	10.1 2.2 14.5 
a: 4.9 or 7.1; b: 4.4 or 6.4 or 7.0; nd: not determined 
Table 15 
2.1.9.3 Confirmation of Stereochemistry in 1 ,3-Diols 
In order to confirm the above structural predictions the 5,7-0-
isopropylidene ketals were prepared. The diol unit was thus locked in a 6-
membered ring (1 ,3-dioxane), for which the vicinal coupling constants of the 
chair conformer are predictable. 
Each of the individual 1 ,3-diols, together with the inseparable 
mixtures of (266)1(267) and (268)/(269), were treated with acetone and 2,2-
dimethoxypropane in the presence of a catalytic amount of p-
toluenesulphonic acid to afford the corresponding ketals (Scheme 82). The 
diol mixtures provided inseparable mixtures of their ketals; the minor isomers 
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Scheme 82 
Examination of the 1 H NMR spectra in the region of the C-6 
methylene protons revealed patterns which closely parallel those for the 
diols from which they are derived. One isomer of each pair had very 
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distinctive chair-type couplings: 6a-H shows two axial-axial sized J-values, 
whereas 6b-H possesses two small axial-equatorial couplings. Such chair 
structures (Figure 26) may be accommodated by the 5R,7S isomer in which 
both dioxane substituents can occupy the equatorial positions. The other 
isomer must have the 5R,7R stereochemistry for which a chair structure 
would necessitate one of the substituents to be located in an unfavourable 
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Figure 26 
The J-values obtained for these isomers are indeed indicative of the 
adoption of non-chair structures and may be explained by the 1 ,3-dioxane 
rings existing in 2,5-twist boat conformations ( skew) (Figure 27). These 
conformers would enable both bulky substituents (R1 and R2) to occupy 
pseudo-equatorial positions. The 11.1  NMR spectrum for the mixture of (276) 
and (277) illustrates the clear spectral distinction between the isomers. 
Figure 25 displays this spectrum together with that for the diol mixture, (268) 
and (269), from which it was derived, highlighting their parallel relationship. 
The J-values for the protons of the 1 ,3-dioxane rings in compounds (270) 
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and (271) are compared in Table 16; for those of the other ketal pairs refer 
to Tables 43 and 45. 
I 
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Further support for these assignments is provided from 13C  NMR. 
Buchanan et a,e60 have correlated the ring size of isopropylidene ketals (i.e. 
1 ,3-dioxolane, 1 ,3-dioxane and 1 ,3-dioxepane), and the conformational 
properties of 1 ,3-dioxanes, to the chemical shift associated with the 
quaternary and methyl acetal carbons. Selected results are summarised in 
Table 17. The quaternary carbon for the newly formed 5,7-0-isopropylidene 
acetal is therefore readily distinguishable from the corresponding signals for 
the three 1 ,3-dioxolane rings which appear at higher 5-value. Furthermore, 
its actual value enables prediction of a chair or skew-type conformation and, 
therefore, the configuration at C-7. The positioning of the methyl 
resonances also gives this information. In a chair structure the methyl 
groups occupy axial and equatorial positions. This is translated into a 
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chemical shift difference of approximately 10 ppm, with the axial methyl at 









5 23.3-28.2 0.0-4.6 
111.3-115.7 (fused 
to_furanoid_ring)  
97.1-99.9 (chair) 18.2-19.3 (ax) 9.8-10.9 
6 28.6-29.2 (eq)  
100.6-101.1 (skew) 23.5-24.5 (skew) 0.0-0.9 
Table 17260 
Table 18 shows the 6-values  assigned to the methyl and quaternary 
carbons of the 1 ,3-dioxane rings in each of the 5,7-0-isopropylidene ketals 
prepared. These compounds have been grouped according to the structures 
proposed by the above 1 H NMR analyses: the 5R,7S chair forming 
structures first, followed by the 5R,7R structures. The carbon chemical shifts 
are also found to divide the compounds clearly into two categories which are 
in agreement with the previous predictions. Hence further confirmation of 
the assigned stereochemistries is provided. 
A final point of interest with regard to the 1 C NMR data is the 
distinction between the chemical shifts of the quaternary acetal carbons for 
monocyclic and furanoid-fused 1 ,3-dioxolanes (Table 17). This difference is 
indeed observed in these compounds, and their precursors, each of which 
contain three such rings. Two of the three resonances appear close 
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together with the third shifted to higher chemical shift thus identifying it as 
the furanoid-fused quaternary acetal carbon. 
sc/ppm (Dioxane ring) 
C(Me) 2 2xMe Ketal Assignment Conformation 
(270) 5R, 7S CHAIR 98.5 19.7, 29.7 
(272) 5R, 7S CHAIR 98.4 19.7, 29.8 
(274) 5R, 7S CHAIR 98.7 19.4, 29.7 
(276) 5R, 7S CHAIR 98.4 19.3, 29.6 
(271) 5R, 7R NON-CHAIR 100.4 24.7-27.4 
(273) 5R, 7R NON-CHAIR 100.3 24.9-27.6 
(275) 5R, 7R NON-CHAIR 100.6 24.5-27.5 
(277) 5R, 7R NON-CHAIR 100.7 24.2-27.6 
Table 18 
2.1.9.4 Rationalisation of Stereoselectivity in Reductions 
A review of the above reduction reactions indicates the following 
points: 
The predominant isomer obtained was dependent on the starting 6-
deoxy-7-undecosulose and independent of the sodium borohydride or L-
selectride reducing agent; 
L-selectride, as expected, provided greatly increased levels of 
selectivity relative to sodium borohydride; 
The D-arabino-containing -hydroxyketones provided the 7S isomers 
predominantly; and 
The L-arabino-containing -hydroxyketones provided mainly the 7R 
isomers. 
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Hence the configuration at C-8, the position adjacent to the carbonyl 
function, was found to determine the stereochemistry of the major product 
obtained. The major isomer in all cases possessed a threo relationship 
about the C-7/C-8 bond. 
In the absence of chelating reagents these results may be explained 
in terms of a Felkin-Anh transition state modeL 261 The three lowest energy 
staggered transition states, based solely on steric factors, are in order of 
increasing energy Al, Bi and B2 (Figure 28). 
"H" ---- 







When an electronegative group is present in L, M or S the relative energies 
are altered: interaction of "H -" with the electronegative species has a 
destabilising effect. The relevant transition states for reduction of the D-
arabino-u ndecosu loses are illustrated in Figure 29. The presence of the 
electronegative oxygen at 0-8 would be expected to have most influence in 
the alteration of the relative energies of these transition states. Interaction 
of the hydride species with this oxygen is minimised in 62, relative to Al and 
Bi, which thus becomes the dominant transition state leading to product. 
Hence the formation of threo product is explained. Similarly in the L-arabino 
compounds the most favoured transition state again leads to the observed 
threo product. 
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For the corresponding reductions using L-selectride the substantially 
higher levels of selectivity may be rationalised by the greater bulk of this 
reagent. 
0 0 0 
Al 
0 












R = 	 OR 
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BnO X 	0 0 
Figure 29 
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2.1.10 Conversion of Undecofuranose Compounds (262) and (265) to 
Octaacetate-pyranose Derivatives 
Both D- and L-gluco-a-D-gluco-undecoses (262) and (265) were 
subjected to isopropylidene deprotection (TFA/H20) followed by 
peracetylation (Ac20/pyridine/DMAP) to afford the corresponding 
octaacetates as mixtures of cx- and 13- isomers (Scheme 83). 
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The products were readily separable by chromatography. 1 H NMR analysis 
of each showed the same general features. The observed J23, J34 and 45 
values (9.3-10.1 Hz) were typical of the axial-axial couplings associated with 
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the adoption of a pyranose ring of D-gluco configuration. This further 
reinforces the assignment of R-configuration given to the chiral centre at C-5 
in the major adduct formed by nitrile oxide cycloaddition (Section 2.1.5). 
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Figure 30 
In contrast the isoxazoline isomers with the opposite configuration at C-5 
would yield the corresponding L-idopyranose derivatives (Figure 31) which 
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The distinction between cx and P forms was readily made on the basis of the 
anomeric proton resonances. The isomers with small J1,2 values (3.7, 3.9 
Hz) were assigned as the cx-anomers (278) and (280), while those with J1 ,2 
values of 8.3 Hz corresponded to the 3-anomers (279) and (281). A large 
chemical shift difference between the anomeric protons was observed 
between either pair of isomers, with the signal for the a-form appearing at 
the higher chemical shift (A8 0.6ppm). The 1 H NMR spectra for the 
octaacetates (280) and (281) are illustated in Figure 32. Compound (281) 




This investigation has established a synthetic route to 6-deoxy-
undecoses using nitrile oxide-isoxazoline chemistry. The cycloaddition of 
five-carbon sugar-derived nitrile oxides to hex-5-enofuranoses provided 
eleven carbon isoxazoline-bridged units in 56-65% yields. The it-facial 
selectivity was good, 88:12 to 89:11, with the erythro adduct predominating 
in each instance. These selectivities were determined by the dipolarophile 
component, whereas the nature of the nitrile oxide was found to have 
negligible effect. 
Raney-nickel catalysed hydrogenolysis of these 2-isoxazolines 
afforded 6-deoxy-7-undecosuloses as the major products, together with 
smaller quantities of the corresponding 7-amino-6,7-dideoxyundecoses. 
Reduction of the carbonyl group of the former provided access to partially 
protected 6-deoxyundecoses. When L-selectride was employed as the 
reducing agent excellent selectivity in favour of the 7,8-threo isomers was 
achieved (often >95% de). The major D- and L-g/uco-undecOseS (262) and 
(265) were partially deprotected and peracetylated to give the corresponding 
pyranose derivatives. 
The 1 ,3-diol (262) possesses the framework structure of hikosamine, 
the undecose fragment of the antibiotic hikizimycin. 
In summary this work has provided a further demonstration of the 





Azasugars are monosaccharides with the ring oxygen replaced by 
nitrogen and include polyhydroxylated piperidines and pyrrolidines. Several 
such compounds show remarkable inhibition of glycosidase enzymes and 
consequently have potential therapeutic uses e.g. as antiviral, anticancer or 
antidiabetes agents (see section 1.4.5). These possible applications, 
coupled with the opportunity they offer to gain further information about the 
enzymes they inhibit, have attracted the attention of synthetic chemists. The 
promise shown by N-butyldeoxyriojirimycin (122) as an anti-HIV drug has 
further spurred interest in the synthesis of more potent and specific azasugar 
analogues. For a review of the syntheses of monocyclic azasugars see 
section 1.4.7. 





We considered that the Nitrile Oxide Cycloaddition (NOC) route, as 
described previously in our approach to higher sugars (section 2.1.1), could 
be adapted to the synthesis of azasugar derivatives. The strategy 
envisaged is illustrated retrosynthetically in Scheme 84. 
The target 1 ,5-dideoxy-1 ,5-iminohexitols (282) may be formed by 
intramolecular ring closure of tosylated amino hexitol derivatives (283), 
obtained via amino deprotection of the oxazolidine precursors (284). These 
in turn could be prepared by reduction of either ketone (285) or (286) for 
which the isoxazolines (287) or (288) represent synthetic equivalents (routes 
'A' and 'B'). 
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Cycloaddition of the nitrile oxide (290) with the allyl tosylate (291) would 
provide the latter isoxazoline (288). Alternatively combination of 
ethoxycarbonylformonitrile oxide (83) with the 4-vinyloxazolidine derivative 
(289) would, after introduction of the tosyl group, correspondingly afford 
isoxazoline (287). Both (289) and (290), which provide the nitrogen sources 
for the resulting azasugars, could be obtained from the same serine-derived 
aldehyde (292). The tosylate leaving group is introduced at complementary 
stages in the two routes. In 'A' it is inserted after manipulation of the initially 
formed isoxazoline, whereas in 'B' it is introduced directly via NOC by 
incorporation in the dipolarophile component. 
The feasibility of both of these routes to azasugar derivatives was 
investigated using the (S)-serine-derived alkene (293) and the 
corresponding nitrile oxide (294) as starting materials. The oxazolidine 
aldehyde (153) which serves as a precursor to these compounds has been 
shown262 to be a useful homochiral building block. Furthermore, methods 
for the generation of nitrile oxide (294) have been established by Boyd 263 
and cycloaddition reactions involving both (293) and (294) have also been 
studied. 263,264  In the following sections the syntheses of the oxazolidine 
alkene (293) and nitrile oxide (294) is described, and thereafter the progress 
made towards the utilisation of the above strategies in the formation of the 
target iminohexitols is discussed. 
+ 
NEC 
Boc )< Boct>< Bocl>< 
(293) (294) (153) 
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2.2.2 Synthesis of (4 R)-3-(N- t-butoxycarbonyl)-2,2-d i methyl-4-
vinyloxazolidine (293) 
The title alkene (293) was prepared in five steps from readily 
available (S)-serine in an overall yield of 43% (Scheme 85). 
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N-tert-Butoxycarbonyl methyl ester (297) was obtained by 
conversion of (S)-serine (295) to its methyl ester hydrochloride (296) 
(SOCl2/MeOH) followed by treatment of the latter with di-tert-butyl 
dicarbonate in pyridine in a modification 264  of a literature procedure. 265 The 
reported265 route to the aldehyde (153) was then followed. lsopropylidine 
protection of the 1,2-amino alcohol function of (297) afforded an oxazolidine 
(298), the ester substituent of which was reduced with DIBAL to give the 
aldehyde (153). The next step was Wittig conversion to the alkene (293) by 
treatment with the ylide generated from met hyltriphenylphosphonium iodide 
and potassium tert-butoxide. This method was shown by Boyd 264 to avoid 
the reported266 racemisation without the need to resort to non-basic 
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olefination procedures. Freshly distilled aldehyde was employed as it 
showed signs of hydration on storage. 
Each of the oxazolidine containing compounds (293), (153) and 
showed doubling of many of the signals in both the 1 H and 1c NMR 
spectra at room temperature. This is consistent with the observations of 
Garner and Park265 for compounds (153) and (298), and is attributed to the 
low rate of inversion between two conformations of the oxazolidine ring 
associated with the steric bulk of the tert-butoxycarbonyl group. They 
reported that when the spectra of (153) and (298) were obtained at higher 
temperatures the expected coalescence of signals occurred; recording the 
spectrum of the alkene (293) at 55°C did indeed bring about increased 
spectral resolution. 
2.2.3 Synthesis of (4R)-4-aldoximino-3-(N-t-butoxycarbonyl)-2,2-
dimethyloxazolidine (299) 
The oxazolidine nitrile oxide (294) was generated from the oxime 
by the procedure developed by Torssel1 23 which involves in situ 
chlorination using N-chlorosuccinimide followed by dehydrochiorination with 
triethylamine. The oxime (299) was obtained from the corresponding 
aldehyde (153) by treatment with hydroxylamine hydrochloride in the 
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Either base proved equally efficient and, as in the synthesis of the 
corresponding alkene, freshly distilled aldehyde was preferred. It should be 
noted that the yields obtained in the above procedures (79%, 80% 
respectively) were significantly better than that reported by Boyd 263 (40%) 
for the pyridine based method. The low yield in that case was attributed to 
the use of aldehyde which was obtained impure even after distillation. As for 
the previous oxazolidine containing systems the 1 H and 1 C NMR spectra of 
the oxime at room temperature showed considerable doubling of the signals. 
When these spectra were run at 55-60°C in C61D6 the resolved signals then 
indicated the presence of an approximately 2:3 mixture of E/Z isomers, the 
separation of which was not required for subsequent steps. 
2.2.4 Cycloaddition of Ethoxycarbonylformonitrile Oxide with (4R)-3- 
(N-t-Butoxycarbonyl)-2,2-dimethyl-4-vi nyloxazol idine (293) 
Nitrosation of glycine ethyl ester hydrochloride (300) using sodium 
nitrite and hydrochloric acid afforded 267 ethyl chloro(hydroxyimino)acetate 









The cycloaddition was carried out by the slow addition (via syringe pump 
over 17 hours) of an ether solution of triethylamine to a cooled (0°C) ether 
















To maximise the consumption of the alkene, excess hydroximoyl chloride 
was used. The slow addition of the base ensured the generation of low 
concentrations of the nitrile oxide (83) thus minimising the formation of 
furazan N-oxide (225) by-product. 
After chromatography to remove the unreacted alkene and unwanted 
furazan N-oxide, an inseparable mixture of cycloadducts (302) and (303) 
was obtained in a combined yield of 81%. The isomer ratio was determined 
by comparison of the integrated signals in the 1 H NMR for the 5-H protons at 
4.78 and 5.10 ppm. The value obtained (70:30) was similar to that 
previously reported 264 by Boyd and Paton (68:32). The major isomer was 
assigned the R-configuration at the new asymmetric centre (0-5), 
corresponding to an erythro relationship about the C-4'/C-5 bond, by analogy 
with similar cycloadducts for which the structures had been unambiguously 
determined.263  
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2.2.4.1 Stereoselectivity of Nitrite Oxide Cycloadditions to Chiral Allyl 
Amines 
In contrast to nitrile oxide cycloadditions to chiral allyl ethers 
(Section 2.1 .6) the it-facial selectivity of the corresponding additions to chiral 
allyl amines has received much less attention. 268-273 Most interest has 
focused on the use of vinylglycine and derivatives thereof as dipolarophiles 
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Scheme 89 
Wade, 271 as part of his studies towards the synthesis of this target 
compound, has investigated the stereoselectivity of such cycloadditions. In 
this work benzenesulphonylcarbonitrile oxide was cycloadded to a number of 
vinyiglycine derivatives (305) in which the nitrogen was protected as a 
carbamate, amide or phthalimide (Table 19). The results indicated that for a 
given N-protected compound conversion of the acid group to its methyl ester 
did not effect the selectivities observed, which varied from 55:45 to 70:30. 
The predominant isomer in each instance possessed the R-configuration 
about the new chiral centre. In contrast, when the carboxylate was replaced 
by an alcohol group reversed selectivity was observed. The addition of 
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CO2H NHCO2C(Me)3 70: 30 
CO2H NHCO2C(Et)3 60 : 40 
CO2H NHCO2CH2-[3,5-(NO2)2C6H3] 70: 30 
CO2H NHCO-[3,5-(NO2)2C6H3] 60 : 40 
CO2H NHCOMe 62 : 38 
CO2H NPhth 62 : 38 
CO2H NHCbz 55:45 
CO2Me NHCbz 55:45 
CO2Me NHPhth 60 : 40 
CH20H NHCbz 47:53 
CH20Ac NHCbz 50 : 50 
C(Me)20H NHCbz 34: 66 
Table 19 
Wade271 interpreted his findings in terms of an extension of the 
Houk model for the equivalent addition to chiral allyl alcohols (see section 
2.1.6). He stated that, as for the allylic oxygen, the allylic nitrogen would 
prefer the inside position near the alkene double bond. Apart from this 
preference a steric model was adhered to. On this basis the two dominant 
transition states for the present cycloaddition are as shown in Figure 33. 
The major product is rationalised as being formed from transition state 'A' in 
which the bulky alkyl group occupies the sterically least demanding anti 
position, the hydrogen is located outside and the nitrogen is inside. This 
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arrangement correctly predicts the R-configuration assigned to the major 
isomer. Thus the results to date may be rationalised using Houk's 'inside 
alkoxy' model in which the allylic alkoxy group is replaced by a nitrogen 
su bstitue nt. 
EtO2CCNQ 





A 	 B 
Figure 33 
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2.2.5 Reduction of Ethoxycarbonyl Function of (302) and (303) 
The next step en route to the azasugar requires reduction of the 
ester group to provide a hydroxymethyl substituted isoxazoline thus enabling 
introduction of the required tosylate leaving group as indicated in the above 
retrosynthetic sequence (Scheme 84). 
The mixture of isoxazolines (302) and (303) was treated with sodium 
borohydride in ethanol to provide the corresponding diastereoisomeric 
mixture of alcohols (306) in excellent yield (96%). As for the parent 
compounds these were found to be chromatographically inseparable 
(Scheme 90). 
N-O 	 N-O 




(302)/(303) 	 (306) 
Scheme 90 
The isomer ratio, measured by integration of the 5-H signals at 4.62 and 
4.96 ppm in the 1 H NMR, was found to be 70:30, consistent with the value 
obtained for the ester mixture from which the alcohols were derived. Despite 
the complexity of the room temperature NMR spectra, signals attributable to 
the major and minor isomers could be identified in the 1 H NMR when run in 
C6D6 at 70°C. The compounds were further characterised by 130  NMR 
(70°C) and infra-red spectroscopy. The chemical formula was verified by 
high resolution FAB mass spectrometry. 
Separation of the C-5 epimers is required at some stage in this 
sequence, preferably prior to introduction of a further chiral centre resulting 
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from reduction of the ketone (Scheme 84). It should be noted that Boyd 263 
and Paton 264 achieved isolation of the individual isomers only after partial 
deprotection (p-TsOH, MeOH) of the ethoxycarbonyl-substituted 
isoxazolines (302)/(303) forming compounds (307) and (308) (Scheme 91). 
However, even after a 70 hour reaction time some starting material was 
recovered and multiple chromatographic steps were found necessary to 















We therefore decided to investigate the feasibility of subsequent steps in the 
proposed route using the diastereoisomeric mixture prior to separation. 
Isolation of optically pure isomers would then be attempted later in the 
reaction sequence, i.e after formation of the sulphonate ester and/or 
cleavage of the isoxazoline ring. 
2.2.6 Attempted Formation of Azasugar Precursors (312)/(313) 
Conversion of the 3-hydroxymethyl group of (306) to the 
corresponding sulphonate ester would provide a suitably positioned leaving 
group which, after manipulation of the isoxazoline and exposure of the amino 
function, could be intramolecularly displaced to afford 1 ,5-imino-sugars. 
Several attempts to tosylate (T5CI, pyridine) or mesylate (MsCI, 
pyridine) the alcohols (306) to provide (309) or (310) proved unsuccessful. 
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(See section 2.2.9 for later success in this respect.) The subsequent 
catalytic hydrogenolysis followed by ketone reduction to provide the 
appropriate diols (312) or (313) could therefore not be achieved. 
Consequently an alternative pathway to these latter compounds was 
attempted. It was proposed that direct catalytic hydrogenolysis of (306) to 
give (311), followed by reduction of the resulting ketone to give a triol, the 
primary hydroxyl of which could be selectively converted to its sulphonate 
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Pd/C, H 2 
Boric Acid 
(a): Ring opening by catalytic hydrogenolysis; (b): Ketone reduction; 
(C): Selective tosylat ion or mesylation. 
Scheme 92 
Unfortunately problems were again encountered. TIc monitoring of the 
palladium-on-charcoal mediated hydrogenolysis of (306) (the procedure as 
detailed in section 2.1.8.1 was employed) indicated the consumption of 
starting material after 4 hours to provide what appeared to be predominantly 
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one more polar product. However, after a standard work-up and attempted 
purification by preparative thin layer chromatography virtually no material 
was recovered. Repetition of the experiment and immediate examination of 
the crude product (initially one spot which was stained by Brady's reagent on 
tic) by 13C  NMR failed to show the expected new carbonyl absorption at 
>-200 ppm. Subsequent tic analysis of this sample indicated significant 
sample deterioration. It is assumed that the -hydroxyketone is formed, but 
decomposes rapidly under the conditions employed. 
In the light of these disappointing results it was decided to pursue 
the alternative route 'B' in which the leaving group (OTs) is built into the 
dipolarophile component at the outset. However, prior to commencing with 
this strategy a brief study of the catalytic hydrogenolysis of simpler non-
oxazolidine substituted isoxazoline systems was carried out in order to 
establish (I): whether the presence of the N-tert-butoxycarbonyl-oxazolidine 
moiety precluded successful ring opening, and (ii): the compatibility of the 5-
tosyloxymethyl-substituted isoxazolines to the reaction conditions. 
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2.2.7 Syntheses of 'Test Isoxazolines' 
Three isoxazolines (314), (315) and (316), all devoid of the N-tert-
butoxycarbonyl-substituted oxazolidine group, were selected for study. The 
latter two serve as models for the 5-substituted isoxazoline fragment of 
(288), whereas the former non-tosylated analogue serves as a comparison 
allowing the effect of a tosyl group to be assessed; the introduction of a 
sulphonate ester group onto the hydroxymethyl containing compounds (314) 
and (315) was also studied. The syntheses of these test compounds will be 
briefly outlined. (Note: In this and subsequent Schemes [Si] = SiMe2tBu.) 
HO(O[Si] 
N—O 






[Si] = SiMe2tBu 
2.2.7.1 Synthesis of (RS)-5-tert- Butyldimethy!si!oxymethy!-3-hydroxy- 
methy!-2-isoxazoline (314) 
The title compound was prepared in an overall yield of 64% according 
to Scheme 93. Readily available ethoxycarbonylformonitrile oxide (83) (1.5 
eq) cycloadded to allyl alcohol (1 eq) to afford isoxazoline (317) in 73% 
yield. The expected diethoxycarbonylfurazan N-oxide (225) (nitrile oxide 
dimer) together with a small quantity of a further material were isolated as 
by-products. This latter compound is assigned the structure (319) resulting 
from cycloaddition of a second nitrile oxide to the imine function of the first 
formed isoxazoline (317). It was identified on the basis of its spectral 
properties. It showed characteristic peaks in the 1 H and 13C  NMR spectra 
for two distinct ethoxycarbonyl groups (& 154.5 and 160.0 ppm, 2xC=O), 
with a quaternary signal at 8 c 151.1 ppm in the latter corresponding to the 
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carbon of the C=N bond. High resolution mass spectrometry verified a 
chemical formula consistent with this structure. The formation of such 2:1 
adducts is not without precedent, 237 ' 274 especially when excess nitrile oxide 
is employed, but is more common for activated C=N bonds. Two 
diastereoisomers would be expected for such a bis-adduct; however, only 
one compound is apparent from both 1 H and 13C NMR. This suggests that 
the steric bulk of the 5-hydroxymethyl group in (317) shields one face of the 
C=N bond from attack thus resulting in the cycloadduct (319) with 





















CO2Et 	 N—Ok 
(320) 
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The free hydroxyl in (317) was converted to its tert-butyldimethylsilyl 
ether (318) in order to decrease the overall polarity of subsequent reaction 
products and therefore aid in their isolation by chromatographic means. 
Difficulties in the ring cleavage of 3-ethoxycarbonyl-substituted isoxazolines 
have previously been reported; 211 '43 a problem attributed to N-O bond 
strengthening as a result of the contribution from the resonance form of type 
(320). The ester functionality of (318) was therefore reduced to afford the 3-
hydroxymethyl-substituted isoxazoline (314). 
2.2.7.2 Synthesis of Isoxazolines (315) and (316) 
Both isoxazolines (315) and (316) were prepared as illustrated in 
Scheme 94. Ethoxycarbonylformonitrile oxide (83) (2.2 eq) was cycloadded 
to p-toluenesulphonic acid allyl ester (291) (prepared by tosylation of allyl 
alcohol with tosyl chloride and pyridine) to afford the required isoxazoline 
(321) in 77% yield. The ester function was reduced (NaBH4) to give alcohol 
(315) (93%) which was then readily converted to the tert-butyldimethylsilyl 





















2.2.8 Reductive Hydrolytic Ring Cleavage of (314), (315) and (316) 
Each of the isoxazolines (1 eq) (314), (315) and (316) was subjected 
to palladium-on-charcoal mediated reductive hydrolytic ring cleavage 
employing boric acid (6 eq) in a methanol:water (5:1) solvent system 
(Scheme 95). In these and subsequent structures for which the 
stereochemistry is indicated only one enantiomer of each pair is shown. 
RO ' Y  OR' 	 RO( OR' + RO OR' 
	
N—O 	 0 OH 	 NH2 OH 
R=H,R=TBDMS (314) 
R=H,R'=Ts 	(315) 





Isoxazoline (314) afforded, after subjection to the above reaction 
conditions for 8.5 hours, the expected J3-hydroxyketone (322) in 47% yield. 
A smaller quantity of a more polar material, which was stained by ninhydrin 
on tic, was also isolated. This was tentatively assigned as structure (323) on 
the basis of high resolution FAB mass spectrometry which verified a 
chemical formula consistent with the formation of these compounds. Further 
evidence for such compounds was not obtained since the attempted 
acetylation (Ac20, pyridine) resulted in decomposition. 
The corresponding hydrogenolysis of isoxazoline (315) was 
complete within 40 mm. After preparative tic the expected 3-hydroxyketone 
(324) was obtained in a disappointing 36% yield. Again a much more polar 
(baseline) material which was stained by ninhydrin was also recovered. This 
material was believed to comprise the pyrrolidine compounds (328)1(329) on 
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the basis of its FAB mass spectrum which contained a strong peak of the 
correct mass (118 M++H). Accurate mass analysis of this peak confirmed 
a formula consistent with such structures. Further analysis was not carried 
out due to the low quantity of material recovered. However, the available 
data does suggest the initial formation of y-amino alcohols (325) followed by 
intramolecular ring closure with displacement of p-toluenesulphonic acid 
(Scheme 96). The low recovery of these compounds is attributed to their 
high affinity for silica gel. The ring cleavage of the isoxazoline (316) was 
therefore examined as in this case the corresponding pyrrolidines (330) and 
(331), if formed, would be less polar and hence more easily purified. 
RO 	 OTs 
NH2 OH 
R = H 	(325) 













Isoxazoline (316) was consumed after 1.5 hours affording the 13-
hydroxyketone (326) in 47% yield (Scheme 95). A more polar band also 
isolated after preparative tIc was found to be composed of both aqueous 
soluble and organic soluble components. The aqueous fraction was 
evaporated in vacuo to afford a solid which by 1 H and 1 C NMR was 
believed to comprise a mixture of p-toluenesulphonic acid and a single 
pyrrolidine, (330) or (331) (Scheme 96). The structural identification of the 
latter compound is discussed in Section 2.2.8.2. The 1 H NMR spectrum of 
the organic fraction was found to be very similar: peaks attributable to p- 
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toluenesulphonic acid and a major pyrrolidine, (330) or (331), could again be 
assigned. In this instance a smaller quantity of the minor isomer (< 20%) 
could be observed, but characterisation was not possible. It is assumed that 
the ring closed compounds exist partly in the form of their tosylate salts thus 
giving rise to the aqueous soluble component. In an attempt to obtain the 
pure compound free of p-toluenesulphonic acid, the organic fraction was 
washed with 5% sodium hydrogen carbonate solution. The 1 H and 1 30 NMR 
spectra of the resulting material did indeed indicate the absence of the 
suiphonic acid (providing further evidence for the ring closure) and, although 
the 1 H NMR was found to be of poorer quality, the 13C NMR spectrum 
contained signals consistent with the proposed pyrrolidine structure. 
Smaller satellite peaks were attributed to the minor isomer. The chemical 
formulae of the pyrrolidines in both samples were verified by high resolution 
FAB mass spectrometry. 
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2.2.8.1 Characterisation of 3-Hydroxyketones 
The 1 H and 1 C NMR of each of the -hydroxyketones (322), (324) 
and (326) showed the characteristic chemical shift changes associated with 
the conversion from their precursor 2-isoxazolines (314), (315) and (316). 
These differences parallel those found for the undecose systems previously 
discussed (Section 2.1.8.3). Tables 20 and 21 compare the data for 
compounds (314) and (322). 
Each 3-hydroxyketone also showed the expected carbonyl 
absorption in the region 1720-1725 cm -1 of the IR spectrum and their 
chemical formulae were verified by high resolution FAB mass spectrometry. 
a a' c c' e e' 	 a a' c c' e  e' 
HO O[Sij 	
HQfl Q[Si] 
(314) 	 (322) 
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10.3 1 7.8 7.6 4.5 
Table 20 
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2.2.8.2 Structural Assignment of Major Pyrrolidine (330) [or (331)] and 
Rationalisation for its Formation 
It has been proposed38 that the catalytic hydrogenation of 2-
isoxazolines resulting in N-O bond cleavage follows the pathway outlined in 
Scheme 75 which is reproduced below. The initially formed -hydroxyimine 
may be hydrolysed to the corresponding -hydroxyketone or undergo further 
reduction to the diastereoisomeric y-amino alcohols. 













In the case of isoxazoline (316) the resulting amino compounds (327) may 
subsequently undergo intramolecular displacement of tosylate to afford the 
corresponding pyrrolidines (330) and (331). In this instance the major 
pyrrolidine was obtained in a ratio of >80:20 ( 1 H NMR). 
The 1 C NMR data support the formation of such cyclic structures. 
Table 24 displays the carbon chemical shifts for the five-carbon chains in the 
isoxazoline (316), 3-hydroxyketone (326) and pyrrolidine (330) or (331). As 
expected the value assigned to 'e' moves to lower chemical shift value in the 
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a b c d e 
Isoxazoline (316) 58.0 158.1 37.2 76.6 69.2 
3-Hydroxyketone (326) 69.3 209.9 40.9 65.3 72.2 
Pyrrolidines (330)/(331) 61.5 59.8 34.6 69.6 52.8 
Table 24 
The available 1 H NMR data are also consistent with the isomeric 
pyrrolidines (330) and (331). The assignment of signals and associated 
coupling constants are presented, together with the two possible isomers 
(only one enantiomer of each shown) in Table 22. The two small couplings 
(Hz) J2b,3  1.3 and J3,4a  1.8, together with the long range W-coupling 
observed between 2b-H and 4a-H (4J2b,4a - 1.3 Hz), support the cis 
arrangement for these protons and their trans relationships with 3-H which 
would be present in either isomer. The J4a,5 and  J4b,5  values of 6.6 and 
10.2 Hz respectively could be accounted for by either isomer through the 
adoption of the conformations 'A' or 'B' presented in Figure 34 (one 
enantiomer shown for each compound). In the (3R5S/3S5R)-i some r, with 
the bulky siloxymethyl group occupying the pseudo-equatorial position as 
shown in 'A', the pseudo trans-diaxial relationship of 5-H and 4b-H is 
consistent with the large 10.2 Hz coupling observed. Likewise the existence 
of a cis relationship between these protons in conformer 'B' for the 
(3R5R/3S5S)-i some r is also consistent with the observed couplings. These 
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arguments assume the preference of the -OCH20[SiJ group to occupy the 
pseudo-equatorial position in the two envelope conformations indicated. 
In order to distinguish between these two possible structures NOE 
experiments were carried out. The protons irradiated and the associated 
NOE enhancements observed are summarised in Table 23. Irradiation of 
the 4a-H signal resulted in the expected enhancement of the 4b-H signal, 
but also an enhancement of the overlapping multiplets for 5-H and 6b-H. In 
contrast no such increase in the 5-H/6b-H multiplets was observed on 
irradiation of 4b-H; only enhancements for 4a-H and 3-H were observed. 
These results are evidence in favour of the (3R5S/3S5R)-pyrrolidine (330), 
in which 4a-H and 5-H would be close in space. The other enhancements 
observed are also consistent with this structure. 
The new chiral centre at 0-5 is generated by hydrogenation of the 
proposed imine intermediate (Scheme 75). The stereochemistry of this 
process is dictated by the selective attack of hydrogen from one face of the 
C=N bond. The predominant formation of the (3R5S/3S5R)-isomer (330) 
would indeed be consistent with the approach of hydrogen from the less 
hindered face of the proposed cyclic borate ester intermediate (332) 
(Scheme 97) which could be formed under the reaction conditions employed. 
The erythro y-amino alcohol (333) thus formed would subsequently cyclise to 
the pyrrolidine (330). 
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The catalytic hydrogenation of 2-isoxazolines substituted at C-3 and 
C-5 to provide diastereoisomenc y-amino alcohols has been reported 42 to 
proceed with low selectivity. In contrast, the hydrogenolysis of similar C-4 
hydroxylated isoxazolines has been found 187 to occur with high levels of 
selectivity (70:30 to 95:5). Boric acid had been deliberately omitted from 
these reactions as its use38 is generally believed to minimise the amount of 
y-amino alcohols formed (Section 2.1.8) by promoting imine hydrolysis. The 
results obtained here were therefore surprising and disappointing, and 
indicate significant competition between the imine hydrolysis and reduction 
pathways even in the presence of boric acid. Attempts to accomplish the 
hydrogenolysis of (315) using Raney-nickel as catalyst provided none of the 
desired -hydroxyketone. 
2.2.9 Mesylation of 3-Hyd roxymethyl-su bstituted Isoxazol i nes 
The inability to tosylate or mesylate the 3-hydroxymethyl substituted 
oxazolidine-isoxazolines (306)/(307) using pyridine as base (section 2.2.6) 
was also found for tosylation of the hydroxymethyl group of (314), starting 
material being recovered in this latter case. However, in a test experiment, 
when the alcohol (315) was reacted with methanesulphonyl chloride in dry 
dichloromethane using triethylamine as base, the desired mesylate (334) 
was obtained in 66% yield together with a smaller quantity of an unidentified 
material (Scheme 98). 






Mesylation of the mixture of (306) under these latter conditions produced a 
compound which appeared by 1 H and 1 C NMR to be the desired mesylate 
(310) (68%). The conditions required for the introduction of a mesyl group 
onto a hydroxymethyl group at the 3-position of an isoxazoline are thus 
established. At this point attention was concentrated on route 'B' (Scheme 
84) the results of which are discussed in the following sections. 
2.2.10 Cycloaddition of Oxazolidine Nitrile Oxide (294) to 
p-Toluenesulphonic Acid Allyl Ester (291) 
The cycloaddition was carried out by the procedure developed by 
Torssell et al. 23 The oxime (leq) (299) was chlorinated in situ using N-
chlorosuccinimide and a catalytic amount of pyridine. Addition of alkene 
(1.5eq) (291) followed by the slow addition, via a syringe pump over 20 
hours, of a chloroform solution of triethylamine (1.1eq) to generate the nitrile 
oxide (294), provided a mixture of isoxazolines (335) and (336) in a 
combined yield of 62% (Scheme 99). After chromatography to remove 
unreacted alkene and furazan N-oxide (337) (identified by high resolution 
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The lack of it-facial selectivity observed here parallels the results 
obtained by Boyd 263  for cycloadditions involving addition of this nitrile oxide 
to achiral dipolarophiles. These observations are also consistent with the 
absence of selectivity reported for the additions of chiral nitrile oxides to 
achiral alkenes,23 249-251  a result attributed to the distance between the 
existing chiral centre in the dipole and the one formed in the cycloaddition. 
The first eluting isoxazoline was assigned the 5R-configuration by 
analogy with other adducts derived from the oxazolidine nitrile oxide the 
stereochemistry of which had been established by chemical correlation. 263  
The 1 H and 13C NMR spectra for each pair of diastereoisomers were found 
to be very similar. The principal distinguishing feature in the reported 
examples was the chemical shift for C-5, the first eluting isoxazoline being 
found to possess a lower chemical shift value A5 0.1 ppm. This was also 
observed for the isoxazolines (335) and (336) with the former less polar 
adduct displaying a signal for C-5 at 77.0 ppm in its 1 C nmr spectrum 
(60°C) with the corresponding signal for (336) occurring at 77.3 ppm. Thus 
route 'B' has the initial advantage over route 'A' in that the individual isomers 
could be separated at the cycloaddition stage, albeit in a 1:1 ratio. 
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2.2.11 Reductive Hydrolytic Ring Cleavage Of Isoxazoline (335) 
The next step involved isoxazohne ring opening to give a 3-
hydroxyketone, the subsequent reduction of which would provide the diols 
(312) previously targeted in route 'A'. 
The reductive hydrolytic cleavage of the isoxazoline (335) was 
carried out in the same manner as for the test isoxazolines (314), (315) and 
(316) (section 2.2.8). Compared to the non-oxazolidine containing 
isoxazolines a longer reaction time was required to achieve consumption of 
the isoxazoline (335) (31 hours vs 1-5 hours). After preparative tic only one 













The compound was characterised by lR spectrometry which indicated the 
presence of carbonyl absorptions at Vmax  1730 and 1715 cm -1 and an 
associated hydroxyl absorption at 3471 cm -1 , 1 H NMR and 13C  NMR 
spectroscopy (207.2/207.7 ppm carbonyl signals for -hydroxyketone and 
tert-butoxycarbonyl functions) and the chemical formula was verified by high 
resolution FAB mass spectrometry. None of the possible y-amino alcohols 
or pyrrolidine compounds comparable with those obtained in the test series 
were isolated. Unfortunately the instability of this compound again 
prevented further steps in this route being attempted. 
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2.2.12 Conclusions 
The practical difficulties encountered at the isoxazoline ring opening 
stages in both routes 'A' and 'B' [i.e. hydrogenolysis of (287) and (288)] 
meant that further study into the viability of this strategy for the synthesis of 
azasugars was not achieved. The ability to release an amino function and 
bring about displacement of a tosylate in an intramolecular fashion in the 
model systems, thereby forming pyrrolidine frameworks, was encouraging. 
However, the failure to isolate isoxazoline ring-cleavage products from the 
corresponding oxazolidine containing systems precluded these compounds 
from being carried through to the targets. The vulnerability of these ring 
cleaved compounds, and/or of the precursor oxazolidine-substituted 
isoxazolines to the hydrogenolysis conditions, is attributed to the tefl-
butoxycarbonyl protected oxazolidine group used to mask the vicinal amino 
alcohol moiety. This suggests that, if this strategy is to be pursued, 
alternative protection of this functionality should be investigated. Reasons 





Elemental analyses were performed by Miss H. Grant, Miss E. 
Stevenson and Mrs. L. Eades using a Perkin Elmer 2400 elemental analyser. 
Infrared spectra were recorded as films or nujol mulls on a Perkin 
Elmer 781 spectrometer and on a Bio-Rad FTS-7 spectrometer. 
FAB mass spectra and exact mass measurements were recorded 
by Mr. A. Taylor on a Kratos MS50TC instrument using either glycerol or 
thioglycerol as a matrix. 
Melting points were measured on a Gallenkamp capillary tube 
apparatus and are uncorrected. 
1 H NMR spectra were recorded on Bruker WP200SY, AX250 and 
WH360 or Varian VXR600 instruments by Miss H. Grant, Mr. J.R.A. Millar, 
Dr. D. Reed and Dr. J. Parkinson. Two-dimensional spectra were recorded 
on the WH360 instrument. 13C  NMR spectra were recorded on the 
WP200SY and WH360 instruments. Chemical shifts () in all spectra are 
measured in parts per million using tetramethylsi lane (8 = 0.0) as the 
reference signal. 
Optical rotations were measured on a Perkin Elmer 141 
polarimeter using 1.8 ml of filtered solution. 
X-ray diffraction analyses were performed on a Stoë STADI-4 four 




Preparative thin layer chromatography was carried out on glass 
plates (20 x 20 cm) coated with a layer of Kieselgel GF2 (0.5 mm) which 
contains 13% calcium sulphate and a fluorescent indicator. Analytical thin 
layer chromatography was carried out on Merck aluminium-backed plates 
coated with Kieselgel GF2 (0.2 mm). 
Dry flash chromatography was carried out with a variety of sintered 
funnels filled with Kieselgel GF254 and eluted under water pump vacuum. 
3.1.3 	Solvents and Reagents 
All reagents and solvents were standard laboratory grade and were 
used as supplied unless otherwise stated. 
Dry ether and toluene were Analar grade dried over sodium wire. 
Dry acetone was Analar grade stored over 4A molecular sieve. 
Pyridine was dried by distillation from and stored over potassium 
hydroxide. 
Dry THF was freshly distilled from sodium and benzophenone. 
Dry ethanol was obtained by distillation from magnesium ethoxide. 
Dry chloroform was obtained by distillation from phosphorous 
pentoxide and stored over molecular sieve. 
Dry DMSO was obtained by allowing the solvent to stand over 
activated calcium sulphate for 24 hr, filtering and distilling from calcium 
hydride under water pump vacuum. The distilled solvent was stored over 
molecular sieve. 
Acetic anhydride was purified by fractional distillation and stored 
over 4A molecular sieve. 
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3.2 	Synthesis of Higher Sugars 
3.2.1 Syntheses of Nitrile Oxide Precursors 
The nitrile oxides were generated in situ by dehydrochlorination of 
the parent hydroximoyl chloride with triethylamine. 
3.2.1.1 Benzohydroximoyl Chloride 
The title compound was prepared according to the method of 
Chiang. 213 Chlorine gas was added slowly to a cooled (-10°C) solution of 
benzaldoxime (10.1 g, 8.35 mmol) in chloroform (300 ml), until the colour of 
the solution had turned green-yellow (via an intermediate blue colour). 
Excess chlorine was removed by bubbling nitrogen through the solution for 
30-40 mm. The solvent was removed in vacuo, chloroform (4 ml) and 
petroleum ether (b.p. 40-60°C) (5 ml) were added and the mixture left in the 
freezer overnight. The white crystals which formed were collected by 
filtration (9.09 g, 70%), m.p. 48-50°C (lit. 213 50-51°C). 
3.2.1.2 2,3:4,5-Di-O-isopropylidene-D-arabinose oxime (203) 
The oxime was prepared from D-arabinose in four steps according 
to Scheme 63. 
3.2.1.28 D-Arabinose diethyl dithioacetal (200) 
Ethanethiol (16 ml, 0.22 mol) was added dropwise, over 20 min to 
a mechanically stirred solution of D-arabinose (15.0 g, 0.10 mol) in 
concentrated hydrochloric acid (15 ml). The mixture was cooled to 0°C, 
stirred for a further 5 mm, then water (40 ml) was added. The off-white solid 
was collected, washed with water (2 x 25 ml) and purified by crystallisation 
from boiling water with hot filtration to produce the product as white needles 
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(12.12 g, 47%), m.p. 125-126°C (lit. 214 126°C from isobutanol); 8H(200 MHz, 
D20) 1.20(3H, t, J7.4, CHCH), 1.21(3H, t, J7.4, CH3CH), 2.60-2.76 (4H, 
m, 2xCH3CH2), 3.54-4.07(6H, m, 1-H, 2-H, 3-F-I, 4-H and 5-H 2); M50 MHz, 
D20) 13.7(2xCH3CH 2), 24.8(2xCH 3 CH 2), 53.8(C-1), 63.0(C-5), 70.4 and 
71.3(C-2, C-3, C-4); m/z (FAB) (Found: M, 256.08031. C 9H04S2 requires 
M, 256.08029). 
3.2.1.2b 2,3:4,5-Di-0-isopropylidefle-D-arabiflOSe diethyl 
dithioaceta1 215 (201) 
A mixture of D-arabinose diethyl dithioacetal (200) (6.0 g, 23.4 
mmol), acetone (60 ml) and concentrated sulphuric acid (0.9 ml) was shaken 
overnight at room temperature. The solution was neutralised with anhydrous 
ammonia gas. The filtrate was stirred overnight with anhydrous copper 
sulphate (3.0 g), filtered and the solvent removed to produce an oil (6.37 g, 
90%); H(360 MHz, CDCI 3) 1.21(3H, t, J 7.4, CI-13CH), 1.23(3H, t, J 7.4, 
CH3CH2), 1.29, 1.32, 1.36, 1.40(12H, 4s, 4xMe), 2.62-2.74(4H, m, 
2xCH 3CH2 ), 3.89-3.93, 3.98-4.11 and 4.23-4.26(1 H, 4H and 1H, 3m, 1-H, 2-
H, 3-H, 4-H, 5-H 2); (50 MHz, 0D013) 14.1 and 14.2(2xCH 3CH2), 
24.6(2xCH3CH 2), 24.9, 26.4, 26.8 and 27.0(4xMe), 52.0(C-1), 67.5(0-5), 
76.8, 78.8 and 84.1(C-2, 0-3 and C-4), 109.4 and 109.9(2xC(Me) 2); m/z 
(FAB) Found: M, 336.14292. C 15 H 2804S2 requires M, 336.14289) 
3.2.1.2c 2,3:4,5Di-0isopropylidefle-a!dehydO-D-arabiflOSe (202) 
The aldehyde was prepared by the method of Zinner et al.215 
Mercuric oxide (14.9 g, 68.8 mol) and mercuric chloride (14.9 g, 54.9 mol) 
were added to a mechanically stirred solution of the bisacetonide (201) (10.0 
g, 29.7 mol) in acetone (90 ml) and water (7.5 nil) then the mixture was 
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heated at 30°C for 2 hr, 50°C for 1 hr and at reflux for 2 hr. The cooled 
mixture was filtered through celite and the solvent removed to give a yellow 
oily residue. Chloroform (250 ml) was added and the mixture shaken with 
aqueous saturated potassium iodide (2 x 250 ml). The organic fraction was 
washed with water (150 ml), dried over sodium sulphate, filtered and 
evaporated to produce a yellow oil. The pure aldehyde was obtained by 
distillation (62°C, 0.01 mmHg) as a clear oil (5.08 g, 74%); [a] -16.1 (c 4.51 
in CHCI3) [Lit. 215  [a] -17.1 (c 7.6 in CHCI3)]; Vm  (neat)/cm -1 1730 (C=O); 
8H(200 MHz, CDCI3), 1.31, 1.34, 1.38 and 1.43(12H, 4s, 4xMe), 3.90-
4.15(4H, m, 3-H, 4-H and 5-H 2), 4.37(1 H, dd, J12 1.0, J23 5.9, 2-H), 9.72(1H, 
d, J12 1.0, 1-H); (50 MHz, CDCI3) 24.9, 26.0, 26.5 and 26.8(4xMe), 66.8 
(C-5), 76.3, 77.5 and 83.1(C-2, C-3 and C-4), 109.8 and 111.7(2xC(Me) 2), 
199.7(C-1); m/z (FAB) 230 (M). 
3.2.1.2d 2,3:4,5-Di-O-isopropylidene-D-arabinose oxime (203) 
Sodium carbonate (2.08 g, 19.6 mmol) was added in portions to a 
solution of hydroxylamine hydrochloride (2.59 g, 37.3 mmol) in water (35 ml) 
and methanol (35 ml). Freshly distilled aldehyde (202) (5.08 g, 22.1 mmol) 
was added and the mixture stirred at room temperature overnight. The 
methanol was removed in vacuo and the aqueous residue extracted with 
chloroform (3 x 60 ml). The combined organic fractions were washed with 
water (50 ml), dried over magnesium sulphate and evaporated in vacuo to 
give a clear oil. Purification by flash chromatography (50% ethyl acetate in 
hexane) afforded the title compound, an oil (5.14 g, 95%), as an 
approximately 5:1 mixture of E and Z isomers; vm /cm 1  (neat) 3375 (OH); 
8H(360 MHz, CDCI3) 1.29, 1.32, 1.36, 1.37, 1.38 and 1.41 (12H, 6s, 4xMe), 
3.89-3.97(1.8H, m), 4.03-4.15(2.OH, m), 4.30(0.2H, dd, J 6.1, J 11.5), 4.48 
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(0.8H, dd, J12 6.3, J23  7.2, 2-H), 4.95(0.2H, dd, J12 5.9, J23 6.9, 2-H), 
6.81(0.2H, dd, J12 5.8, 1-H), 7.39(0.8H, d, J12 6.2, i-H), 8.95(0.8H, br s, 
OH), 9.30(0.2H, br s, OH); 8(50 MHz, CDCI 3) 24.9, 26.5 and 26.7(4xMe), 
65.3(C-5, minor), 66.7(C-5, major), 76.1, 76.5 and 79.1(0-2, C-3 and C-4), 
109.8 and 110.4(2xC(Me) 2), 148.6 (C-i, major), 149.9(0-1, minor); m/z 
(FAB) Found: M+H, 246.13415. C 11 HN05 requires Mi-H, 246.13414. 
3.2.1.3 2,3:4,5-Di-O-isopropylidefle-L-arabinose oxime (204) 
The oxime was prepared from L-arabinose in the same manner as 
for the D-arabinose analogue. 
3.2.1.38 L-ArabinOSe diethyl dithioacetal 
This compound was obtained by the same procedure as was used 
for the D-arabinose derivative (Section 3.2.1.2a). 
Starting with L-arabinose (15.0 g, 0.10 mol) an off-white crystalline 
solid (13.03 g, 51%) was obtained; m.p. 125-126°C (from water), (lit. 275 125-
125.5°C from water); v m /cm 1  (nujol) 3260 (OH); 6H(200  MHz, D20) 1.25(3H, 
t, J 7.4, CH3CH), 1.26(3H, t, J 7.4, CH3CH), 2.68-2.79(4H, m, 2xCH 3CH2), 
3.62-4.12(6H, m, 1-H, 2-H, 3-H, 4-H and 5-H 2); (50  MHz, D20) 
13.6(2xCH 3CH2), 24.7(2xCH 3 CH 2), 53.7(C-1), 63.0(0-5), 70.3 and 71.2(C-2, 
C-3 and C-4); m/z (FAB) Found: M, 256.08031. C 9H04S2 requires M, 
256.08029. 
3.2.1.3b 2,3:4,5- Di- O-iso pro pylidene-L-arabinose diethyl dithioacetal 
The title compound was synthesised in the manner described in 
section 3.2.1.2b. 	Dithioacetal (6.0g, 0.023 mol) from section 3.2.1.3a 
produced the 	required isopropylidene derivative, 	after column 
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chromatography (5% ethyl acetate in hexane), as a pale yellow oil (6.96 g, 
88%); 8H(200 MHz, CDCI 3) 1.22(3H, t, J 7.4, CHCH), 1.24(3H, t, J 7.4, 
CH3CH2), 1.29, 1.33, 1.37, 1.40(12H, 4s, 4xMe), 2.52-2.77(4H, m, 
2xCH3CH2), 3.87-4.12 and 4.21-4.26(5H and 1H, 2m, 1-H, 2-H, 3-H, 4-H, 
5-H2); 8(90 MHz, CDCI 3) 14.2 and 14.3(2xCH 3CH2), 24.8(2xCH 3CH 2), 25.1, 
26.5, 26.9 and 27.2(4xMe), 52.2(0-1), 67.6(C-5), 77.0, 79.0 and 84.3(C-2, 
0-3 and 0-4), 109.6 and 110.1 (C(Me)2);  m/z (FAB) (Found: M, 336.14288. 
C 15H04S2  requires M, 336.14289). 
3.2.1.3c 2,3:4,5-Di-0-isopropylidefle-a!dehYdO-L-arabiflOSe 216 
Bisacetonide (6.6 g, 19.6 mmol) from the preceding section 
produced, after distillation (58°C, 0.01 mmHg), a clear oil (2.99 g, 66%); v 
(neat)/cm -1 1735 (C=O); 6H(200 MHz, CDCI 3) 1.31-1.44(4xMe), 3.89-4.16(m, 
3-H, 4-H and 5-H 2), 4.38(dd, J 1.1, J 6.0, 2-H), 9.72(d, J 1.1, 1-H); (50 
MHz, CDCI3) 24.9, 26.0, 26.5 and 26.8(4xMe), 66.7(C-5), 76.2, 77.5 and 
83.0(C-2, 0-3 and C-4), 109.8 and 111 .7(2xC(Me) 2), 199.8(0-1). (Note: 1 H 
and 130 NMR indicated that the sample was not entirely pure, probably as a 
result of hydration and polymerisation of the initially formed aldehyde, but 
freshly distilled material was used successfully in the next step). m/z (FAB) 
Found: M+H, 231.12322. C 11 H 1905 requires M+H, 231 .12324. 
3.2.1.3d 2,3:4,5-Di-0-isopropylidene-L-arabiflOSe oxime (204) 
Freshly distilled aldehyde (2.88 g, 12.5 mmol) from section 3.2.1.3c 
produced the title oxime as a clear oil (2.85 g, 93%) after flash 
chromatography (50% ethyl acetate in hexane). 1 H NMR analysis revealed 
the presence of an 5:1 mixture of E and Z isomers. vm /cm 1  (neat) 3380 
(OH); H(360 MHz, CDCI 3) 1.32, 1.34, 1.38, 1.39, 1.40, 1.43(12H, 6s, 4xMe), 
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3.91-3.99(1.8H, m), 4.04-4.17(2.OH, rn), 4.31(0.2H, dd, J 6.1, J 11.6), 
4.50(0.8H, dd, J12 6.2, J23  7.3, 2-H), 4.97(0.2H, dd, J12 5.9, J23 6.9, 2-H), 
6.83(0.2H, d, J12 5.8, 1-H), 7.42(0.8H, d, J12 6. 1, 1-H), 8.59(0.8H, br s, OH), 
8.90(0.2 H, br s, OH); (90 MHz, CDCI 3) 25.0, 25.2, 26.3, 26.5, 26.6, 
26.7(4xMe), 65.4(C-5, minor), 66.8(C-5, major), 76.2, 76.5 and 79.2(0-2, C-3 
and C-4), 109.8 and 110.5(2xC(Me) 2), 148.8(0-1, major), 150.2(0-1, minor); 
m/z (FAB) (Found: M+H, 246.13415. C 11 HN05 requires M+H, 246.13414). 
3.2.2 Syntheses of Sugar Alkenes 
3.2.2.1 3- O-Benzyl-5,6-dideoxy-1 ,2- O-isopro pylidene-a-D-xylo-hex-5-
enofuranose (84) 
The title alkene was prepared in four steps from commercially 
available diacetone-D-glucose (Scheme 64). 
3.2.2.1a 3-O-Benzyl-1 ,2:5,6-di-0-isopropylidene-a-D-gIuCO-fUraflOSe 
(206) 
The title compound was prepared by the method of Iwashige and 
Saeki. 218 Diacetone-D-glucose (205) (25 g, 96 mmol) in DMSO (125 ml) was 
added dropwise to a suspension of sodium hydride (80% dispersion in 
mineral oil, 6.25 g) in DM50 (125 ml) under nitrogen and stirred for 45 mm 
at room temperature. Benzyl chloride (32 ml) was added dropwise and the 
mixture stirred for a further 1 hr, before being poured onto an ice/water slurry 
(400 ml) followed by extraction with ether (3 x 250 ml). The combined 
organic fraction was evaporated in vacuo, diluted with petroleum ether (b.p. 
60-80°C, 200 ml) and washed with water (4 x 150 ml). The organic layer 
was dried (MgSO4) and evaporated in vacuo to produce the crude product as 
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a yellow oil (35 g). This crude material was used without purification in the 
next stage. 
3.2.2.1b 3-O-Benzyl-1 ,2- O-isopropylidene-a-D-g/uco-fu ran OSe (207) 
The title compound was prepared according to a literature 
procedure. 219 The crude compound (206) (33.7 g, from section 3.2.2.1a) 
was stirred overnight at 40°C in glacial acetic acid (100 ml) and water 
(65 ml). The excess acid was neutralised by addition of saturated aqueous 
potassium carbonate solution, and the mixture extracted with chloroform (3 x 
100 ml). The combined organic extract was washed with 10% sodium 
chloride solution (60 ml), dried (MgSO 4) and evaporated under reduced 
pressure to afford the crude diol (207) which was used directly in the next 
stage. 
3.2.2.1c 3-O-Benzyl-1 ,2-O-isopropylidene-5,6-bis-O-methafleSUlPhOflYl-
a-D-gIuCO-f U ran ose (208) 
Methanesuiphonyl chloride (18.5 ml, 0.239 mol) was added to an 
ice-chilled solution of the crude dial (207), from section 3.2.2.1b, in pyridine 
(60 ml) and stirred overnight while warming to room temperature. Water 
(100 ml) and chloroform (100 ml) were added and the aqueous layer 
extracted with chloroform (3 x 50 ml). The combined organic fraction was 
washed with 1M sulphuric acid (100 ml) and saturated sodium hydrogen 
carbonate solution (100 ml), then dried (MgSO 4) and evaporated in vacuoto 
an oft-white solid. Recrystallisation from ethanol-methanol (1:1) afforded the 
title compound as a white solid (24.9 g, 56% from diacetone-D-glucose), m.p. 
124-125°C (lit. 220 124-1250C); m/z (FAB) Found: M-i-H, 467.10460. 
C 1 8H27S2010 requires M+H, 467.10455. 
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3.2.2.1d 3- O-Benzyl-5,6-dideoxy-1 ,2-O-isopropyl idene-a-D-xyIo-hex-5 
enofuranose (84) 
The alkene was prepared by redtjction 211 of dimesylate (208). 
Zinc/copper couple (freshly prepared 276  from 10.56 g of powdered zinc) was 
added to a stirred solution of the dimesyl compound (208) (15 g, 32.2 mmol), 
dried sodium iodide (24.1 g, 0.16 mol), DMF (152 ml) and dimethoxyethane 
(26ml) and refluxed for 70 mm. The cooled solution was poured onto H 20 
(600 ml) with rapid stirring then toluene (250 ml) added and the mixture 
filtered through celite. The filter pad was washed with toluene (2 x 250 ml) 
and the filtrates used to extract the aqueous layer. The combined organic 
fractions were washed with water (2 x 150 ml), dried (MgSO 4) and 
evaporated to the pure title compound (7.9 g, 89%); 6H(250 MHz, CDCI 3) see 
Table 25; 6(63 MHz, CDCI3) 26.0, 26.6(2xCH 3), 71.8(CH2Ph), 81.3, 82.6, 
83.1(C-2, 0-3, C-4), 104.6(C-1), 111.3(C(Me) 2), 118.9(0-6), 127.3, 127.6, 
128.2(5xPhCH), 132.1(C-5), 137.3(PhC); m/z (FAB) Found: M+H, 




Resonance  Coupling J/Hz 
1 5.97 1,2 4.0 
2 4.62 2,3 <1 
3 3.88 3,4 3.1 
4 4.63 4,5 7.1 
5 6.02 5,6a 10.4 
6a 5.32 5,6b 17.4 
6b 5.44 6a,6b 1.6 
PhCH2 4.54, 4.65 PhCH2 12.2 
Ph 7.27-7.35 
CH3 1.32,1.50  
Table 25 
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3.2.2.2 3- O-Benzyl-5,6-dideoxy-1 ,2- O-isopropylidene-a-D-ribO-heX-5-
enofuranose (198) 
The alkene (198) was prepared in six steps from commercially 
available diacetone-D-glucose (Scheme 65). 
3.2.2.2a 1 ,2:56-Di- O-isopropylidene-a-D-a!!o-furanose 
The title compound was prepared according to a literature 
procedure. 223  Acetic anhydride (20 ml) and dry DMSO (80 ml) were heated 
to ref lux under nitrogen. Diacetone-D-glucose (205) (10.0 g, 38.5 mmol) was 
added portionwise and the mixture stirred at ref lux for 1 hr before the solvent 
was removed by evaporation in vacuo. The residue containing the ketone 
(209) was dissolved in ethanol (60 ml) and the resulting solution cooled in an 
ice-salt bath. Sodium borohydride (1.2 g, 31.7 mmol) was added in portions 
and the resulting mixture stirred overnight while warming to room 
temperature. The mixture was concentrated in vacuo then dissolved in 
chloroform (20 ml) and water (60 ml). The aqueous fraction was extracted 
with chloroform (2 x 20 ml), and the organic fraction was washed with water 
(20 ml). The combined organics were dried (MgSO 4) and evaporated in 
vacuo to afford the crude product as an oil (9.88 g, 99%), which slowly 
crystallised on standing to a white solid, m.p. 77-78°C (lit. 223 77-78°C, from 
benzene/petroleum ether, 1:5). 
3.2.2.2b 3-0-Benzyl-1 ,2:5,6-di-0-isopropylidene-ct-D-aIIO-fUraflOSe (210) 
Diacetone-D-a//o-furanose (9.0 g, 34.6 mmol) from section 3.2.2.2a 
in DMSO (45 ml) was added dropwise to a stirred suspension of sodium 
hydride (80% dispersion in mineral oil, 2.3 g) in DMSO (45 ml) under 
nitrogen and the resulting mixture stirred for a further 45 min at room 
temperature. Benzyl chloride (11.5 ml) was added dropwise, the mixture 
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stirred for 1 hr then poured onto an ice/water slurry (250 ml), and the product 
extracted with ether (3 x 100 ml). The combined organic fractions were dried 
(MgSO4) and concentrated in vacuo to an oil which precipitated a white solid 
on the addition of hexane. Recrystallisation of the solid from hexane 
afforded the title compound (4.81 g, 40%), m.p. 66-67°C (lit. 211 65-67°C, 
from hexane). 
3.3.3.3c 3- O-Benzyl-1 ,2- O-isopropylidene-a-D-aIIo-fu ran OSe (211) 
A solution of 3-0-benzyl-1 ,2:5,6-di-Q-isopropylidene-a-D-aIIO-
furanose (210) (2.65 g, 7.6 mmol) in glacial acetic acid (8 ml) and water (5 
ml) was stirred overnight at 40°C. The excess acid was neutralised by 
addition of aqueous saturated potassium carbonate solution. The mixture 
was extracted with chloroform (3 x 20 ml) and the combined organic fractions 
were washed with 10% sodium chloride (20 ml), dried (MgSO 4) and 
evaporated in vacuo to afford the crude diol (211), which was used without 
purification in the next step. 
3.2.2.2d 3-O-Benzyl-1 ,2O.isopropylidene-5,6-biS-O-methafleSUIPhOflYl -
a-D-aI!o-furanose (212) 
Methanesulphonyl chloride (15 ml, 0.194 mol) was added to a 
solution of the diol (211), from section 3.3.3.3c, in pyridine (4.6 ml) at 0°C 
and the mixture stirred overnight while warming to room temperature. After 
pouring onto water (10 ml) the mixture was extracted with chloroform (3 x 15 
ml). The combined organic fraction was washed with 2M HCI (5 ml) and 
saturated sodium bicarbonate (5 ml) then dried (MgSO 4) and evaporated in 
vacuo to an off-white solid. Recrystallisation from methanol:ethanol (1:1) 
afforded white crystals (2.1 g, 60% from (205)), m.p. 110-111°C (Lit. 211 111-




Zinc/copper couple (freshly prepared 276 from 1.02 g of powdered 
zinc) was added to a stirred solution of dimesyl compound (212) (1.45 g, 3.1 
mmol), dried sodium iodide (2.32 g, 15.5 mmol), DMF (15.2 ml) and 
dimethoxyethane (2.6 ml) and stirred under reflux for 70 mm. The cooled 
mixture was poured onto water (59 ml) with stirring, toluene (24 ml) added 
then the mixture filtered through celite. The filter pad was washed with 
toluene (2 x 24 ml) and the filtrates used to extract the aqueous phase. The 
combined toluene layers were washed with water (2 x 15 ml), dried (MgSO 4 ) 
and evaporated in vacuo to an oil which was purified by dry flash 
chromatography on silica (40% ether in hexane) to afford the title compound 
as an oil (0.62 g, 73%); H(200  MHz, CDCI3) see Table 26; 6(50  MHz, 
CDCI3) 26.3, 26.6(C(Me) 2), 72.1(OCH 2Ph), 77.4, 78.9, 81.7(0-2, C-3, 0-4)), 
103.6(0-1), 112.7(C(Me) 2), 127.8, 128.3(PhCH), 134.7(C-5), 137.4(PhC). 
Bn& 
(198) 
Resonance  Coupling J/Hz 
1 5.73 1,2 3.7 
2 4.55 2,3 4.3 
3 3.50 3,4 9.0 
4 4.47 4,5 6.6 
5 5.81 5,6a 10.3 
6a 5.25 5,6b 17.2 
6b 5.44 6a,6b 1.0 
PhCH2 4.61,4.75 PhCH2 12.2 
Ph 7.25-7.38 
CH3 1.36, 1.61  
Table 26 
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3.2.2.3 Methyl 5,6-dideoxy-2,3- O-isopro pyl iderie-a-D..Iyxo-hex-5-
enofuranoside (199) 
The title alkene was prepared in four steps from D-mannose 
according to Scheme 66. 
3.2.2.3a Methyl 2,3:5,6- Di- O-isopropylidene-cz-D-manno-fu ran OSide (213) 
The title compound was prepared according to a literature 
procedure. 225  D-Mannose (20.0 g, 0.11 mol), 2,2-dimethoxypropane (68 ml), 
acetone (66 ml), ethanol (66 ml) and concentrated hydrochloric acid (2 ml) 
were heated under ref lux for 2 hr with stirring. Water (200 ml) was added to 
the cooled solution then the volume reduced to - 200 ml by evaporation 
under reduced pressure. The product was used without isolation in the next 
stage. 
3.2.2.3b Methyl 2,3- 0-isopropyl idene-a-D-manno-fu ran oside 2 (214) 
Methanol (200 ml) and concentrated hydrochloric acid (5 ml) were 
added to the solution of (213) from section 3.2.2.3a and the mixture stirred at 
23°C for 200 mm, before 1M sodium hydrogen carbonate (150 ml) was 
added. Methanol was removed by concentration in vacuo and the product 
obtained by continuous liquid-liquid extraction with chloroform. The 
chloroform layer was dried (MgSO 4) and evaporated in vacuo to a syrup 
which was used directly in the next stage. 
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3.22.3c Methyl 2,3-0-isopropyl idene-5,6-d I- O-methanesu I phonyl-a-D-
manno-furanoside 2 (215) 
The diol (214), from section 3.2.2.3b, was dissolved in pyridine 
(100 ml) and methanesulphonyl chloride (30 ml, 0.387 mol) was added 
slowly maintaining the internal temperature below 35°C. After stirring for 2 
hr at room temperature water (300 ml) was added slowly, and the mixture 
filtered to obtained the crude product as a white solid. Recrystallisation from 
ethanol afforded the product as a white crystalline solid (30.7 g, 71% from D-
mannose), m.p. 144-145°C (lit. 225 144.5-146.0°C from ethanol); m/z (FAB) 
Found: M-i-H, 391.07324. C 12 H 23010 S2 requires M+H, 391.07325. 
3.2.2.3d Methyl 5,6-d ideoxy-2,3- O-iso pro pylidene-a-D-Iyxo-hex-5-
enofuranoside (199) 
Zinc/copper couple (freshly prepared 276 from 10.7 g of powdered 
zinc) was added to a solution of the dimesyl compound (215) (12.8 g, 32.8 
mmol), dried sodium iodide (24.6 g, 0.16 mol), DMF (150 ml) and 1,2-
dimethoxyethane (25 ml) and stirred under ref lux for 70 mm. After cooling to 
room temperature the mixture was poured onto water (600 ml) with rapid 
stirring, toluene (250 ml) added and the mixture filtered through celite. The 
filter pad was washed with toluene (2 x 250 ml) and the filtrate used to 
extract the aqueous layer. The combined toluene layers were washed with 
water (2 x 150 ml), dried (MgSO 4) and evaporated in vacuo to an oil (199) 
(6.3 g, 96%); H(200 MHz, ODd 3) see Table 27; (50 MHz, CDCI3) 24.7, 
25.8(C(Me) 2), 54.4(OMe), 80.9, 81.3, 85.1(0-2, C-3, C-4), 106.9(C-1), 
112.3(C(Me) 2), 118.8(0-6), 132.2(0-5); m/z (FAB) Found: M+H, 201 .11265. 




Resonance  Coupling J/Hz 
1 4.87 1,2 <1 
2 4.53 2,3 5.8 
3 4.63 3,4 3.6 
4 4.34 4,5 7.4 
5 5.95 5,6a 10.3 
6a 5.29 5,6b 17.5 
6b 5.36 6a,6b 1.8 
OCH3 3.30 
CH3 1.27, 1.42  
Table 27 
3.2.3 Nitrile Oxide Cycloadditions: Stereoselectivity 
Studies 
3.2.3.1 Cycloaddition of Benzonitrile Oxide to 3-O-Benzyi-5,6-dideoxy- 
1 ,2-O-isopropylidene-a-D-ribo-hex-5-enofuranose 2 (198) 
Triethylamine (325 mg, 3.2 mmol) in 1 ,2-dichioroethane (13 ml) 
was added, via motorised syringe pump, over 36 hr to a stirred solution of 
aikene (198) (438 mg, 1.95 mmol) and benzohydroximoyl chloride (455 mg, 
2.9 mmoi) in 1 ,2-dichloroethane (7 nil). After stirring for a further 6 hr the 
mixture was poured onto water (25 ml) and extracted with chloroform (3 x 30 
ml). The combined organic extracts were dried (MgSO 4) and evaporated in 
vacuo to a yellow syrup. Dry flash chromatography (20-80% ether in 
hexane, gradient elution) yielded, in order of elution, 3,4-diphenylfurazan N-
oxide (224) (108 mg, 31%), identified by comparison tic with an authentic 
199 
sample, and a mixture of (5R)- and (5S)-5-(3-O-benzyl-1 ,2-O-isopropylidene-
a-D-ri bo -tetrofuranos-4 -yi)-3 -phenyl-2 -isoxazoline (216) + (217) (541 mg, 
70%); m.p. 85-86°C (from cyclohexane); (Found: 0, 69.5; H, 6.2; N, 3.6. 
CHNO5 requires C, 69.9; H, 6.3; N, 3.5%); H(360  MHz, CDCI3) see Table 
28; 5(50 MHz, CDCI 3) 26.4, 26.7(C(Me) 2), 36.0, 36.7(C-6), 72.4(CH 2Ph), 
77.3, 77.6, 77.9, 78.0, 79.0, 79.5(C-2, C-3, 0-4, 0-5), 103.8, 104.1(C-1), 
112.9(C(Me) 2), 126.6-130.0(Ph envelope), 129.1, 129.3(C-8), 136.8, 
137.3(PhC), 156.45, 156.53(C-7); m/z (FAB) Found: M+H, 396.18107. 
CHN 1 05  requires M+H, 396.18108. The ratio (216):(217) was determined 
as 42:58 from 1 H NMR. Crystals of the minor isomer suitable for X-ray 
analysis were obtained by repeated recrystallisation from chloroform. The 











Erythro Threo Erythro Threo 
Resonance (216) (217) Coupling (216) (217) 
1 5.77 5.72 1,2 3.7 3.7 
2 4.55 4.57 2,3 4.4 4.3 
3 3.84 4.07 3,4 8.8 8.8 
4 4.17 4.14 4,5 2.1 2.4 
5 5.05 4.85 5,6a 6.6 11.4 
6a 3.43 3.37 5,6b 11.6 7.7 
6b 3.30 3.49 6a,6b 16.6 16.6 
PhCH2 4.27, 4.55 4.79, 4.63 PhCH2 11.2 11.7 
Ph 7.00-7.65 
OH3 1.34, 1.58, 1.59  
Table 28 
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3.2.3.2 Cycloaddition of Benzonitrile Oxide to Methyl 5,6-dideoxy-2,3- 
0.isopropylidene-a-D-!yxo-hex-5-eflofUraflOSide (199) 
Triethylamine (0.39 g, 3.9 mmol) in ether (25 ml) was added, via 
motorised syringe pump, over 41 hr to a solution of the alkene (199) 
(0.965 g, 4.8 mmol) and benzohydroximoyl chloride (0.50 g, 3.2 mmol) in 
ether (25 ml) at 0°C. After stirring for a further 6 hr the precipitated 
triethylamine hydrochloride was removed by filtration and the filtrate washed 
with water (25 ml). The organic layer was dried (MgSO 4 ) and evaporated to 
a yellow solid. Dry flash chromatography on silica gel (15-30% ether in 
hexane, gradient elution) afforded, in order of elution, unreacted alkene 
(199) (0.26g, 27%), 3,4-diphenylfurazan N-oxide (224) (62 mg, 16%) 
(identified by comparison tIc with an authentic sample), and a pair of 
diastereoisomeric isoxazoline cycloadducts in a ratio of 82:18 (determined 
from 1 H NMR). The major isomer, which eluted first, was identified as (5R)-
5-(2 ,3-0-isopropylidene-1 -o -methyl-cx-D-lyxo -tetrofuranos-4-yI)-3-phenyl-2 - 
isoxazoline (220) (0.708 g, 69%), white needles, m.p. 123-125°C (from 
MeOH); [a] 	-35.2 (c 1.29 in CHCI 3); (Found: C, 64.0; H, 6.8; N, 4.3. 
C17H 21 N05 requires C, 63.9; H, 6.6; N, 4.4%); 6H(200  MHz, CDCI3 ) see Table 
29; 6 (50 MHz, CDCI 3) 24.3, 25.7(C(Me) 2), 37.3(C-6), 54.6(OMe), 78.1 (C-5), 
79.1, 79.4, 84.8(C-2, C-3, 0-4), 107.1(0-1), 112.5(C(Me) 2), 129.4(PhC), 
126.6, 128.5, 129.9(5xPhCH), 156.7(C-7); m/z (FAB) Found: M+H, 
320.14979. C 17 H 22N05 requires M+H, 320.14979. The minor isomer was 
identified as (5S)-5- (2,3 -O -isopropylidene- 1 -0 -met hyl-a-D-lyxo- tetrofuranos-
4-y!)-3-phenyl-2-isoxazoline (221) (0.134 g, 13%), a white solid, m.p. 130- 
131°C (from MeOH); [a] + 84.8 (C 1.17 in CHCI3); (Found: C, 63.8; H, 6.4; 
N, 4.6. C 17H 21 N05 requires C, 63.9; H, 6.6; N, 4.4%); 6H(200 MHz, CDCI 3 ) 
see Table 29; (50 MHz, CDC,) 24.6, 25.8(C(Me) 2), 37.5(0-6), 54.6(OMe), 
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79.6(0-5), 80.2, 81.3, 84.7(C-2, C-3, 0-4), 107.3(0-1), 112.8(C(Me) 2), 
129.2(PhC), 126.5, 128.5, 130.0(5xPhCH), 156.2(0-7); m/z (FAB) Found: 
M+H, 320.14979. C 17 H 22N05 requires M+H, 320.14979. 
Ph 	H6b 
%
, oi H6a 







Erythro Threo Eiythro Threo 
Resonance (220) (221) Coupling (220) (221) 
1 4.91 4.99 1,2 <1 <1 
2 4.58 4.57 2,3 5.9 5.9 
3 4.81 4.75 3,4 3.6 3.8 
4 4.08 4.07 4,5 6.3 8.6 
5 5.05 4.94 5,6a 8.6 10.7 
6a 3.45 3.57 5,6b 9.7 8.7 
6b 3.45 3.12 6a,6b - 16.9 
OMe 3.30 3.34 
Ph 7.36-7.71 7.34-7.70 
CH3 1.33, 1.50 1.29, 1.44 
Table 29 
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3.2.4 Nitrile Oxide Cycloaddition Reactions: Undecose 
precursors 
3.2.4.1 Cycloadditions of Nitrile Oxides to 3-0-Benzyl-5,6-dideoxy-1,2-
0-isopropyl idene-cx-D-xylo-hex-5-eflofu ran ose (84) 
3.2.4.1 a 2,3:4,5-Di-O-Iso pro pylidene-D-arabi non oflitriIle Oxide (196) 
The oxime (203) (1.20 g, 4.9 mmol) in dry chloroform (5 ml) was 
added to a suspension of N-chlorosuccinimide (0.65 g, 4.9 mmol) in dry 
chloroform (5 ml) and dry pyridine (0.05 ml) and stirred at room temperature 
for 30 mm. The alkene (84) (2.03 g, 7.3 mmol) in chloroform (5 ml) was 
added and the mixture cooled in an ice-salt bath. Triethylamine (0.54 g, 5.4 
mmol) in dry chloroform (35 ml) was pumped in, via motorised syringe pump, 
over 11 hr then the mixture stirred for a further 10 hr. The solution was 
washed with water (2 x 20 ml), dried (MgSO 4) and evaporated in vacuo. The 
resulting oil was purified by dry flash chromatography on silica (15-30% 
ether in hexane, gradient elution) to afford, in order of elution, unreacted 
alkene (0.71 g, 35%), an inseparable mixture (0.20 g) of 3,4-di-(1 ,2:3,4-di-O-
isopropylidene-D-arabino-tetritol-yl)-furazan N-oxide (226) (m/z (FAB) Found: 
M+H, 487.22918. C22HN20 10 requires M+H, 487.22915) and 3,5-di- 
(1,2:3,4- di-O -isopropylidene-D-arabi no -tetritol-yl)- 1,2,4 -oxadiazole (227) (m/z 
(FAB) Found: M+H, 471.23428. C 22HN209 requires M+H, 471.23424); 
(50 MHz, CDCI3) quaternary signals for (226) and (227): 109.7, 109.9, 
111 .4, 111 .7, 111 .9, 11 2.2(C(Me)2, C3t,jrox ), 1 56.0(C4i ,jroxai,), 161.7 
(C5odIazoIe) and a pair of diastereoisomeric isoxazolines in the ratio of 
89:11 (determined from 1 H NMR). The major isomer, which eluted first, was 
obtained as a white solid and was identified as (5R)-5-(3-0-benzy1-1 , 2-O-
isopropylidene-a -D-xy lo -tetrofuranos- 4 -yI)-3- (1,2:3,4 -di-O -isopropylidene-D-
arabino-tetritol-yI)-2-isoxazoline (230) (1.60 g, 63%), m.p. 74-75°C (from 
203 
EtOH); [CC] 21 -60.5 (C 0.44 in 0H013); (Found: C, 62.4; H, 7.3; N, 2.7. 
C27H 37N09 requires C, 62.4; H, 7.2; N, 2.7%); 6H(360  MHz, CDCI 3) see 
Tables 30 and 31; 8(90  MHz, CDCI3) 24.8, 25.9, 26.2, 26.4, 26.5, 
26.7(6xMe), 37.2(C-6), 66.5(C-11), 72.2(CH 2Ph), 74.3(C-8), 75.9(C-10), 
76.9(0-5), 78.6(0-9), 80.2(0-4), 81.2(C-3), 82.4(0-2), 104.9(C-1), 109.5, 
110.4, 111.6(3xC(Me) 2), 127.4, 127.7, 128.2(5xPhCH), 137.1(PhC), 157.6(C- 
7); m/z(FAB) Found M+H, 520.25463. 	C27HN09 requires M+H, 
520.25464. The minor isomer, which was obtained as an oil, was identified 
as 	(5S)-5- (3-0 -benzyl- 1,2-0 -isopropylidene-a -D-xy lo -tetrofuranos-4 -yI)-3- 
(1,2:3,4 -di-O-isopropylidene-D-arabi no -tetritol-yI)-2 - isoxazoline (231) (0.20 g, 
8%); [a] +20.4 (c 1.22 in CHCI 3); H(360  MHz, CDCI 3) see Tables 30 and 
31; (50 MHz, CDCI3) 24.8, 26.2, 26.4, 26.7(6xMe), 36.0(C-6), 66.4(0-11), 
71.4(CH 2Ph), 74.2(C-8), 75.8(C-10), 78.4(0-9), 79.4(C-5), 81.6(0-2, 0-3, 
0-4), 105.5(C-1), 109.5, 110.4, 111.9(3xC(Me) 2 ), 127.9, 128.0, 
128.4(5xPhCH), 136.7(PhC), 156.4(0-7); m/z (FAB) Found: M+H, 
520.25463. C 27HN09 requires M+H, 520.25464. 
3.2.4.1 b 2,3:4,5-Di-0-isopropylidene-L-arabinOflOflitrile oxide (197) 
The oxime (204) (1.00 g, 4.1 mmol) in dry chloroform (4 ml) was 
added to a suspension of N-chlorosuccinimide (0.55 g, 4.1 mmol) in dry 
chloroform (4 ml) and pyridine (0.04 ml) and stirred for 30 min at room 
temperature. Alkene (84) (1.69 g, 6.1 mmol) in dry chloroform (5 ml) was 
added and the solution cooled in an ice-salt bath. Triethylamine (0.45 g, 4.5 
mmol) in dry chloroform (30 ml) was added, via motorised syringe pump, 
over 10 hr and the mixture stirred for a further 6 hr. The solution was 
washed with water (3x25 ml), dried (MgSO 4) and evaporated to an oil. The 
oil was purified by dry flash chromatography on silica (10-40% ether in 
hexane, gradient elution) to afford, in order of elution, unreacted alkene 
204 
(0.92 g, 54%), an inseparable mixture (0.11g) of the nitrile oxide dimers 3,4- 
di-( 1,2:3,4 -di-O -isopropylidene-L -a rabi no -tetritol-yl) -furazan N - oxide (228) 
(m/z (FAB) Found: M+H 487.22912. C 22HN20 10 requires M+H, 487.22915) 
and 3,5-di-(1 ,2 :3,4-di-O-isopropylidene-L-aräbi no-tetritol-yI)-1 ,2 ,4-oxadiazole 
(229) (m/z (FAB) Found: M+H, 471.23422. C 22HN209 requires M+H, 
471.23424); (S°  MHz, CDCI3) quaternary signals for (228) and (229): 
109.6, 109.8, 111.3, 111 .6, 111 .8, 112.1 (C(Me)2, C3 roç ), 1 56 .O(C 4fjrox,), 
161 .6(CSoxdioIe); and a pair of diastereoisomeric isoxazolines in a ratio of 
88:12 (determined from 1 H NMR). The first eluting isoxazoline, obtained as 
a white solid, was identified as (5R)-5-(3-O-benzyl-1 ,2-O-isopropylidene-(x-D-
xylo-tetrofuranos-4-yI)-3-(1 ,2 :3,4 -di-O -isopropyiidene-L-arabi no -tetritol-yI)-2 - 
isoxazoline (232) (1.26 g, 59%), m.p. 99-100°C (from EtOH); [a] -99.9 (C 
0.93 in CHCI3); (Found: C, 62.2; H, 7.3; N, 2.75. C27H37N09 requires C, 
62.4; H, 7.2; N, 2.7%); R(360  MHz, ODd 3) see Tables 30 and 31; 8(50 
MHz, CDCI 3) 25.0, 26.0, 26.4, 26.6, 26.8(6xMe), 37.6(C-6), 66.6(C-11), 
72.4(CH 2Ph), 74.4(C-8), 75.9(C-10), 77.0(C-5), 78.7(C-9), 80.4(0-4), 81.3(C-
3), 82.6(0-2), 105.0(C-1), 109.7, 110.6, 111.8(3xC(Me) 2), 127.5, 127.8, 
128.3(5xPhCH), 137.3(PhC), 157.5(0-7); m/z (FAB) Found: M+H, 
520.25463. C27HNO9 requires M+H, 520.25464. The minor isomer, 
obtained as a white solid, was identified as (5S)-5-(3-0-benzy1-1 ,2-O-
isopropylidene-cx -D-xy lo -tetrofuranos-4 -yl) -3- (1,2:3,4 -di-O -isopropylidene-L-
arabino-tetritol-yI)-2-isoxazoline (233) (0.17 g, 8%), m.p. 121-122°C (from 
EtOH); [a] -20.3 (C 0.29 in CHCI 3); H(360  MHz, CDCI3) see Tables 30 and 
31; (50  MHz, CDCI3) 24.9, 26.4, 26.8(6xMe), 36.3(0-6), 66.7(C-11), 
71.5(CH2Ph), 74.4(C-8), 75.9(0-10), 78.6(C-9), 79.4(C-5), 81.7(C-4), 81.9(0-
3), 82.0(0-2), 105.6(0-1), 109.7, 110.4, 112.0(3xC(Me) 2), 127.9, 128.1, 
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128.4(5xPhCH), 136.7(PhC), 156.3(C-7); m/z (FAB) Found: M+H, 











R 0 ;Y( 
8H 8H 
Ethryo Threo Ethryo Threo 
Resonance (230) (231) (232) (233) 
1 5.88 5.97 5.89 5.97 
2 4.59 4.64 4.58 4.66 
3 4.05 3.94 4.06 3.95 
4 4.15 4.23 4.18 4.19 
5 4.94 4.80 4.91 4.85 
6a 3.20 2.86 3.23 3.02 
6b 3.20 2.58 3.14 2.56 
8 4.73 4.61 4.70 4.65 
9 4.21 4.05 4.19 
10 4.16 4.10 4.15 4.054.13a 
ha 3.94 3.93 4.09 4.07 
lib 4.10 4.06 3.95 3.91 
Ph 7.26-7.37 7.25-7.36 7.24-7.34 7.27-7.38 
PhCH2 4.61, 4.67 4.39, 4.68 4.63, 4.66 4.42, 4.71 
1.29, 1.32 1.29, 1.30 1.29, 1.32 1.30, 1.31 
1.38, 1.42 1.32, 1.35 1.38, 1.40 1.35, 1.36 
1.43, 1.46 1.37,1.45 1.42, 1.46 1.40,1.44 

















Ethryo Threo Ethryo Threo 
Coupling (230) (231) (232) (233) 
1,2 3.7 3.9 3.7 3.9 
2,3 <1 <1 <1 <1 
3,4 3.2 3.8 3.2 4.2 
4,5 7.8 7.8 8.0 7.3 
5,6a 8.8 10.9 7.5 11.0 
5,6b 8.8 8.9 10.5 8.4 
6a,6b 0 17.4 17.8 17.1 
8,9 6.5 6.9 6.6 6.7 
9,10 6.7 7.0 6.6 nd 
10,11a 4.6 4.7 6.1 nd 
10,11b 6.1 6.1 4.7 4.5 
lla,llb 8.3 8.9 8.4 8.0 
PhCH2  1 	11.8 1 	12.0 	11 11.6 f 	12.0 
nd: not determined 
Table 31 
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3.2.4.2 Cycloadditions of Nitrile Oxides to Methyl 5,6-dideoxy-2,3-0- 
isopropyl idene-cx-D-Iyxo-hex-5-enofuranoside (199) 
3.2.4.2a 2,3:4,5-Di-0-isopropylidene-D-arabinononitrile Oxide (196) 
The oxime (203) (0.90 g, 3.7 mmol) in dry chloroform (5 ml) was 
added to a suspension of N-chlorosuccinimide (0.49 g, 3.7 mmol) in dry 
chloroform (5 ml) and pyridine (0.04 ml) and stirred for 30 min at room 
temperature. The solution was cooled in an ice-salt bath, the alkene (199) 
(1.10 g, 5.5 mmol) in chloroform (5 ml) was added and a solution of 
triethylamine (0.41 g, 4.1 mmol) in chloroform (30 ml) added over 10 hr using 
a motorised syringe pump. After stirring for a further 8 hr the solution was 
washed with water (3 x 25 ml), dried over magnesium sulphate, filtered and 
evaporated to an oil. The mixture was purified by dry flash chromatography 
on silica gel (15-30% ether in hexane, gradient elution) to afford, in order of 
elution, unreacted alkene (0.52 g, 47%), an inseparable mixture of furazan 
N-oxide (226) and oxadiazole (227) (0.09 g) (identified by tic comparison 
with dimeric mixture from section 3.2.4.1a) and a pair of diastereoisorneric 
isoxazolines in a ratio of 82:12 (determined from 1 H NMR). The major 
isomer, which eluted first, was identified as (5R)-5-(2,3-0-isopropylidene-1 - 
o -methyl-u -D-lyxo -tetrofuranos-4 -yO-3-  (1,2:3,4 -di-O -isopropylidene-D- 
arabino-tetritol-yI)-2-isoxazoline (234) (0.75 g, 46%), a white solid, m.p. 86- 
87°C (from EtOH), [a] +15.1 (c 1.45 in CHCI 3); (Found: C, 56.4; H, 7.7; N, 
3.2. C21 HN09 requires C, 56.9; H, 7.5; N, 3.2%); 5H(360  MHz, CDCI 3 ) see 
Tables 32 and 33; 6(90  MHz, CDCI3) 24.2, 25.0, 25.6, 26.4, 26.5, 
26.9(6xMe), 36.5(C-6), 54.6(OMe), 66.6(C-11), 74.5(C-8), 76.0(C-10), 
77.9(C-5), 78.6(C-9), 79.1, 79.5, 84.7(0-2, C-3, C-4), 107.1(C-1), 109.7, 
110.6, 112.5(3xC(Me) 2), 157.5(0-7); m/z (FAB) Found: M+H, 444.223341. 
C21 HNO9 requires M+H, 444.22334. The minor isomer, a white solid, was 
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identified as (5S)-5- (2,3-0 -isopropylidene- 1 -0-methyl-ct-D-lyxo -tetrofuranos- 
4-yI)-3-(l ,2 :3,4-di-0-isopropylidene-D-arabi no -tetritol-yI)-2 -isoxazoline (235) 
(0.18 g, 11%), m.p. 77-79°C (from 50% propan-2-ol in hexane); [a] 20 +68.0 
(c 0.93 in CHCI3); 6H(360  MHz, ODd 3) see Tables 32 and 33; (90MHz, 
ODd 3) 24.6, 24.9, 25.8, 26.4, 26.5, 26.8(6xMe), 36.6(0-6), 54.7(OMe), 
66.6(0-11), 74.4, 74.6, 78.7, 79.6(C-5, C-8, 0-9, 0-10), 80.0, 81.1, 84.7(C-2, 
0-3, 0-4), 107.4(0-1), 109.7,110.6, 112.8(3xC(Me) 2), 156.7(C-7); m/z (FAB) 
Found: M++H, 444.22333. C21 1-1N09 requires M+H, 444.22334. 
3.2.4.2b 2,3:4,5-Di-0-isopropylidene-L-arabinononitrile Oxide (197) 
The oxime (204) (0.96 g, 3.9 mmol) in dry chloroform (4 ml) was 
added to a suspension of N-chlorosuccinimide (0.53 g, 3.9 mmol) in dry 
chloroform (4 ml) and pyridine (0.04 ml) and stirred for 30 min at room 
temperature. The solution was cooled in an ice bath, the alkene (199) 
(1.18 g, 5.9 mmol) in dry chloroform (5 ml) was added and a solution of 
triethylamine (0.44 g, 4.4 mmol) in dry chloroform (30 ml) was pumped in, via 
a motorised syringe, over 10 hrs, then the solution left to stir for a further 
8 hr. The mixture was washed with water (3 x 25 ml), dried over magnesium 
sulphate, filtered and concentrated in vacuo to afford a yellow oil which was 
purified by dry flash chromatography on silica (15-35% ether in hexane, 
gradient elution). This yielded, in order of elution, unreacted alkene (0.69 g, 
58%), an inseparable mixture of furazan N-oxide (228) and oxadiazole (229) 
(0.11 g) (identified by tIc comparison with dimeric mixture from section 
3.2.4.1b) and a pair of diastereoisomeric isoxazolines in the ratio of 83:17 
(determined from 1 H NMR). The major isomer, which eluted first, was 
identified as (5 R)-5- (2,3-0 -isopropylidene-1 -0-methyl-a-D-lyxo -tetrofuranos-
4-yI)-3-( 1,2 :3,4-di-0- isopropylidene-L-arabino-tetritol-yI)-2 -isoxazoline (236), 
209 
a white solid (0.78 g, 45%), m.p. 88-89°C (from hexane); [a] -45.8 (c 0.53 
in CHCI3); (Found: C, 56.8; H, 7.7; N, 3.5. C 21 HNO9 requires C, 56.9; H, 
7.5; N, 3.2%); 6H(360  MHz, CDCI 3) see Tables 32 and 33; 	(50  MHz, 
CDCI3) 24.2, 24.9, 25.6, 26.4, 26.8(6xMe), 36.7(C-6), 54.5(OMe), 66.5(C- 
11), 74.3(C-8), 75.9(C-10), 78.0(C-5), 78.6(C-9), 79.0, 79.1, 84.7(C-2, C-3, 
C-4), 107.0(C-1), 109.6, 110.5, 112.4(3xC(Me) 2), 157.5(C-7); m/z (FAB) 
M+H, 444.223341. C 21 H1\109 requires M+H, 444.22334. The identity of 
this compound was confirmed by X-ray crystallography. The minor isomer, 
an oil, was identified as (5S)-5-(2 ,3-O -isopropylidene- 1 -o -methyl-cx-D-lyxo - 
tetrofuranos-4 -yl)  -3-( 1,2:3,4 -di-O -isopropylidene-L-arabi no -tetritol-yl) -2- 
isoxazoline (237) (0.27 g, 16%); [x] +11.1 (C 0.61 in CHCI3); 8 R (360 MHz, 
CDCI3) see Tables 32 and 33; 	(90  MHz, CDCI 3) 24.6, 24.8, 25.8, 26.4, 
26.7(6xMe), 36.8(0-6), 54.6(OMe), 66.7(C-11), 74.5(C-8), 75.9(C-10), 
78.6(C-9), 79.5(C-5), 80.0, 81.2, 84.6(C-2, C-3, C-4), 107.3(C-1), 109.6, 
110.4, 1 12.8(3xC(Me) 2), 156.6(0-7); m/z (FAB) Found: M+H, 444.22333. 




N. 	 1 
 





0 -\- H 	0 
R 
8H 8H 
Ethryo Threo Ethryo Threo 
Resonance (234) (235) (236) (237) 
1 4.84 4.95 4.86 4.93 
2 4.52 4.55 4.52 4.52 
3 4.72 4.68 4.72 4.65 
4 3.96 4.00 4.00 3.93 
5 4.91 4.79 4.87 4.80 
6a 3.14 3.22 3.17 3.27 
6b 3.14 2.86 3.08 2.79 
8 4.70 4.70 4.69 4.68 
9 4.16 4.13-4.17 4.19 a 
10 4.10-4.16 4.13-4.17 4.13 a 
11 a 3.94 3.96 4.06 a 
11 b 4.07 4.09 3.93 b 










1.42 1.41,1.42 1.41 1 	1.39, 1.41 
a: 4.06-4.16(3H, second order multiplet); b: 3.90-3.95 (21-1, multiplet 






Ha	 I Ha6 
N i 
Erythro Isomer 	 Threo Isomer 
H11b4 , a ° 0 H1lb)ç O 
R 
J/Hz J/Hz 
Coupling Ethryo Threo Ethryo Threo 
(234) (235) (236) (237) 
1,2 <1 <1 <1 <1 
2,3 5.9 5.9 5.9 5.9 
3,4 3.7 3.7 3.7 3.8 
4,5 5.9 8.6 6.2 8.6 
5,6a 9.1 10.5 8.1 10.5 
5,6b 9.1 9.0 10.7 8.7 
6a,6b 0 17.3 17.5 17.4 
8,9 6.4 6.9 6.6 6.7 
9,10 6.8 nd 6.8 nd 
10,11a 4.4 4.5 6.1 nd 
10,11b 6.0 6.1 4.8 nd 
lla,llb 1 	8.5 1 	8.5 8.5 1 	8.3 
nd: not determined 
Table 33 
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3.2.5 Reductive Hydrolytic Cleavage of 2-Isoxazolines to - 
Hydroxyketones 
3.2.5.1 Palladium-on-Charcoal Catalysed Hydrogenolysis of (230) 
Isoxazoline (230) (100 mg, 0.19 mmol) and boric acid (72 mg, 
1.16 mmol) were dissolved in methanol (15 ml) and water (3 ml). 10% 
Palladium-on-charcoal (19 mg) was added and the mixture degassed using a 
water pump and hydrogen flushed five times, then left to stir vigorously 
under a hydrogen atmosphere for 18 hr. The mixture was filtered through 
celite and evaporated in vacuo (no heating). Methanol was added and 
evaporated several times to remove the excess boric acid as the volatile 
trimethylborate. Tic analysis indicated the presence of unreacted 
isoxazoline and a more polar component. The reaction was set up again 
with the same quantities of reagents and left to stir vigorously for a further 20 
hr. Work up as above afforded, after preparative tIc (60% ether in hexane), 
unreacted isoxazoline (230) (51 rug, 51%) and a more polar component 
which stained with Brady's solution and was identified as 3-0-benzyl-6-
deoxy- 1 ,2 :8,9:10,1 1- tri-O-isopropylidene-D-arabi no -a-D-g luco-7 -undecos-
ulose-(1 ,4) (252) (19 mg, 19%); vm/cm1  (neat) 3490 (OH), 1724 (C=O); 
8H(360 MHz, CDCI 3) see Tables 34 and 35; (50  MHz, ODd 3) 25.0, 26.1, 
26.3, 26.6, 26.9(6xMe), 43.4(0-6), 64.6(C-5), 66.5(0-11), 72.3(CH 2Ph), 76.3, 
78.0(0-9, 0-10), 81.1, 81.7, 82.4, 82.9(0-2, C-3, 0-4, C-8), 104.9(0-1), 
109.8, 111.4, 111.6(3xC(Me) 2), 127.7, 128.0, 128.5(5xPhCH), 137.3(PhC), 
210.2(C-7); m/z (FAB) Found: M+2H, 524.26217. C 27H010 requires 
M+2H, 524.26213. 
The reaction was repeated as above using isoxazoline (230) 
(200 mg) and the other reagents scaled as appropriate. Tetrahydrofuran (2 
ml) was added to aid dissolution of the isoxazoline and the overall reaction 
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time was 63 hr. After preparative tic (60% ether in hexane) three bands 
were isolated: unreacted isoxazoline (230) (17 mg, 9%), 3-hydroxyketone 
(252) (74 mg, 37%) and a more polar band (46 mg) which comprised a 
mixture of debenzylated compounds. The major component of this mixture 
was believed to be 6-deoxy-1 ,2:8,9:1 0,11 -tri-0-isopropylidene-D-arabino-a-D-
gluco-7-undecosulose-(1 ,4) (2538) in its hemiketal form (253b); H(360  MHz, 
CDC13) 1.30, 1.33, 1.37, 1.40, 1.41, 1.50 (12H, 6s, 3xC(Me)2), 1.77(1H, dd, 
5,6a 5.0, J6a,6b 12.5, 6a-H), 1.86(1H, -t, J5,6b- 11.6, 6b-H), 2.0(1H, br s, 
OH), 3.66(1 H, s, OH), 3.91-3.98(2H, m, 3-H, 4-H), 3.96(1 H, dd, J10,11a  4.8, 
11a,11b 8.4, ha-H), 3.99-4.10(1H, m, 10-H), 4.14(1H, dd, J10,11b  6.0, 
11a,11b 8.5, 11b-H), 4.24-4.34(1H, m, 5-H), 4.32(1H, d, J8,9 2.0, 8-H), 
4.37(1 H, dd, J89 2.1, J9,10 3.4, 9-H), 4.55(1 H, d, J12 3.6, 2-H), 5.91(1 H, d, 
J1,2 3.6, 1-H); (50  MHz, CDCI 3) 25.0, 26.1, 26.3, 26.6, 26.8, 27.9(6xMe), 
33.5(0-6), 63.6(0-5), 67.4(C-1 1), 75.0, 76.3, 77.1, 77.9, 84.2, 84.5(0-2, C-3, 
C-4, 0-8, C-9, 0-10), 97.3(0-7), 105.0(C-1), 110.0, 111.0, 111.9(3xC(Me)2). 
3.2.5.2 Raney-Nickel Induced Hydrogenolysis of 2-Isoxazolines 
General Procedure 
The isoxazoline (1 M eq) and boric acid (6M eq) were dissolved in a 
mixture of methanol and water (5:1) (8-12 ml per 100 mg of isoxazoline) and 
Raneynickela (3 spatula tips per 100 mg of isoxazoline) added. The mixture 
was degassed and hydrogen filled several times then left to stir vigorously 
under a hydrogen atmosphere. Upon reaction completion (monitored by tic) 
the mixture was filtered through a celite pad and concentrated in vacuo (bath 
temperature <25°C). The excess boric acid was removed by repeated 
a Best results were obtained when Raney-nickel was washed with water (stir, decant x20) 
then stored under methanol in a freezer for 3-4 weeks prior to use. 
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methanol addition and evaporation. The resulting oil was purified by 
preparative tic on silica gel. 
3.2.5.2a Hydrogenolysis of (5R)-5-(3-O-Benzyl-1 ,2-O-isopropylidene-cc-
D-xylo- tetro furanos-4-yI)-3-(1 ,2 :3,4- di-O-i sopropylidene-D- 
arabi no- tetrito!-yI)-2-isoxazoline (230) 
According to the general procedure given above, isoxazoline (230) 
(200 mg, 0.56 mmol) yielded, after 7 hr, a mixture of crude products. After 
separation by preparative tIc (70% ether in hexane) pure 3-0-benzyl-6-
deoxy-1 ,2 :8,9:1 0,11 -tri-O -isopropylidene-D-arabi no -a-D-g luco -7 -undecos- 
ulose-(1 4) (252) was obtained as a clear oil (194 mg, 66%) (for 
characterisation see Section 3.2.5.1). A colourless oil, which gave a positive 
ninhydrin stain on tIc, was also isolated and identified as an inseparable 
mixture (1:1) of y-amino alcohols 7-amino-3-O-benzyl-6,7-dideoxy-
1,2:8,9:10,11 -tri-O-isopropylidene-D-gluco-a-D-gluco-undecose-(1 ,4) and 7-
amino-3 -o -benzyl-6 , 7 -dideoxy- 1 ,2 :8,9:10,1 1 -tri-O -isopropylidene-D-man no - 
cx-D-gluco-undecose-(1 ,4) (254) (73 mg, 25%); 6H(200  MHz, CDCI3) 1.24, 
1.28, 1.29, 1.32, 1.33, 1.35, 1.38, 1.39, 1.40, 1.46(18H, lOs, 6xMe), 1.71-
2.09(2H, m, 6-H 2), 2.92(2H, br s, NH 2), 3.16-3.28(1H, m), 3.54-4.30(9H, m,), 
4.55(0.5H, d, J12 3.5, 2-H), 4.57(0.5H, d, J12 3.8, 2-H), 4.67(1 H, s, CH2Ph), 
4.68 and 4.79(1 H, 2d, J 11.9, CH2Ph), 5.87 and 5.89(1 H, 2d overlapping, J12 
--3.7, J12 -3.7, 1-H), 7.23-7.39(5H, m, Ph); 6(50  MHz, CDC,) 25.0, 25.1, 
26.1, 26.4, 26.6, 26.8, 26.9(6xMe), 34.6 and 37.5(0-6), 50.7 and 52.3(0-7), 
67.8(C-11), 72.3 and 72.5(CH 2Ph), 66.5, 69.5, 76.9, 77.0, 77.3, 79.9, 81. 1, 
81.8, 82.0, 82.4, 82.7, 83.5, 84.2, 84.5(C-2, C-3, 0-4, 0-5, C-8, 0-9, 0-10) 
104.8 and 105.0(C-1), 109.1, 109.6, 109.7, 111.3, 111.4(3xC(Me) 2), 127.5, 
127.6, 128.2, 128.3(5xPhCH), 137.6, 138.0(PhC). (Note: Doubling of peaks 
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in both 1 H and 13C NMR consistent with 2 diastereoisomeric T-amino 
alcohols); m/z (FAB) Found: M+H, 524.2859. C 27H42 N09 requires M+H, 
524.28593. 
3.2.5.2b Hydrogenolysis of (5R)-5-(3-O-Benzyl-1 ,2-O-isopropylidene-o-
D-xylo- tetrofuranos-4-y-3-(1 ,2 :3,4- di-O-isopropylidene-L- 
arabi no- tetritol-yI)-2- isoxazoline (232) 
According to the general procedure isoxazoline (232) (223 mg, 
0.43 mmol) yielded, after 3 hr, a mixture of crude products. Separation by 
preparative tic (80% ether in hexane) afforded, in order of elution, the 
desired 3-O-benzyl-6-deoxy-1 ,2:8,9:10,11 -tri-O-isopropylidene-L-arabino-a-
D-gluco-7-undecosuIose-(1,4) (255) as a clear oil (122 mg, 54%), v,./cm -1 
(neat) 3516 (OH), 1719 (C=O); H(360  MHz, CDCI3) see Tables 34 and 35; 
(50 MHz, ODd 3) 25.0, 26.0, 26.1, 26.3, 26.6, 26.9(6xMe), 43.4(0-6), 
64.8(C-5), 66.5(0-11), 72.2(CH 2Ph), 76.4, 77.8(C-9, 0-10), 81.1, 81.8, 82.3, 
83.0(0-2, 0-3, C-4, C-8), 104.9(C-1), 109.8, 111.3, 111.6(3xC(Me) 2), 127.7, 
127.9, 128.4(5xPhCH), 137.2(PhC), 209.9(0-7); m/z (FAB) Found: M+2H, 
524.26210. C27H 40010 requires M+2H, 524.26213; and an oil, which gave a 
positive ninhydrin stain on tic, believed to contain an inseparable mixture of 
the y-aminoalcohois 7-amino-3-0-benzyl-6,7-dideoxy-1 ,2 :8,9:10,11 -tri-O-
isopropylidene-L-gluco-a-D-gluco-undecose-(1 ,4) and 7-amino-3-0-benzyl-
6,7-dideoxy-1 ,2:8,9:1 0,11 -tri-0-isopropylidene-L-manno-a-D-giuco-undecose-
(1,4) (256) (60 mg, 27%); H(200  MHz, ODd 3) 1.29, 1.31, 1.33, 1.36, 
1.44(18H, 5s, 6xMe), 1.77-1.91 and 2.18-2.26(2H, m, 6-H 2), 2.83(2H, br 5, 
NH2), 3.05-3.13 and 3.22-3.31(1H, 2m), 3.60-4.28(9H, m,), 4.56(1 H, d, J12 
3.8, 2-H), 4.59-4.78(2H, m, CH2Ph), 5.87(1 H, d, J12 3.7, 1-H), 7.21-7.37(5H, 
m, Ph); (50 MHz, CDC1 3) 25.0, 26.2, 26.6, 26.8, 27.1(6xMe), 35.4 and 
35.8(0-6), 48.9 and 54.3(0-7), 67.6 and 67.9(C-11), 72.3 and 72.5(CH2Ph), 
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66.5, 69.6, 76.9, 77.8, 79.5, 81.3, 81.6, 82.5, 83.5, 84.0, 85.3(C-2, C-3, 0-4, 
C-5, C-8, C-9, 0-10), 105.0(0-1), 109.1, 109.5, 111.3(3xC(Me) 2), 127.5, 
127.7, 128.3(5xPhCH), 137.6, 138.0(PhC). (Note: Doubling of peaks in 1 H 
and 13C NMR consistent with presence of 2 diastereoisomeric -y-amino 
alcohols); m/z (FAB) Found: M+H, 524.28597. 0 27H42N09 requires M+H, 
524.28593. 
3.2.5.2c Hydrogenolysis of (5R)-5-(2,3-O-Isopropylidene-1 -0-methyl-a-
D-lyxo- tetro furanos-4-yl)-3-(1 ,2 :3,4-di-0-isopropylidene-D-
arabino-tetritol-yl)-2-isoxazoline (234) 
According to the general procedure, isoxazoline (234) (100 mg, 
0.23 mmoi) yielded, after 5 hr, a mixture of crude products. Separation by 
preparative tic (100% ether) afforded, in order of elution, the desired methyl 
2,3:8,9:10,11 -tri-O -isopropylldene-D-arabi no -cx-D-manno -7 -undecosuloside- 
(1,4) (257) as a clear oil (55 mg, 55%), Vm /cm 1  (neat) 3497 (OH), 1725 
(0=0); 8060 MHz, ODd 3) see Tables 36 and 37; 5r(50 MHz, ODd 3) 24,5, 
25.0, 25.8, 26.1, 26.3, 26.9(6xMe), 43.4(0-6), 54.4(OMe), 65.5(0-5), 66.5(0- 
11), 76.3, 78.0(0-9, 0-10), 79.4, 81,1, 82.9, 84.7(0-2, C-3, 0-4, 0-8), 
107.0(0-1), 109.7, 111.4, 112.5(3xC(Me) 2), 209.1(C-7); m/z (FAB) Found, 
M+H, 447.22301. C 21 H010 requires M+H, 447.22300; and an oil, which 
gave a positive ninhydrin test on tic, believed to contain an inseparable 
mixture of the -y-amino alcohols methyl 7 -amino -6,7-dideoxy-2,3:8,9:1 0,11 -tn-
O-isopropylidene-D-g luco -a -D-man no -undecoside-( 1,4) and methyl 7-amino-
6 ,7-dideoxy-2 ,3 :8,9:10,1 1 -tni-0 -isopropylidene-D-manno -a-D-manno - 
undecoside-(1,4) (258) (34 mg, 34%), 5H(200  MHz, ODd 3) 1.30, 1.32, 1.35, 
1.37, 1.38, 1.44(6s, 6xMe), 1.75-2.03(2H, m, 6-H 2), 2.92(3H, br s, NH 2/OH), 
3.28(3H, s, OMe), 3.56-4.28(8H, m), 4.52 and 4.53(1 H, 2d, J23 6.0 and J23 
6.0, 2-H), 4.81 -4.84(1H, m), 4.83 and 4.86(1 H, 2s, 1-H); (50 MHz, ODd3) 
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22.9, 23.2, 24.5, 24.6, 25.0, 25.1, 25.2, 25.9, 26.4, 26.6, 26.9, 27.0(6xMe), 
35.1 and 37.2(C-6), 51.1 and 52.5(C-7), 54.4(OMe), 67.8 and 67.9(0-11), 
67.3, 70.5, 76.9, 77.0, 79.5, 79.9, 80.3, 81.5, 82.6, 84.2, 84.7(0-2, C-3, 0-4, 
0-5, C-8, 0-9, C-b), 107.2 and 107.4(C-1), 109.1, 109.3, 109.6, 109.8, 
112.2, 112.4(3xC(Me) 2); m/z (FAB) Found: M+H, 448.25467. C 21 HNO9 
requires M+H, 448.25464. 
3.2.5.2d Hydrogenolysis of (5R)-5-(2,3-O-Isopropylidene-1 -0-methyl-cc-
D-lyxo- tetrofuranos-4-yfl-3-(1 ,2 :3,4-di-O-isopropylidene-L-
arabino-tetritol-yI)-2-isoxazoline (236) 
According to the general procedure isoxazoline (236), (300 mg, 
0.68 mmol) yielded, after 5.5 hr, a mixture of crude products. Separation by 
preparative tic (100% ether) afforded, in order of elution, the desired methyl 
2,3:8,9:10,11 -tri-O -isopropylldene-L-arabi no -cx-D-manno -7 -undecosuloside-
(1,4) (259) as a clear oil (156 mg, 52%), v m /cm 1  (neat) 3498 (OH), 1727 
(C=O); H(360  MHz, CDCI 3) see Tables 36 and 37; 6(50  MHz, ODd 3) 24.5, 
24.9, 25.8, 26.1, 26.3, 26.9(6xMe), 43.3(0-6), 54.4(OMe), 65.7(0-5), 66.5(0-
11), 76.3, 77.7(0-9, 0-10), 79.3, 81.2, 83.0, 84.6(0-2, C-3, 0-4, 0-8), 
106.9(0-1), 109.7, 111.2, 112.5(3xC(Me) 2), 208.9(0-7); m/z (FAB) Found: 
M+2H, 448.23083. C 21 H010 requires M+2H, 448.23082; and an oil, which 
gave a positive ninhydrin test on tic, believed to contain an inseparable 
mixture of y-amino alcohols methyl 7-amino-6,7-dideoxy-2,3:8,9:10,11 -tri-O-
isopropylldene-L-g luco -a-D-man no -undecoside- (1,4) and methyl 7 -amino-6 ,7-
dideoxy-2,3:8,9 :10,11 -tri-O-isopropylidene-L -man no-cc-D-manno-undecoside-
(1,4) (260) (54 mg, 18%); H(200  MHz, CDC 3) 1.28, 1.30, 1.33, 1.35, 1.37, 
1.40, 1.44(7s, 6xMe), 1.79-1.85(2H, m, 6-H 2), 2.76(3H, br s, NH 2/OH), 3.26 
and 3.27(3H, 2s, OMe), 3.62-4.24(8H, m), 4.51 and 4.52(1H, 2d, J 3 6.0 and 
J 3 6.0, 2-H), 4.71-4.91(2H, m, 1-H, 3-H); (S°  MHz, CDCI3) 24.5, 25.1, 
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25.9, 26.5, 26.9, 27.2(6xMe), 35.9(C-6), 49.1(C-7), 54.2 and 54.3(OMe), 
67.6(0-11), 67.3 1  77.0, 78.0, 79.8, 80.8, 84.1, 84.7(C-2, C-3, 0-4, C-5, 0-8, 
0-9, 0-10), 107.1(0-1), 109.2, 109.5, 112.3(3xC(Me) 2); m/z (FAB) Found: 
M+H, 448.25462. C 21 1-1NO9 requires M+H, 448.25464. 
A 	6b 




Ry i 8 
8H 5H 
(252) (255) Resonance 
1 5.87 5.88 
2 4.59 4.59 
3 4.07 4.08 
4 4.02 4.02 
5 4.44 4.43 
6a 2.89 2.91 
6b 3.14 3.10 
8 4.35 4.36 
9 4.15 4.19 
10 4.084.16a 4.15 
ha 3.94 4.10 
lib 4.10 3.95 
Ph 7.26-7.37 7.33-7.35 
PhCH2 4.59, 4.70 4.58, 4.69 
OH 2.91 2.91 
1.30,1.33 1.30,1.32 
OH3 1.36, 1.40 1.33, 1.41 
1.43,1.47 1.43,1.46 










(252) (255) Coupling 
1,2 3.8 3.8 
2,3 <1 <1 
3,4 3.1 3.2 
4,5 8.6 8.6 
5,6a 9.1 9.1 
5,6b 2.6 2.7 
6a,6b 18.3 18.1 
8,9 5.8 5.5 
9,10 nd 6.6 
10,11a 4.5 6.2 
10,1 lb 7.1 4.5 
lla,llb 8.4 8.5 
PhCH2 11.8 11.8 








H ll 	Hlla 
0 -\- H , g-\-  
0 J 0 
8H 8H 
(257) (259) Resonance 
1 4.83 4.81 
2 4.53 4.50 
3 4.79 4.75 
4 3.79 3.76 
5 4.42 4.38 
6a 2.91 2.92 
6b 3.08 2.98 
8 4.37 4.37 
9 4.17 4.18 
10 4.15 4.12 
ha 3.93 4.05 
lib 4.08 3.91 
OMe 3.27 3.24 
OH 3.03 3.10 
1.29, 1.31 1.26, 1.29 
CH3 1.36, 1.39 1.30, 1.37 





,, o H 6a 
J/Hz J/Hz 
Coupling (257) (259) 
1,2 <1 <1 
2,3 5.9 5.9 
3,4 3.7 3.7 
4,5 8.5 8.2 
5,6a 8.9 7.8 
5,6b 3.0 4.1 
6a,6b 17.9 17.4 
8,9 5.6 5.6 
9,10 6.8 6.8 
10,11a 4.5 6.2 
10,1 lb 6.1 4.8 
lla,llb 8.5 8.5 
Table 37 
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3.2.6 Reduction of -Hydroxyketones to 1 ,3-Diols 
3.2.6.1 Reduction using Sodium Borohydride 
General procedure 
A solution of sodium borohydride (0.4M eq) in water (2 ml per 100 
mg isoxazoline) was added dropwise to an ice-chilled, stirred solution of the 
3-hydroxyketone (1M eq) in ethanol and water (3:1, -4 ml per 100 mg of 
isoxazoline). The resulting solution was stirred overnight while warming to 
room temperature. The ethanol was removed in vacuo, acetone (2-3 drops) 
was added to decompose any remaining reagent and the solution extracted 
with chloroform. The combined organics were dried over magnesium 
sulphate, filtered and evaporated to afford the crude mixture of 
diastereoisomeric diols. The ratio of diastereoisomers was measured by 
comparison of the integrals for corresponding signals in the 1 H NMR of the 
mixtures. 
3.2.6.1 a Reduction of 3-0-Benzyl-6-deoxy-1 ,2:8,9:1 0,11 -tri-O- 
isopropylidene-D-.ara bi no-a-D-g I uco-7- undecosulose-(1 ,4) (252) 
The reduction was carried out using the general procedure 
described above. 3-Hydroxyketone (252) (150 mg, 0.29 mmol) yielded a 
62:38 mixture of 1 ,3-diots in a combined yield of 79%. The diols were 
separated by preparative tIc on silica (80% ether in hexane, triple elution) to 
afford, in order of elution, 3-0-benzyl-6-deoxy-1,2:8,9:10,1146-0- 
isopropylidene-D-gluco-a-D-gluco-undecose-(1 ,4) (262) (66 mg, 44%); [a] 26 - 
13.1 (c 1.78 in CHCI3); H(360  MHz, CDCI3) see Tables 38 and 39; (50 
MHz, CDCI3) 25.1, 26.1, 26.4, 26.6, 26.9, 27.0(6xMe), 37.9(C-6), 67.7(C-1 1), 
69.1, 71.2(C-5, C-7), 72.3(CH 2Ph), 77.0, 77.1, 81.3, 82.3, 82.6, 82.9(C-2, C-
3, C-4, C-8, C-9, C-b), 104.8(C-1), 109.4, 109.7, 111.5(3xC(Me) 2), 127.7, 
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127.8, 128.4(5xPhCH), 137.4(PhC); mlz (FAB) Found: M, 524.26217. 
C27HI 010 requires M, 524.26213; and 3-O-benzy/-6-deoxy-1,2:8,9:10,l1-tri- 
O-isopropylidene-D-manno -cx-D-g lu Co -undecose- (1,4) (263) (41 mg, 27%), 
26 -11 .0 (c 1 .11 in CHCI 3); H(600  MHz, ODd 3) see Tables 38 and 39; (S° 
MHz, CDCI3) 25.0, 26.2, 26.6, 26.7(6xMe), 37.1(C-6), 66.2(C-5 or 0-7), 
67.7(C-11), 69.6(C-7 or C-5), 72.0(CH 2Ph), 76.3, 80.8, 82.0, 82.1, 82.2, 
82.9(C-2, C-3, C-4, C-8, C-9, 0-10), 105.0(0-1), 109.2, 110.0, 
111 .4(3xC(Me) 2), 127.7, 127.9, 1 28.4(5xPhCH), 1 37.2(PhC); m/z (FAB) 
Found: M+H, 525.26996. C 27 H 41 0 10 requires M+H, 525.26995. 
3.2.6.1b Reduction of 3-0-Benzyl-6-deoxy-1 ,2:8,9:1 0,11 -tri-O- 
isopropylidene- -a rabin o-c-D-g I uco-7- undecosulose-(1 ,4) (255) 
The reduction was carried out according to the general procedure 
outlined above. -Hydroxyketone ( 255) (171 mg, 0.33 mmol) produced a 
40:60 mixture of 1 ,3-diols which were separated by preparative tic on silica 
(70% ether in hexane, triple elution). The minor isomer which eluted first 
was identified as 3-0-benzyl-6-deoxy-1 ,2:8,9:1 0,11 -tri-0-isopropylidene-L- 
manno-a-D-giuco-undecose-(1 ,4) (264) (55 mg, 32%), [cx] -20.3 (c 1.56 in 
CHCI3); 360 MHz, CDC1 3) see Tables 38 and 39; ( 50  MHz, CDCI3) 25.0, 
26.2, 26.3, 26.6, 26.8(6xMe), 37.4(C-6), 67.6(0-11), 69.2(C-5 or C-7), 
72.3(CH 2Ph), 73.5(C-7 or C-5), 76.1, 80.8, 81.3, 82.5, 82.7, 82.9(C-2, C-3, 
C-4, C-8, C-9, 0-10), 104.9(0-1), 109.2, 110.1, 111.5(3xC(Me) 2), 127.6, 
127.7, 128.4(5xPhCH), 137.7(PhC); m/z (FAB) Found: M, 524.26217. 
C27 1-1 40010 requires M, 524.26213. The major isomer was identified as 3-0- 
benzyl-6-deoxy-1 ,2:8,9 :10,11 -tri-0-isopropylidene-L-gluco-a-D-gluco-
undecose-(1,4) (265) (79 mg, 46%), [a] -28.8 (c 1.33 in CHCI3); H(360 
MHz, CDCI3) see Tables 38 and 39; ( 50  MHz, CDCI3) 25.1, 26.1, 26.5, 
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26.7, 26.9, 27.0(6xMe), 38.2(C-6), 66.2, 67.1(C-5, C-7), 67.6(C-11), 
71.8(CH 2Ph), 77.0, 77.3, 81.6, 82.0, 82.1, 83.0(0-2, 0-3, C-4, C-8, 0-9, C-
10), 105.0(0-1), 109.3, 109.6, 111.5(3xC(Me) 2 ), 127.8, 128.1, 
128.6(5xPhCH), 137.0(PhC); m/z (FAB) Found: M+H, 525.26996. 
C27 1-1 41 010 requires 525.26995. 
3.2.6.1c Reduction of Methyl 2,3:8,9:10,11 -tri-O-isopropylidene-D- 
arabino-cx-D-manno-7-undecosuloside-(1 ,4) (257) 
The reduction was carried out according to the above procedure. 
f-Hydroxyketone (257) (168 mg, 0.38 mmol) afforded, after purification by 
preparative tic on silica (70% ether in hexane), an inseparable mixture of 
1,3-diols (266) and (267) (122 mg, 72%) [m/z (FAB) Found: M+H, 
449.23868. C21 H37010 requires M+H, 449.23865] in the ratio of 62:38. The 
major isomer was identified as methyl 6-deoxy-2,3:8,9:10,1146-0-
isopropylldene-D-gluco-a-D-manno-undecoside-(1 ,4) (266) by comparison of 
the 1 H and 130  NMR spectra for the diol obtained in section 3.2.6.2c with 
those for the present mixture. The minor isomer was identified as methyl 6-
deoxy-2,3:8,9:1 0,11 -tri-0-isopropylidene-D-manno-a-D-manno-undecoside-
(1 ,4) (267); H(360  MHz, ODd 3) (peaks in mixture attributed to minor isomer) 
1.27, 1.30, 1.32, 1.39, 1.42(6xMe), 1.91(2H, m, 6-H 2), 2.09(1H, OH), 3.24-
4.18(9H, complex series of multiplets), 3.25(3H, s, OMe), 4.50(1 H, d, J 
5.8, 2-H), 4.80(1 H, dd, J3.4  3.7, J23 5.8, 3-H), 4.85(1 H, s, 1-H); (90  MHz, 
CDCI3) (peaks attributed to minor isomer selected) 25.3, 25.7, 26.5, 26.9, 
27.3, 27.4(6xMe), 37.6(0-6), 54.6(OMe), 67.8(0-11), 67.1, 69.8(0-5, 0-7), 
76.3, 79.9, 80.6, 81.5, 82.8, 84.6(0-2, 0-3, 0-4, 0-8, 0-9, 0-10), 106.6(0-1), 
108.8, 109.1, 109.5(3xC(Me)2). 
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3.2.6.1d Reduction of Methyl 2,3:8,9:10,11 -tri-O-i sopropylidene-L- 
arabino-a-D-manno-7-undecosuloside-(1 , 4) (259) 
The reduction was carried out using the procedure described 
above. -Hydroxyketone (259) (156 mg, 0.35 mmol) afforded, after 
preparative tic on silica (100% ether) an inseparable mixture of 1,3-diols 
(268) and (269) (128 mg, 82%) (m/z (FAB) Found: M+H, 449.23862. 
C21 H 37010 requires M+H, 449.23865), in the ratio 37:63. The major isomer 
was identified as methyl 6-deoxy-2,3:8,9:1 0,11 -tri-0-isopropylidene-L-gluco-
a-D-manno-undecoside-(1 ,4) (269) by comparison of the 'H and 13C NMR 
spectra for the diol obtained in section 3.2.6.2d with those for the present 
mixture. The minor isomer was identified as methyl 6-deoxy-2,3:8,9:10,11-
tri-0-isopropylidene-L-man no -a -D-manno -undecoside-( 1 ,4) (268), 6(360 
MHz, CDCI 3) (peaks in mixture attributed to minor isomer) 1.23, 1.31, 1.34, 
1.35, 1.43, 1 .47(6xMe), 1.64(1 H, dt, 2xJ 10. 1, J 14.5, 6b-H), 2.22(1 H, dt, 2xJ 
2.2, J 14.5, 6a-H), 3.30(3H, s, OMe), 3.76(1H, dd, J 3.3, J 8.1, 4-H), 
4.54(1H, d, J6.0, 2-H), 4.81-4.84(1H, dd, overlaps with dd for 3-H of major 
diol, 3-H), 4.87(1 H, s, 1-H); 6(50  MHz, CDCI 3) (peaks in mixture attributed 
to minor isomer) 24.9, 25.8, 26.2, 26.7, 26.8(6xMe), 36.9(C-6), 54.3(OMe), 
66.8, 69.9(C-5, C-7), 67.3(0-11), 76.2, 79.6, 80.2, 81 .9, 82.8, 84.6(C-2, C-3, 
0-4, C-B, 0-9, C-i 0), 107.0(C-1), 1 09.3, 109.8, 11 2.2(3xC(Me) 2). 
3.2.6.2 Reduction of -Hydroxyketones Using L-Selectride 
General Procedure 
1 M L-Selectride in THF (1.4 M eq) was added dropwise to a 
solution of the -hydroxyketone (1 M eq) in dry THE (- 10 ml per 100 mg of 
-hydroxyketone) at -78°C under nitrogen. The resulting solution was stirred 
for 30 min at -78°C and for 45 min at room temperature. After cooling to 000 
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the reaction was quenched by the successive slow additions of water (0.3 ml 
per ml L-selectride), ethanol (1.3 ml per ml L-selectride), 3 M sodium 
hydroxide (1.7 ml per ml L-selectride) and 30% hydrogen peroxide (1.3 ml 
per ml L-selectride). The aqueous layer was saturated with potassium 
carbonate and extracted with ether-THE (1:1) (3 x 6 ml). The combined 
organics were dried over magnesium sulphate and concentrated in vacuo. 
The ratio of diastereoisomeric 1 ,3-diols was determined by 1 H NMR. 
3.2.6.2a Reduction of 3-0- Benzyl-6-deoxy-1 ,2:8,9 :10,11 -tri-0- 
isopropylidene-D-arabi no -a-D-g I uco-7-undecosulose-(1 ,4) (252) 
According to the general procedure 3-hydroxyketone (252) (136 
mg, 0.26 mmol) afforded a clear oil which by 1 H NMR (360 MHz) appeared 
as a single diastereoisomer (>97:3) assigned as 3-0-benzy/-6-deoxy-
1,2:8,9:10,11 -tri-0-isopropylidene-D-gluco-a-D-gluco-undecose-(1 ,4) (262) 
(134 mg, 98%); for characterisation see section 3.2.6.1 a. 
3.2.6.2b Reduction of 3-0-Benzy!-6-deoxy-1 ,2:8,9:1 0,11 -tri-0- 
isopropylidene- L-ara bi no-a-D-g I uco-7- undecosulose-(1 ,4) (255) 
According to the general procedure 3-hydroxyketone (255) 
(119 mg, 0.23 mmol) afforded a mixture of the diastereoisomeric alcohols 
and (265) in the ratio 12:88 and a combined yield of 90% (107 mg). 
The diols were separated by preparative tIc on silica gel (70% ether in 
hexane, double elution) to afford, in order of elution, the minor isomer which 
was identified as 3-O-benzyl-6-deoxy-1 , 2:8,9:1 0,11 -tri-O-isopropylidene-L-
manno-a-D-gluco-undecose-(1 , 4) (264) (10 mg, 8%) [for characterisation see 
section 3.2.6.1 b] and the major isomer which was identified as 3-0-benzyl-6-
deoxy- 1,2:8,9:10,11 -tri-O -isopropylidene-L-g luco -a -D-g luco -undecose- (1,4) 
(71 mg, 59%) [for characterisation see section 3.2.6.1 b]. 
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3.2.6.2c Reduction of Methyl 2,3:8,9:10,11 -tri-O-isopropylidene-D- 
arabino-a-D-manno-7-undecosuloside-(1 ,4) (257) 
According to the above general procedure 3-hydroxyketone (257) 
(95 mg, 0.21 mmol) afforded after preparative thin layer chromatography 
(80% ether in hexane) a clear oil, which by 1 H NMR (360 MHz) appeared as 
a single diastereoisomer (>95:5). This was identified as methyl 6-deoxy-
2,3:8,9:10,11 -tri-0-isopropylidene-D-gluco-a-D-manno-undecoside-(1 ,4) 
(266) (90 mg, 94%); H(360  MHz, CDCI 3) see Tables 40 and 41; (50  MHz, 
ODd 3) 24.3, 24.9, 25.7, 26.3, 26.7, 27.0(6xMe), 37.5(0-6), 54.1 (OW), 
67.4(0-11), 69.8, 70.9(0-5, C-7), 76.8, 76.9, 79.3, 81.8, 82.9, 84.4(0-2, C-3, 
0-4, 0-8, 0-9, 0-10), 106.8(C-1), 109.3, 109.4, 112.1(3xC(Me) 2); m/z (FAB) 
Found: M+H, 449.23868. C 21 H 370 10 requires M+H, 449.23865. The minor 
isomer (267) was not detectable by 1 H or 13C NMR. 
3.2.6.2d Reduction of Methyl 2,3:8,9:10,11 - tri-O-isopropylidene-L- 
arabi no-a-D-man no-7- undecosuloside-(1 ,4) (259) 
According to the above general procedure 3-hydroxyketone (259) 
(58 mg, 0.13 mmol) afforded, alter preparative tic on silica gel (100% ether), 
predominantly one diol (>97:3) (44 mg, 76%). This isomer was identified as 
methyl 6 -deoxy-2 ,3:8 ,9 :10,111 -tri-O -isopropylidene-L-g luco -a-D-man no - 
undecoside-(1,4) (269); 8060 MHz, CDCI3) see Tables 40 and 41; 5(50 
MHz, CDCI3) 24.5, 25.1, 25.8, 26.4, 27.0, 27.1 (6xMe), 38.3(0-6), 54.4(OMe), 
67.1, 67.2(0-5, 0-7), 67.6(C-11), 77.0, 77.4, 79.9, 81.5, 83.2, 84.6(0-2, 0-3 7  
C-4, C-8, C-9, C-b), 106.9(0-1), 109.4, 109.6, 112.5(3xC(Me) 2); m/z (FAB) 
Found: M+H, 449.23868. 0 21 H 37010 requires M+H, 449.23865. The minor 
isomer (268) was not detectable by 1 H or 130  NMR spectroscopy. 
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R 	H6b >4 , I IH6a 
HO 	5 0 
1,110 
HO 




MAJOR MINOR MAJOR MINOR 
Resonance (262) (263) (265) (264) 
1 5.88 5.93 5.92 5.90 
2 4.58 4.60 4.60 4.57 
3 4.09 4.11 4.08 4.11 
4 3.97 4.07 4.03 3.98 
5 4.22 4.27 4.27 4.23 
6a 1.72 1.93 1.92 1.59 
6b 2.08 1.93 1.68 2.29 
7 399..404a 3.97 399..406d 3.92 
8 384..390b 3.78 3.86 366..395e 
9 3•843•90b 3.75 3.90 366..395e 
10 399.404a 407C 399..406d 4.06 
ha 3.93 3.99 4.11 4.17 
lib 4.12 4.17 3.92 3.99 
Ph 7.26-7.36 7.25-7.34 7.27-7.37 7.27-7.37 
PhCH2 4.64, 4.70 4.58, 4.70 4.52, 4.70 4.70 
OH 3.0, 3.6 3.11, 3.67 2.54, 2.78 3.83, 4.06 
1.29, 1.32 1.30,1.33 1.30, 1.31 1.29,1.33 
CH3 1.35, 1.39 1.34,1.42 1.34, 1.37 1.36,1.44 
1.41, 1.46 1 	1.46 1.38,1.45 1.47 
a: (21-1, complex multiplet); b: (21-1, complex second order multiplet); 
C: unresolved, underlies 4-H signal: d: (21-1, complex multiplet, overlaps 4-H): 













MAJOR MINOR MAJOR MINOR 
Coupling (262) (263) (265) (264) 
1,2 3.8 3.7 3.8 3.8 
2,3 <1 <1 <1 <1 
3,4 3.0 3.3 3.5 3.0 
4,5 8.3 7.7 8.0 8.3 
5,6a 10.2 a 2.7 10.1 
5,6b 2.1 a 9.2 1.7 
6a,6b 14.7 nd 14.5 14.5 
6a,7 10.4 b 10.1 10.1 
6b,7 2.4 b 2.6 1.7 
7,8 nd b 2.6 7.0 
8,9 nd -7.8 7.3 nd 
9,10 nd --7.3 7.6 7.5 
10,11a 5.0 5.3 6.0 6.0 
10,11b 6.0 6.2 5.1 5.3 
lla,llb 8.4 8.7 8.3 8.4 
PhCH2 11.8 	1 1.7 11.8 0 
nd: not determined 









MAJOR MINOR* MAJOR MINOR* 
Resonance (266) (267) (269) (268) 
1 4.82 4.85 4.88 4.87 
2 4.50 4.50 4.54 4.54 
3 4.78 4.80 4.81 
4 3.71 c 3.81 3.76 
5 4.15 c 4.25 g 
6a 1.71 1.91 1.93 1.64 
6b 2.03 1.91 1.79 2.22 
7 397..402a c 400...407d g 
8 3•86..389b c 3.883.92e g 
9 3•863•89b c 3.883.92e g 
10 3•97..408a C 4•00..407d g 
ha 3.91 c 4.11 g 
lib 4.08 c 3.93 g 
We 3.24 3.25 3.28 3.30 
OH 3.10, 3.70 2.09, c 2.5, 3.0 g 
CH3 1.28, 1.33 1.27, 1.30 1.29, 1.30 1.23, 1.31 
1.37, 1.43 1.32, 1.39 1.35, 1.39 1.34, 1.35 
1.42 1.45 1.43, 1.47 
*: Signals attributable to minor isomer from spectrum of mixture. 
a: (21-1, complex unresolved multiplet); b: (2H, complex second order multiplet); C: 3.68-4.18 
(91-1, complex series of multiplets overlapping with signals for major isomer); d: (2H, 
complex unresolved multiplet); e: (2H, complex unresolved multiplet); t: signal overlaps the 





, , H6a 
11b A 11 	
11a - 
R O \ 
J/Hz J/Hz 
MAJOR MINOR MAJOR MINOR Coupling OU 	i
(266) (267) (269) (268) 
1,2 <1 <1 <1 <1 
2,3 5.9 5.9 6.0 6.0 
3,4 3.6 3.7 3.7 3.3 
4,5 8.4 nd 7.9 8.1 
5,6a 10.1 nd 2.8 10.1 
5,6b 2.4 nd 9.1 2.2 
6a,6b 14.5 nd 14.5 14.5 
6a,7 10.1 nd 9.9 10.1 
6b,7 2.4 nd 2.8 2.2 
7,8 nd nd nd nd 
8,9 nd nd nd nd 
9,10 nd nd nd nd 
10,11a 4.9 nd 6.0 nd 
10,1 lb 6.0 nd 4.6 nd 
11 a,1 1 b 8.3 nd 8.3 nd 
*: Couplings for signals attributable to minor isomer in spectrum of mixture. 




3.2.7 Synthesis of 5,7-Isopropylidene Ketals 
General Procedure 
The 1,3-diol (35-165 mg) was dissolved in dry acetone and 2,2-
dimethoxypropane (1:1) (- 3 ml per 40 mg of diol), a catalytic amount of p-
toluenesulphonic acid was added and the mixture stirred for 16 hr at room 
temperature. Saturated sodium hydrogen carbonate (2-4 drops) was added 
and the mixture extracted with dichioromethane. The combined organics 
were dried (MgSO4) and evaporated in vacuo to afford the crude ketal which 
was purified by preparative tic on silica gel. 
3.2.7.1 5,7-Isopropylidene Ketals From D-Glucose-Derived Diols 
3.2.7.1a 5,7-Isopropylidene Ketal of Diol (262) 
This was obtained using the above procedure. Diol (262) afforded, 
after preparative tic on silica (70% ether in hexane), 3-0-benzyl-6-deoxy-
1,2:5,7:8,9:10,11 -tetra-0 -isopropylidene-D-g luco -a-D-g luco -undecose-( 1 ,4) 
(270) as an oil (76%); [(X]27  +3.0 (c 2.99 in CHCI3); H(360  MHz, CDCI3) see 
Tables 42 and 43; 	(50  CDCI3) 19.7, 25.0, 26.1, 26.4, 26.5, 26.6, 27.3, 
29.7(8xMe), 31.1(0-6), 65.7, 67.8(C-5, C-7), 67.4(0-11), 72.2(CH 2Ph), 76.0, 
77.4, 80.6, 82.3, 82.8(0-2, 0-3, 0-4, 0-8, C-9, 0-10), 98.5(C(Me) 2 fdkixane]), 
104.8(C-1), 109.4, 109.5, 111.5(3xC(Me) 2), 127.4, 127.6, 128.2(5xPhCH), 
137.6(PhC); m/z (FAB) Found: M++H, 565.30129. CH 4 010 requires M+H, 
565.30125. 
3.2.7.1 b 5,7-Isopropylidene Ketal of (263) 
The ketai was obtained using the above procedure. The product 
was identified, after purification by preparative tic on silica (70% ether in 
hexane), as 3-0 -benzyl-6 -deoxy-1 ,2 :5,7:8,9:10,1 1 -tetra-0-isopropylidene-D- 
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manno-a-D-gluco-undecose-(1,4) (271) (72%); [a] +12.2 (C 1.4 in CHC13); 
8H(360 MHz, ODd 3) see Tables 42 and 43; (50  MHz, CDCI3), 24.7, 25.0, 
25.2, 26.1, 26.5, 26.7, 27.1, 27.4(8xMe), 30.3(C-6), 63.4, 66.8(C-5, 0-7), 
66.9(C-11), 72.2(CH 2Ph), 76.9, 78.2, 81.2, 81.4, 82.1, 82.8(C-2, C-3, C-4, C-
8, C-9, C-b), 100.4(C(Me) 2 Idioxane]), 104.8(C-1), 109.4, 110.0, 
111 .5(3xC(Me) 2), 127.4, 127.7, 1 28.3(5xPhCH), 1 37.5(PhC); m/z (FAB) 
Found M+H, 565.30129. C 30H010 requires M+H, 525.30125. 
3.2.7.1c 5,74sopropylidene Ketai of (264) 
The ketal was prepared using the above general procedure. The 
product was purified by preparative tic on silica (70% ether in hexane) to 
afford 	3-0 -benzyl-6 -deoxy-1 ,2 :5,7:8,9:10,11 -tetra-0 -isopropylidene-L- 
manno-cL-D-giuco-undecose-(1,4) (272) (89%); [(X]27 -20.0 (c 2.13 in CHC13); 
8H(360 MHz, CDCI3) see Tables 43 and 44; (50  MHz, CDCI3) 19.7, 25.2, 
26.2, 26.4, 26.7, 27.4, 29.8(8xMe), 30.5(0-6), 65.6, 69.8(C-5, C-7), 66.3(0- 
11), 72.3(CH 2Ph), 76.6, 78.5, 80.7, 81.5, 82.3, 83.0(0-2, C-3, 0-4, 0-8, C-9, 
C-10), 98.4(C(Me) 2 Idioxanel), 104.9(C-1), 109.4, 110.0, 111 .7(3xC(Me) 2), 
127.5, 127.7, 128.3(5xPhCH), 137.5(PhC); m/z (FAB) Found: M+H, 
565.30129. CH4 0 10 requires M±H, 565.301 25. 
3.2.7.1d 5,74sopropylidene Ketal of (265) 
The ketal was obtained using the above general procedure. The 
product was purified by preparative tic on silica (70% ether in hexane) to 
afford 3-0 -benzyl-6 -deoxy-1 ,2 :5,7:8,9:10,11 -tetra-0 -isopropylidene-L-g luco - 
a-D-gluco-undecose-(1 ,4) (273) (76%); [a] -11.0 (c 2.39 in CHCI 3); H(360 
MHz, CDCI3) see Tables 42 and 43; (50  MHz, ODd 3) 24.9, 25.0, 25.1, 
26.1, 26.5, 26.7, 26.8, 27.6(8xMe), 31.4(C-6), 63.6, 65.9(C-5, C-7), 67.4(C- 
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11), 72.2(CH 2Ph), 77.1, 77.2, 81.2, 82.0, 82.2, 82.6(C-2, C-3, 0-4, C-8, 0-9, 
0-10), 100.3(C(Me) 2 [dioxane]), 104.9(0-1), 109.5, 109.7, 1 11.4(3xC(Me) 2), 
127.5, 127.7, 128.3(5xPhCH), 137.5(PhC); m/z FAB Found: M++H, 
565.30129. CH 5010 requires M+H, 565.301 25. 
3.2.7.2 5,7-Isopropyfidene Ketals from D-Mannose-Derived Diols 
3.2.7.2a 57-Isopropylidene Ketal of (266) 
This was obtained by the above procedure. The product was 
purified by preparative tic on silica (70% ether in hexane) and identified as 
methyl 6-deoxy-2 ,3:5,7 :8,9:10,11 -tetra-0-isopropylidene-D-giuco-ct-D-manno-
undecoside-(1 ,4) (274) (92%); 5H(360  MHz, CDCI3) see Tables 44 and 45; 
8(50 MHz, ODd 3) 19.4, 24.8, 25.1, 26.0, 26.5, 26.6, 27.5, 29.7(8xMe), 
30.7(0-6), 54.2(OMe), 66.4, 68.1(0-5, 0-7), 67.5(C-11), 76.3, 77.5, 79.1, 
81.7, 82.6, 84.7(0-2, 0-3, C-4, C-8, 0-9, C-b), 98.7(C(Me) 2 [dioxane]), 
106.7(0-1), 109.4, 109.7, 112.0(3xC(Me) 2); m/z (FAB) Found: M+H, 
489.26992. 024 H41 010  requires M+H, 489.26995. 
3.2.7.2b 5,7-Isopropylidene Ketals from Mixture of (266) and (267) 
The ketals were obtained by the above general procedure. The 
diol mixture afforded, after preparative tic on silica (50% ether in hexane) an 
inseparable mixture of ketals (274) and (275) [m/z (FAB) Found: M-i-H, 
489.26992. 024 H 41 010 requires M+H, 489.26995] in the combined yield of 
57%. The major ketal was identified as methyl 6-deoxy-2,3:5,7:8,9:10,11 - 
tetra-O-isopropylidene-D-g luco -a-D-manno -undecoside- (1 ,4) 	(274) 	(see 
Section 3.2.7.2a for analysis). The minor ketal was assigned as methyl 6-
deoxy-2 3:5,7:8,9:10,1 1 -tetra-0 -isopropylldene-D-man no -a-D-manno - 
undecoside-(1 ,4) (275); 6H(360  MHz, CDCI3) see Tables 44 and 45 for partial 
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analysis; (50  MHz, CDCI3) [peaks in mixture attributable to minor isomer] 
24.5-27.5(Me envelope), 30.7(0-6), 54.2(OMe), 66.7(C-1 1), 64.2, 66.9, 76.8, 
78.4, 81.4, 82.0(0-2, C-3, 0-4, C-8, 0-9, 0-10), 100.6(C(Me)2[dioxanej), 109.4, 
110.0, 112.1(C(Me)2). 
3.2.7.2c 5,74sopropylidene Ketal of (269) 
This was obtained by the general procedure above. The product 
was purified by preparative tic on silica (80% ether in hexane) to afford 
methyl 6 -deoxy-2 ,3 :5,7:8,9:1 0,11 -tetra-O-isopropylidene-L-g luco -a-D-manno - 
undecoside-(l ,4) (277) (88%); [ci] +25.7 (c 2.22 in CHCI3); H(360  MHz, 
ODd 3) see Tables 44 and 45; (50  MHz, CDCI3) 24.2, 24.4, 24.8, 25.1, 
25.9, 26.4, 26.8, 27.6(8xMe), 32.1(0-6), 54.2(OMe), 64.1, 66.2(0-5, 0-7), 
67.5(0-11), 77.3, 77.4, 79.2, 82.0, 84.7(C-2, 0-3, 0-4, 0-8, 0-9, 0-10), 
100.7(C(Me) 2 [dioxanel), 106.8(0-1), 109.5, 109.7, 112.2(3xC(Me) 2); m/z (FAB) 
Found: M+H, 489.26992. C 24 1­1 41 010 requires M+H, 489.26995. 
3.2.7.2d 5,7-Isopropylidene Ketals from mixture of (268) + (269) 
Using the general procedure the inseparable diols (268) and (269) 
produced an inseparable mixture of the corresponding ketals (276) and 
(277) [m/z (FAB) Found: M+H, 489.26999. 0 24 H 41 010 requires M+H, 
489.26995] in a combined yield of 81%. The major isomer corresponded to 
ketal (277). The minor ketal was assigned as methyl 6-deoxy-
2,3:5,7:8,9:10,1 1 -tetra-0 -isopropylldene-L -man no -a-D-manno -undecoside-
(1,4) (276); H(360 MHz, ODd 3) for partial analysis see Tables 44 and 
45;(50 MHz, ODd 3) 19.3, 24.7, 25.1, 25.8, 26.3, 27.3, 27.5, 29.6(8xMe), 
30.3(0-6), 54.0(OMe), 66.1(0-11), 66.1, 69.9(0-5, 0-7), 76.5, 78.7, 78.9, 
81.3, 81.7, 84.5(0-2, 0-3, 0-4, 0-8, 0-9, 0-10), 98.4(C(Me) 2 [dioxane)), 





0 Hl1b4 a 
"110 
R OD 	8 
5H 8H 
MAJOR MINOR MAJOR MINOR 
Resonance (270) (271) (273) (272) 
1 5.86 5.88 5.88 5.88 
2 4.54 4.55 4.54 4.55 
3 4.02 4.00 3.99 4.03 
4 393.406a 391...411b 4.08 3.96 
5 4.24 4.24 4.25 4.23 
6a 1.69 2.19 2.16 1.53 
6b 1.77 1.87 1.84 1.92 
7 3.934.06a 391..411b 390..397C 393..401e 
8 aor3.86 391..411b 390..397C 3.934.01e 
9 3.86 or a 3.78 3.903.97C 3.81 
10 3.934.06a 391..411b 400..406d 4.13 
ha 3.96 391...411b 4.12 4.06 
lib 4.11 391..411b 3.93 3.95 
Ph 7.25-7.35 391..411b  7.26-7.35 7.25-7.36 
PhCH2 4.56,4-63 4.55, 4.63 4.55, 4.63 4.57, 4.64 
CH3 
1.28, 1.32 1.29, 1.33 1.29,1.32 1.29, 1.33 
1.35, 1.36 1.34, 1.37 1.33,1-36 1.35, 1.36 




a: (61-1, complex overlapping mufliplets of which only 3-H and 11 a-H are able 
to be assigned); b: complex overlapping multiplets; C: (3H, complex 





%i H6a  
BnO 
11b 	=11a0\ 14 - H11 	11a= 
J/Hz J/Hz 
MAJOR MINOR MAJOR MINOR 
Coupling (270) (271) (2 3) (272) 
1,2 3.7 3.8 3.8 3.7 
2,3 <1 <1 <1 <1 
3,4 3.0 3.6 3.1 2.6 
4,5 8.6 8.5 8.5 8.7 
5,6a 11.6 6.3 6.3 11.8 
5,6b 3.0 8.9 8.6 2.5 
6a,6b 13.1 13.2 13.2 13.2 
6a,7 11.6 9.6 9.8 11.8 
6b,7 3.0 5.9 5.7 2.5 
7,8 nd nd nd nd 
8,9 nd 6.7 nd 5.3 
9,10 nd 6.7 nd 6.3 
10,11a 4.2 nd 6.2 6.3 
10,1 lb 5.7 nd 5.3 5.6 
lla,llb 8.1 nd 8.2 8.3 
PhCH2 	1 11.9 	1 11.7 	11 11.7 	1 11.9 




I i H6a 
O\> .& i 
0 H 	H 	g-\- H 	H 
RA 
8H 8H 
MAJOR MINOR* MAJOR MINOR* 
Resonance (274) (275) (277) (276) 
1 4.80 4.82 4.82 4.81 
2 4.48 4.49 4.50 4.49 
3 4.69 4.67 4.69 4.70 
4 3.71 3.79 3.80 3.68 
5 4.20 c 4.17 c 
6a 1.62 c 2.16 
6b 1.73 c 1.75 1.85 
7 393..399a c 3.92 c 
8 3.88 c 3.97 c 
9 4•014•05b c 3.91 c 
10 4.10 c 4.03 c 
ha 393..399a C 4.12 c 
lib 401..405b c 3.93 c 
OMe 3.24 3.26 3.25 3.26 
1.28,1.30 1.26-1.40 1.27, 1.32 1.22-1.47 
CH3 
1.31, 1.37 (Me 1.33, 1.36 (Me 
envelope) envelope) 
1.38,1.40 1.37,1.39 
 1.41 	1 
*:Signals attributable to minor isomer from spectrum of mixture. 	- - 
a: (2H, complex multiplet); b: (21-1, complex multiplet); C: undetermined due 
to overlap with signals for major diol; d: masked by methyl signals. 
Table 44 
R H H6a 




MAJOR MINOR* MAJOR MINOR* 
Coupling (274) (275) (277) (276) 
1,2 <1 <1 <1 <1 
2,3 5.9 5.9 5.9 5.9 
3,4 3.5 3.9 3.6 3.5 
4,5 8.4 8.3 8.5 8.3 
5,6a 11.8 nd 6.3 11.7 
5,6b 2.6 nd 9.1 2.4 
6a,6b 12.8 nd 13.1 13.0 
6a,7 11.8 nd 10.0 11.7 
6b,7 2.6 nd 5.8 2.4 
7,8 3.1 nd 4.4 nd 
8,9 6.5 nd 6.1 nd 
9,10 1.9 nd 7.9 nd 
10,11a 4.2 nd 6.1 nd 
10,1 lb 8.1 nd 5.3 nd 
lla,llb I 	nd nd 8.3 nd 
*: Couplings attributable to minor isomer in spectrum of mixture 




3.2.8 Isopropylidene Deprotection and Acetylation of 1,3- 
Diols: Synthesis of Octaacetate Derivatives 
3.2.8.1 From 3-O-Benzy!-6-deoxy-1 ,2 :8,9:10,11 - tri-O-isopropylidene-o-
g!uco-a-D-gluco-undecose-(1 ,4) (262) 
The diol (262) (48 mg, 0.09 mmol) in trifluoroacetic acid (0.7 ml) 
and water (0.1 ml) was stirred for 30 min at room temperature. The mixture 
was evaporated in vacuo then water added and evaporated several times. 
Pyridine (1 ml), acetic anhydride (1 ml) and a catalytic amount of 4-
dimethylaminopyridine were added and the mixture stirred overnight at room 
temperature. The resulting solution was poured onto water (4 ml) and 
extracted with dichloromethane (3 x 4 ml). The combined organics were 
dried (MgSO4 ) and evaporated in vacuo to the crude mixture of a- and - 
octaacetates which were purified by preparative tIc on silica (80% ether in 
hexane, double elution). The first eluting product was identified as 3-0-
benzy1-6-deoxy-1 ,2,4,7,8,9,1 0,11 -octa-O-acetyl-D-gluco-a-D-gluco- 
undecopyranose (278) (13 mg, 20%); [a] 	+8.0 (C 2.8 in CHCI3); 
8H(360 MHz, ODd 3) see Tables 46 and 47; 6(90  MHz, ODd 3) 20.3, 20.5, 
20.6, 20.7(8xCH 3CO), 31.6(0-6), 61.4(C-11), 68.2, 68.3, 69.6, 69.7, 70.1, 
71.3, 72.5, 77.0(0-2, 0-3, 0-4, C-5, C-7, 0-8, 0-9, 0-10), 74.6(CH 2Ph), 
88.3(0-1), 127.3, 127.7, 128.3(5xPhCH), 137.9(PhC), 169.0, 169.4, 169.5, 
169.6, 169.7, 169.8, 170.3, 170.4(8xCH 3C=O); m/z (FAB) Found: M - 
CH3002, 681.23940. C32 H41 016 requires M - CH 3002, 681.23943. The 
second eluting product was identified as 3-0-benzyl-6-deoxy-
1,2,4,7,8,9,10,11 -octa-0-acetyI-D-gluco-3-D..gluco-undecopyranose (279) (21 
mg, 30%), [a] +5.9 (c 1.1 in CHCI 3); vm/cm1  (nujol) 1754 (0=0); H(360 
MHz, ODd 3) see Tables 46 and 47; (90  MHz, ODd 3) 20.34, 20.54, 20.60, 
20.62, 20.67(8xCH 300), 31.7(C-6), 61.4(C-1 1), 68.4, 68.5, 69.3, 70.1, 71.6, 
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72.1, 72.4, 79.9(0-2, C-3, 0-4, C-5, C-7, C-8, C-9, 0-10), 74.0(CH 2Ph), 
91.7(0-1), 127.6, 127.8, 128.3(5xPhCH), 137.5(PhC), 168.8, 169.0, 169.59, 
169.64, 169.8, 169.9, 170.4(8xCH 3 C=O); m/z (FAB) Found: M - CH 30021  
681.23940. C32 H 41 0 16 requires M - 0H 3002 , 681 .23943. 
3.2.8.2 From 3-O-Benzyl-6-deoxy-1 ,2:8,9:1 0,11 -fri -O-isopropylidene-L-
gluco-a-D-gluco-undecose-(1 ,4) (265) 
The diol (265) (76 mg, 0.15 mmol) in trifluoroacetic acid (1 ml) and 
water (0.1 ml) was stirred for 30 min at room temperature. The mixture was 
evaporated in vacuo then water added and evaporated several times. 
Pyridine (1 ml), • acetic anhydride (2 ml) and a catalytic amount of 4-
dimethylaminopyridine were added and the mixture stirred overnight at room 
temperature. The resulting solution was poured onto water (2 ml) and 
extracted with chloroform (3 x 5 ml). The combined organics were dried 
(MgSO4), evaporated in vacuo and purified by preparative tIc on silica (80% 
ether in hexane, double elution) to afford the a- and -octaacetates. The 
first eluting product was identified as 3-0-benzyl-6-deoxy-1 ,2,4,7,8,9,1 0,11 - 
octa-0-acetyl-L-gluco-a-D-gluco-undecopyranose (280) (33 mg, 31%), [a] 21 
+21.3 (c 1.8 in CHCI 3); V p ICm 1 (neat) 1745 (0=0); 8H(360  MHz, ODd 3) see 
Tables 46 and 47; 6(90  MHz, CDCI3) 20.28, 20.32, 20.43, 20.51, 20.57, 
20.60, 20.62, 20.69(8xCH 3CO), 32.7(0-6), 61.3(0-11), 67.6, 67.9, 68.0, 68.3, 
70.8, 71.4, 72.5, 77.2(0-2, 0-3, C-4, 0-5, 0-7, 0-8, 0-9, 0-10), 74.5(CH 2Ph), 
88.3(C-1), 127.2, 127.6, 128.3(5xPhCH), 137.9(PhC), 168.9, 169.4, 169.52, 
169.55, 169.61, 169.64, 169.75, 170.40(8xCH3 C=0); mlz (FAB) Found: M-
CH 3002, 681.23940. C32 H 41 0 16 requires M - CH 3CO2 , 681.23943. The 
second eluting product was identified as 3-0-benzyl-6-deoxy-
1,2,4,7,8,9,10,11 -octa-0-acetyI-L-gluco-3-D-gluco-undecopyranose (281), a 
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white solid, (51 mg, 48%), m.p. 104-105°C (from EtOH); [aJ -6.2 (c 0.41 in 
CHCI3); v/cm 1 (neat) 1754, 1741 (C=O); 6H  (360 MHz, CDCI3) see Tables 
46 and 47; (90  MHz, CDCI3) 20.30, 20.34, 20.48, 20.52, 20.56, 20.58, 
20:67(8XCH3CO), 32.0(C-6), 61.4(C-11), 68.1, 68.5, 68.8, 70.5, 71.1, 71.5, 
72.4,79.9(C-2, C-3, C-4, C-5, C-7, 0-8, 0-9, C-b), 73.8(CH 2Ph), 91.7(C-1), 
127.6, 127.7, 128.3(5xPhCH), 137.5(PhC), 168.71, 168.90, 169.36, 169.48, 
169.53, 169.67, 169.76, 170.39(8xCH 3C=O); m/z (FAB) Found: M - 





AcO AcO AcO AcO 
R 
AcO AcO AcO AcO AcO AcO 
8H 8H 
a a Resonance 
(278) (279) (280) (281) 
1 6.23 5.56 6.17 5.51 
2 4.98 5.08 4.99 5.07 
3 3.90 3.67 3.87 3.66 
4 4.85 4.87 4.86 4.89 
5 3.94 3.61 3.66 3.46 
6a 1.74 172..189b 1.59 
6b 1.85 172..189b 1.69 163189d 
7 5.03 5.07 5.15-5.20 5.145.21e 
8 5.23 5.25 5.155.20C 5.145.21e 
9 5.32 5.36 5.37 5.34 
10 4•955•00a 4.98 5.01 5.02 
ha 4.13 4.15 4.04 4.06 
lib 4.13 4.15 4.19 4.23 
Ph 7.21-7.34 7.18-7.33 7.20-7.33 7.17-7.31 
PhCH2 4.59, 4.67 4.56 4.58, 4.67 4.55 
CH3 
1.95, 1.97 1.93, 1.98 1.95,1.97 1.91, 1.97 
2.00, 2.01 1 .99, 2.02 2.00, 2.01 1 .99, 2.00 
2.04, 2.10 2.03, 2.05 2.03, 2.05 2.02, 2.03 
2.19 2.09 2.09, 2.12 2.04 
a: multiplet underlies H-2; b: complex multiplet; C: (2H, complex second 







AcO AcO AcO AcO 
R 
11 
AcO AcO AcO AcO AcO AcO 
J/'-lz J/Hz 
a cx 
Coupling (278) (280) (280) (281) 
1,2 3.7 8.3 3.9 8.3 
2,3 10.0 9.4 10.0 9.4 
3,4 9.4 9.4 9.3 9.3 
4,5 10.0 9.5 10.1 9.6 
5,6a 8.9 nd 1.7 2.4 
5,6b 1.9 nd 10.1 9.6 
6a,6b 15.1 nd 14.0 nd 
6a,7 8.9 nd 9.0 nd 
6b,7 1.9 nd <2 nd 
7,8 8.0 3.9 nd nd 
8,9 3.2 3.9 3.4 4.3 
9,10 8.0 7.4 7.6 6.7 
10,11a nd 4.1 5.2 5.9 
10,1 lb nd 4.1 3.5 3.1 
lla,llb nd 0 12.4 12.5 
PhCH2 11.9 1 	0 	11 11.8 1 	0 




3.3 	Syntheses of Azasugar precursors 
3.3.1 	Compounds for General Use 
3.3.1.1 Ethyl chloro(hydroxyimino)acetate (301) 
Prepared according to the method of Skinner. 267 Glycine ethyl 
ester hydrochloride (30 g, 0.21 mcI) was dissolved in water (90 ml), cooled 
to -30°C (cardice-acetone bath) and concentrated hydrochloric acid (36%, 
18 ml, 0.21 mmol) added. A solution of sodium nitrite (14.5 g, 0.21 mol) in 
water (35 ml) was added at such a rate that the solution temperature never 
exceeded -20°C. Concentrated hydrochloric acid (36%, 18 ml, 0.21 mmol) 
and sodium nitrite (14.5 g, 0.21 mmol) in water (35 ml) were added as before 
and the mixture left to stir for 30 mm. The white precipitate was collected, 
dissolved in diethyl ether, filtered to remove impurities, then reprecipitated 
by addition of excess hexane with cooling. A second batch of crystals was 
obtained by concentration of the initial filtrate, followed by addition of hexane 
and a small volume of diethyl ether. The combined precipitates were dried 
producing the product as white crystals (14.34 g, 44%), m.p. 79-80°C (lit. 267 
79-80°C); m/z (FAB) Found M, 152.01145. C4 H 7NO3CI requires M, 
152.01144. 
3.3.1.2 Synthesis of p-Toluenesulphonic Acid Allyl Ester (291) 
Allyl alcohol (5.0 g, 0.09 mol) in chloroform (90 ml) was cooled to 
0°C. Pyridine (13.6 g, 0.17 mol) was added, then p-toluenesulphonyl 
chloride (16.4 g, 0.09 mol) was added portionwise. The mixture was stirred 
for 5 hr while warming to room temperature after which ether (250 ml) and 
water (65 ml) were added. The organic fraction was washed with 2 M HCI 
(130 ml), 5% NaHCO 3 solution (130 ml) and H 20 (200 ml), dried (MgSO4 ) 
and concentrated in vacuo to yield the crude product. Purification by dry 
flash column chromatography on silica (8% ether in hexane) afforded the 
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product as a clear oil (11.53 g, 63%); v/cm -1 	1364, 1175 (los); 
(90  MHz, 	CDCI3) 	21.5(MeTOS ), 	70.6(C-3), 	120.1(C-1), 	127.7, 
129.7(4xArCH), 130.1(C-2), 133.1, 144.7(2xArC); m/z (FAB) Found M+H, 
21 3.05854. C 10 H 1303S requires M+H, 21 3.05853. 
3.3.2 	Cycloaddition Reactions of Ethoxycarbonylformonitrile Oxide 
3.3.2.1 Cycloaddition to Allyl Alcohol 
Tnethylamine (2.8 g, 27.7 mmol) in ether (50 ml) was added, via 
syringe pump over 17 hr, to an ice-chilled solution of allyl alcohol (1.0 g, 
17.2 mmol) and ethyl chloro(hydroxy)iminoacetate (301) (3.9 g, 25.7) in 
ether (50 ml). The mixture was stirred for a further 1 hr, then filtered through 
celite and evaporated in vacuo. The resulting oil was purified by dry flash 
chromatography on silica gel (30% ether in hexane) to afford, in order of 
elution, 3,4-diethoxycarbonylfurazan N-oxide (225) (0.50 g, 17%) 
[characterised by comparison tic with an authentic sample], 
2,5- diethoxyca rbonyl-7- hydroxymethy/-4 , 8- dioxa- 1 ,3- diaza bi cyclo[3. 3.0] oct-2-
ene (319) (0.23 g, 5%); Vm /cm 1 (neat) 3460 (OH), 1746, 1720 (C=O); 
8H(200 MHz, CDCI3) 1.25(3H, t, J 7.1, CH3CH 20), 1.30(3H, t, J 7.1, 
CH3CH20), 3.03(1H, dd, 16a 78.1, Jra,ft 17.8, 6a-H), 3.28(1H, dd, J6b,7  11.3, 
6a,6b178' 6b-H), 4.09-4.34(1H, OH), 4.15(2H, q, J7.1, CH3CH20), 4.16(1H, 
dd, J 5.4, J 11.8, CH20H), 4.26(1 H, dd, J 4.4, J 11.7, CH20H), 4.29(2H, q, J 
7.1, CH3CH20), 4.99(1 H, dddd, J7,7,  43,  J7.7CC  53,  "6a,7 8. 1, J6b,7  11.3, 7-H); 
8 (90  MHz, CDCI3) 13.8, 13.9(2xCH 3CH20), 35.4(C-6), 61.9, 64.2, 
66.8(2xCH 3CH20, CH20H), 80.2(C-7), 151.1 (C=N), 154.5, 1 60.0(2xC=O); 
mlz (FAB) Found: M+H, 289.10359. C 11 H 17N 207 requires, M+H, 289.10356; 
and (RS)-3-ethoxycarbonyl-5-hydroxymethyl-2-isoxazoline ( 317) as a waxy 
solid (2.18 g, 73%); v,./cm -1 (nujol) 3428 (OH), 1720 (C=O); 6H(200  MHz, 
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CDCI3) see Tables 48 and 49; (50  MHz, CDCI3) 13.7(CH 3CH20), 34.4(C-
4), 61.8, 62.7(CH 3 CH 20, CH20H), 83.7(C-5), 151.6(C-3), 160.2(C=O); m/z 
(FAB) Found: M+H, 174.07662. C 7H 12 N04 requires, M+H, 174.07663. 
3.3.2.2 Cycloaddition to p-Toluenesul phonic acid allyl ester (291) 
Alkene (291) (1.0 g, 4.7 mmol) and ethyl chioro-
(hydroxyimino)acetate (301) (1.07 g, 7.1 mmol) were dissolved in ether 
(25 ml) and cooled to 0°C. Triethylamine 0.76 g, 7.5 mmol) in ether (25 ml) 
was added via motorised syringe pump over 20 hr, then the mixture left to 
stir for a further 4 hr. The mixture was filtered through celite and washed 
with water (2 x 10 ml). The organic fraction was dried (MgSO 4) and 
evaporated in vacuo to produce an oil. Dry flash column chromatography on 
silica (35% ether in hexane, then 100% ether) afforded, in order of elution, 
an inseparable mixture of unreacted alkene (291) and 3,4-  
diet hoxycarbonylfurazan N-oxide (225) (0.57g), then (RS)-3-ethoxycarbonyl-
5-p-toluenesulphonyloxymethyl-2-isoxazoline (321) (1.07 g, 69%). A further 
quantity of hydroximoyl chloride (301) (0.5 g, 3.3 mmoi) was added to the 
mixture of recovered alkene and furazan N-oxide in ether (20 ml). 
Triethylamine (0.37 g, 3.6 mmol) in ether (20 ml) was pumped in over 16 hr, 
then the mixture left to stir for a further 4 hr. Work up, followed by column 
chromatography as before, afforded 3,4-diethoxycarbonylfurazan N-oxide 
(225) (0.73 g, 61%), characterised by comparison tic with an authentic 
sample, and a further quantity of isoxazoline (321) (0.12 g). The isoxazoline 
(321) was obtained as a white solid (1.19 g, 77% overall yield), m.p. 85-86°C 
(from EtOH); (Found: C, 51.6; H, 5.4; N, 4.3. C 14 H 17N06S requires C, 51.4; 
H, 5.2; N, 4.3%); H(200  MHz, CDCI3) see Tables 48 and 49; (50  MHz, 
CDCI3) 1 3.8(CH3CH2), 21 .4(MeTOS ), 35.3(C-4), 62.0(CH 3CH 2), 68.6(CI-I2OTs), 
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79.7(0-5), 127.7, 129.8(4xArCH), 131.9, 145.2(2xArC), 151.2(C-3), 
159.8(C=O); mlz (FAB) Found: M+H, 328.08545. C 14 H 18 N06S requires 
M+H, 328.08547. 
	
3.3.3 	Modification of 2-Isoxazolines 
3.3.3.1 Reduction of Ethyl Ester Function 
3.3.3.1a Reduction of (RS)-5- tert-butyldimethylsiloxymethyl-3-
ethoxycarbony!-2-isoxazo!ine (318) 
The isoxazoline (318) (0.36 g, 1.3 mmol) was dissolved in ethanol 
(15ml) and sodium borohydride (28 mg, 7.6 mmol) added in portions. The 
resulting solution was stirred at room temperature overnight then poured 
onto water (35 ml) and extracted with chloroform (3x 70 ml). The combined 
organics were dried (MgSO 4 ) and evaporated in vacuo to afford, after dry 
flash column chromatography on silica(70% ether in hexane), (RS)-5-tert-
butyldimethyl-siloxymethyl-3 -hydroxymethyl-2 -isoxazoline (314) (0.28 g, 
91%); v/cm -1 (neat) 3410 (OH); 6H(200  MHz; CDCI3) see Tables 48 and 
49; (50  MHz, CDCI3 ) -5.6(Si(Me) 2), 18.1(C(Me) 3 ), 25.6(C(Me) 3), 36.5(C-4), 
57.8(CH 20H), 63.8(CH 20Si), 80.7(0-5), 158.4 (C-3); m/z (FAB) Found: 
M+H, 246.15256. C 11 H 24 NO3Si requires M+H, 246.15254. 
3.3.3.11b Reduction of (RS)-3- Et hoxycarbonyl-5-p- toluenesuiphonyloxy-
methy!-2-isoxazoline (321) 
The isoxazoline (321) (0.70 g, 2.1 mmol) was added to ethanol (20 
ml) and THF (11 ml) added to aid dissolution. Sodium borohydride (49 mg, 
12.8 mmol) was added in portions and the resulting solution was stirred 
overnight at room temperature before being poured onto water (50 ml). The 
product was extracted with ethyl acetate (3 x 50 ml), the combined organics 
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dried (MgSO4) and evaporated in vacuo to give a oil. Purification by dry 
flash chromatography on silica (70% ethyl acetate in hexane) afforded (RS)-
3-hydroxymethyl-5 -p -to/uenesulphonyloxymethyl-2 -isoxazoline (315) (0.57 g, 
93%); m.p. 78°C (from EtOH); (Found: C, 50.9; H, 5.4; N, 5.1. 0 12 H 15 N05S 
requires C, 50.5; H, 5.3; N, 4.9%); vm /cm 1 (nujol) 3444 (OH), 1170, 1360 
Jos); H(200  MHz, ODd 3) see Tables 48 and 49; (50  MHz, CDCI3 ) 
21 .3(Me.1-0 ), 36.8(C-4), 57.1 (CH 2OH), 69.6(CH 2OT5), 76.8(0-5), 127.6, 
129.8(4xArCH), 131.8, 145.1(2xArC), 158.6(C-3); m/z (FAB) Found: M+H, 
286.07492. C 12 H 16 N05S requires M+H, 286.07491. 
3.3.3.2 Silylation of Hydroxymethyl Functionality 
3.3.3.2a Si lylati on of (RS)-3- Ethoxycarbonyl-5- hydroxymethy!-2-
isoxazoline (317) 
Isoxazoline (317) (0.30 g, 1.7 mmol), tert-butyldimethylsilyl chloride 
(0.39 g, 2.6 mmol), triethylamine (0.21 g, 2.1 mmol) and a catalytic amount of 
4-dimethylaminopyridine were dissolved in dry dichloromethane (10 ml) and 
the mixture stirred at room temperature overnight under nitrogen. The 
mixture was washed with water (2 x 10 ml) and saturated ammonium chloride 
(10 ml). The organic layer was dried (MgSO 4 ) and evaporated to an oil 
which was purified by dry flash chromatography on silica gel (50% ether in 
hexane) to afford (R S) -5 -(te rt -butyldimethylsiloxymethyl) -3 -ethoxycarbonyl-2 - 
isoxazoline (318) (0.48 g, 96%); v,,./cm -1 (neat) 1720 (C=O); H(360  MHz, 
CDCI3) see Tables 48 and 49; (50, CDCI 3 ) -5.5(Si(Me) 2), 13.9(CH 3CH 20), 
1 8.O(SiC(Me) 3), 25.5(C(Me) 3), 34.6(0-4), 61 .7, 63.5(CH 3 CH 20, CH 20SI), 
83.5(0-5), 151.2(0-3), 160.5(0=0); m/z (FAB) Found: M+H, 228.16312 
C13HNO4Si requires M+H, 288.16310. 
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3.3.3.2b Silylation of (RS)-5-p-toluenesu!phonyloxymethyl-3-
hydroxymefhy!-2-isoxazoline (315) 
Isoxazoline (315) (150 mg, 0.53 mmol), tert-butyldimethylsilyl 
chloride (87 mg, 0.59 mmol), triethylamine (64 mg, 0.63 mmol) and a 
catalytic amount of 4-dimethylaminopyridine were dissolved in dry 
dichloromethane (6 ml) and the mixture stirred under nitrogen overnight. 
The mixture was washed with water (3 x 10 ml) and saturated ammonium 
chloride (10 ml). The organic layer was dried (MgSO 4 ) and evaporated in 
vacuo to an oil which was purified by dry flash chromatography on silica gel 
(100% ether) to afford (AS) -5-p -to luen esulphonyloxymethyl-3- (tert - 
butyldimethylsi/oxymethyl)-2-isoxazoline (316) (202 mg, 96%) as a pale 
yellow oil which solidified on standing overnight in the freezer; m.p. 3940 0C; 
5H(200 MHz, CDCI 3) see Tables 48 and 49; (50  MHz, CDCI3 ) -5.7(Si(Me) 2), 
1 8.0(SiC(Me) 3), 21 .5(MeTOS ), 25.5(C(Me) 3), 37.2(C-4), 58.0(CH 20Si), 
69.2(CH 2OT5), 76.6(C-5), 127.8, 1 29.8(4xArCH), 132.2, 1 45.0(2xArC), 
158.1(C-3); m/z (FAB) Found: M+H, 400.16140. C 18 H 30 NO5SiS requires 
M+H, 400.16138. 
3.3.3.3 Tosylation or Mesylation of 3-Hydroxymethyl-Substituted 
Isoxazolines 
3.3.3.3a Attempted Tosylation of (314) 
Pyridine (39 mg, 0.49 mmol) was added to an ice-chilled stirred 
solution of alcohol (314) (60 mg, 0.24 mmol) in chloroform (2 ml). p-
Toluenesuiphonyl chloride (70 mg, 0.37 mmol) was added in portions and 
the mixture stirred overnight at room temperature. TIc indicated no reaction 
so further pyridine (3 drops) and p-toluenesulphonyl chloride (70 mg, 
0.37 mmol) were added and the mixture stirred for a further 7 hr. Ether 
251 
(5 ml) and water (4 ml) were added, then the separated organics were 
washed with 2 N hydrochloric acid (5 ml), 5% sodium hydrogen carbonate (5 
ml) and water (10 ml), dried (MgSO 4) and evaporated in vacuo. Preparative 
tic on silica gel (50% ether in hexane) afforded starting material (314) (42 
mg, 70%), but no tosylated product. 
3.3.3.3b Mesylation of (315) using Triethylamine as Base 
A solution of the alcohol (315) (50 mg, 0.18 mmol), 
methanesuiphonyl chloride (30 mg, 0.26 mmol) and triethylamine (28 mg, 
0.28 mmol) in dry dichloromethane (2 ml) was stirred at room temperature for 
6 hr. The solution was concentrated in vacuo, dichloromethane (5 ml) added 
then the mixture was washed with water (2 x 3 ml). The organic fraction was 
dried (Mg SO4) and evaporated in vacuo to produce an oil which was purified 
by preparative tic on silica gel (80% ethyl acetate in hexane) to afford an 
unidentified pale yellow oil (25 mg) and the desired (RS)-3-
methanesulphonyloxymethyl-5 -p -to/uenesulphonyloxymethyl-2 -isoxazoline 
(334) (42 mg, 66%) Vm /cm 1  1597 (C=N), 1358 and 1173 (Tos); H(200  
MHz, CDCI 3) 2.43(3H, s, MeTOS),  2.95(1H, dd, J7.1, J17.7, 4a-H), 3.18(1H, 
dd, J 11.0, J 17.6, 4b-H), 3.06(3H, s, CH3S02), 4.06(2H, d, J 4.3, CH2OTs), 
4.86(1H, ddt, J4.3, J7.1, J 11.1, 5-H), 4.92(2H, s, CH2OMs), 7.34(2H, d, J 
8.4, 2xPhCH), 7.75(2H, d, J 8.4, 2xPhCH); (90  MHz, CDCI3) 21.5(Me TOS ), 
37.8(MeSO2), 36.5(C-4), 62.6, 69.1 (CH 20Ts, CH20Ms), 78.0(C-5), 127.8, 
129.9(4xPhCH), 132.0, 145.2(2xPhC), 152.8(C-3); m/z (FAB) Found: M-i-H, 






R R' Compound 4a I 	4b 5 5a I 	5f Others 
36 	3y 	11 H  3.06 3.19 4.85 3.58 3.78 1.29(3), 2.85(OH), 4.27(3'y) 
CH3CH2OC - 
36 	3y 	11 OTs (321) 3.05 3.26 4.94 4.07 4.07 1 . 31 (36), 2 .41 (MeTOS)4.29(31),7.32, 
CH3CH20C 
- 7.73(ArCH) 
36 	3y 	11 O[Si]  3.14 3.14 4.82 3.66 374 0.03(Si(Me) 2), 0.82(C(Me) 3), 1.32(3), 
CH3CH2OC 
- 
HOCH2 OlSil  2.92 3.06 4.53 3.65 3.65 0.04(Si(Me) 2), 0.85(C(Me)3), 3.O(OH), 
4.35(3a) 
HOCH2 OTs  2.89 3.14 4.76 4.02 4.02 2.41(Me105 ), 3.25(OH), 4.31(3a), 7.32, 
7.74(ArCH) 
(Si]OCH2 OTs  2.88 3.13 4.74 3.97 4.05 0.05(Si(Me) 2 ), 0.86(C(Me) 3), 2.42(MeTOS ), 










R R' Compound 4a,4b 4a,54b,5 L5,5(x 5,5a' 5a,5a' Others 
38 	3y 	9 H  17.7 8.7 10.9 4.4 3.2 12.5 7.1(3a,3) 
CH3CH2OC - 
38 	3y 	9 OTs (321) 18.0 7.8 11.4 4.4 4.4 0 7.1(3(x,36), 
CH3CH2OC-   8.2(ArH) 




O[Si]  17.2 7.6 10.3 4.5 4.5 0 
3a 
HOCH2 OTs  17.5 7.6 10.3 4.7 4.7 0 8.2(ArH) 
3a 





3.3.4 	Reductive Hydrolytic Cleavage of 2-Isoxazolines 
General procedure 
The isoxazoline (1 M eq) was dissolved in a mixture of methanol 
and water (5:1, - 15 ml per 100 mg of isoxazoline). Boric acid (6 M eq) and 
10% palladium on carbon (100 mg per mmol of isoxazoline) were added and 
the mixture degassed and hydrogen filled five, times before being left to stir 
vigorously under an atmosphere of hydrogen. After all the starting material 
was consumed (monitored by tic) the mixture was filtered through celite and 
the solvent evaporated in vacuo. The excess boric acid was removed by 
repeated methanol addition and evaporation to leave the crude product 
which was purified by preparative tic on silica gel. 
3.3.4.1 Hydrogen olysis of (RS)-5- tert-butyldimethylsiloxymethyl-3-
hydroxymethyl-2-isoxazoline (314) 
Using the general procedure, after 8.5 hr, isoxazoline (314) (100 
mg, 0.41 mmol) afforded, after preparative tIc on silica gel (100% ether, 
double elution) the desired (RS)-1 ,4-dihydroxy-5-tert-
butyldimethylsiloxypentan-2 -one (322) (48 mg, 47%); v m /cm 1 (neat) 3420 
(OH), 1724 (C=O); 5H(360  MHz, ODd 3) see Table 50; 6(50  MHz, CDCI3) - 
5.5(Si(Me) 2), 18.2(SiC(Me) 2), 25.8(C(Me) 3), 41.8(0-3), 66.4(C-1 or 0-5), 
68.2(0-4), 69.0(0-5 or C-i), 209.2(0-2); m/z (FAB) Found: M+H, 
249.15223. C 11 H2504S1 requires M+H, 249.15220; a more polar material 
(14 mg) which produced a positive ninhydrin stain on tic and was believed to 
Contain (RS/S R) -2 -amino-5 -tert-butyldimethylsiloxy-pentan-1 , 4 -diol (323); 
(v/cm 1 (neat) 3380 (OH/NH 2); m/z (FAB) Found: M+H, 250.18383. 
C 11 HNO3Si requires 250.18387) was also obtained. Acetylation 
(Ac20/pyridine/DMAP) of this latter compound led to decomposition so 
further identification was not possible. 
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3.3.4.2 Hydrogenolysis of (RS)-3-Hydroxymethyl-5-p. 
toluenesulphony!oxymethyl-2-isoxazoline (315) 
Using the general procedure given above, after 40 mm, isoxazoline 
(315) (133 mg, 0.47 mmol) afforded, after preparative tic on silica gel (100% 
ethyl acetate), (RS) -1,4 -dihydroxy-5 -p -toluenesulphonyloxypentan-2 -one 
(324) (49 mg, 36%). Vm /Cm 1 (neat) 3360 (OH), 1721 (C=O), 1356, 1174 
(Tos); H(360  MHz, (CD3 ) 2C0) see Table 50; (50  MHz, (CD3 ) 2CO) 
19.7(MeTQS ), 40.4(C-3), 64.1(0-4), 67.6, 72.4(0-1, 0-5), 126.9, 
1 29.0(4xArCH), 132.1, 144.1 (2xArC), 207.4(0-2); m/z (FAB) Found: M+H, 
289.07456. C 12 H 1706S requires M+H, 289.07458. A more polar material (19 
mg) which was stained by ninhydrin and believed to contain (RS)-3-hydroxy-
5-hydroxymethylpyrro/idine (328)/(329) (m/z (FAB) Found: M+H, 118.08681. 
C5 H 12 NO2 requires M+H, 118.08680) was also isolated. 
3.3.4.3 Hydrogenolysis of (RS)-5-p- Toluenesu!phonyloxymethyl-3- 
(te rt-bufyldimethylsi!oxymethyl)-2-isoxazoline (316) 
Using the general procedure, after 1.5 hr, isoxazoline (316) (100 
mg, 0.25 mmol) afforded, after preparative tic on silica gel (100% ether), 
(R S) -1 -te rt -butyldimethylsiloxy-4 -hydroxy-5 -p -toluenesulphonyloxypentan-2 - 
one (326) (47 mg, 47%); v m /cm 1 (neat) 3451 (OH), 1725 (0=0)1357, 1175 
(Tos); 6H(200 MHz, CDC,) see Table 50; 6(90  MHz, ODd 3 ) -5.5(Si(Me) 2), 
18.1 (C(Me) 3), 21 .S(MeTOS ), 25.6(C(Me)3), 40.9(0-3), 65.3(0-4), 69.3, 72.2 
(C-i, 0-5), 127.8, 128.9(4xArCH), 132.4, 144.9(2xArC), 209.9(0-2); m/z 
(FAB) Found: M-i-H, 403.16106. C 18 H 31 06SS1 requires M+H, 403.16105. A 
more polar band (39 mg), also obtained after chromatography, was dissolved 
in water and extracted with chloroform. Concentration of the aqueous 
fraction afforded a white solid (18 mg) believed to contain a mixture of p-
to lu enesu Ipho nic acid and 5 -tert -butyldimethylsiloxymethyl-3 -hydroxy- 
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pyrrolidine (330) in a ratio of - 5:2; 6H(360  MHz, D20) 0.17(6H, s, Si(Me) 2), 
0.95(9H, S, C(CH3 ) 3), 2.03(1H, ddd, J3,4b  4.6,  J4b,5  10.2,  J4,,4b  14.1, 4b-H), 
2.17(1 H, ddt, J3 , 4a and 4J2b 'l.8, J 5 6.6, J4a,4b 14.1, 4a-H), 2.44(7.5H, S, 
MeTOS ), 3.36(1 H, dt, J2b,3  and 4 2b,4 1 •' 2a2b 12.7, 2b-H), 3.47(1 H, dd, J 3 
4.0, J2a,2b  12.7, 2a-H), 3.82(1H, dd, J5 ,6a 6.5, "6a6b  12.0, 6a-H), 4.05(1 H, dd, 
"5,6b 3.8, J6a,6b  obscured by multiplet for 5-H, 6b-H), 4.04-4.11(1 H, m, 5-H), 
4.67-4.71(1H, m, 3-H), 7.41(5H, d, J 8.0, ArCH), 7.74(5H, d, J 8.2, ArCH); 
(90  MHz, D20) -5.5(Si(Me) 2), 17.4(C(Me) 3), 20.4(Me TOS ), 25.0(C(Me) 3), 
34.6(C-4), 52.8(0-2), 59.8(C-5), 61.5(C-6), 69.6(0-3), 125.3, 1 29.3(4xArCH), 
139.3, 142.4(2xArC); m/z (FAB) Found: M+H, 232.17325. C 11 HNO2Si 
requires M+H, 232.17327. The organic fraction was evaporated in vacuo to 
afford an oil (28 mg) believed to contain a mixture of p-toluenesulphonic acid 
and 5 -te rt -butyldimethylsiloxymethyl-3 -hydroxypyrrolidine (330) in a ratio of 
2:3 (from 1 H NMR); H(360  MHz, CDCI3) 0.05(s, Si(Me) 2), 0.81(s, C(CH3) 3), 
1.93(1 H, ddd, J3,4b  47'  J4b,5  94 44b  13.6, 4b-H), 2.07(1 H, ddt, J3 <1, J 5 
7.2, J4a,b  13.6, 4a-H), 2.33(2H, 5, MeT,J,  3.33(1H, dd, J 3 3.7, "2a,2b  12.2, 
2a-H), 3.54(1 H, br d, I2a,2b  12.2, 2b-H), 3.63(1 H, dd, J5 , 6a 4.2,  J6a,6b  11.0, 6a-
H), 3.87(1H, dd, J5,6b  3.8, I6a,6b 6b-H), 4.00-4.06(1H, br m, 5-H), 
4.54(1H, sharp unresolved m, 3-H), 5.08(brs, OH), 7.14(1.3 H, d, J8.0, Ar), 
7.69(1.3 H, d, J 8.2, Ar). [Unresolved, low intensity 'extra' peaks (<20%) 
were attributed to the minor isomer (331)]. The organic fraction was washed 
with 5% NaHCO3, to remove p-toluenesulphonic acid, dried (MgSO 4) and 
evaporated in vacuo to a yellow oil (25 mg); 6H(360  MHz, CDCI3): poorly 
resolved, but exhibited characteristic signals very similar to those observed 
prior to NaHCO3 wash; 6(90  MHz, CDCI3) -3.9(Si(Me) 2), 18.2(C(Me)3), 
25.8(C(Me)3), 37.6(0-4), 54.8(0-2), 58.1(0-5), 65.0(0-6), 72.5(0-3); m/z 
(FAB) Found: M+H, 232.17325. C 11 HNO2Si requires M+H, 232.17327. 





R A' Compound 
&ppm  
1 3a 3b 4 5a 5b Others 
H O[Si] (322) F4.26 2.51 2.58 4.09 3.51 1 	3.58 
- 
0.03(Si(Me) 2), 0.86(C(Me) 3), 3.00(OH) 
H OTs (324) 4.63 3.03 3.11 4.73 443 449 2.89(Me), 3.85(OH), 7.9, 8.3(ArCH) 
[Si]O OTs (326) 4.15 2.71 2.71 4.27 4.00 4.00 0.06(Si(Me) 2), 0.89(C(Me) 3), 2.3-2.7(OH), 
2 . 43(Me.1.0 ), 7.33, 7.77(ArCH) 
J/Hz 
3a,3b 3a,4 3b,4 4,5a 4,5b 5a,5b Others 
H O[Si] (322) 15.8 4.5 7.8 6.1 4.7 10.1  
H OTs (324) 16.3 4.9 7.8 6.1 4.0 10.0 8.4(ArH) 






3.3.5 	Synthesis of Oxazolidine Alkene (293) and Oxazolidine 
Oxime (299) 
3.3.5.1 Synthesis of (S)-Serine Methyl Ester Hydrochloride (296) 
Thionyl chloride (25ml, 0.34 mol) was added slowly to hplc grade 
methanol (90m1) with the temperature of the solution maintained below -20°C 
throughout the addition. (S)-Serine (295) (10.09, 0.09 mol) was added in 
portions over 30 mm, then the mixture allowed to warm to room temperature 
and stirred overnight. The solid obtained was collected by filtration and the 
remaining filtrate evaporated to produce more solid, which was again 
collected by filtration and washed with methanol. The combined solids were 
dried in a desiccator to give the title compound as a white crystalline solid 
(13.2 g, 89%), m.p. 161-163°C, decomp. (lit. 277 167 0C); m/z (FAB) 120 (M -- = 
C4 H 10 NO3). 
3.3.5.2 Synthesis of N-Boc-(S)-Serine Methyl Ester (297) 
t-Butyl dicarbonate (56 g, 0.26 mol) was added over 20 min to a 
stirred solution of (S)-serine methyl ester hydrochloride (296) in dry pyridine 
(400 ml). After stirring overnight at room temperature the mixture was 
concentrated in vacuo and the residue partitioned between ethyl acetate 
(200 ml) and water (250 ml). The aqueous layer was extracted with ethyl 
acetate (2 x 200 ml). The combined organics were washed with 1 M 
potassium hydrogen sulphate (3 x 250 ml), dried (MgSO 4) and concentrated 
by rotary evaporation to afford the title compound as an oil (28.1 g, 100%); 
v/cm 1 (neat) 3400 (OH), 1740, 1700, (C=O); H(80  MHz, CDCI3) 1.37(9H, 
s, C(CH3) 3), 3.13(1 H, br s, OH), 3.69(3H, s, OMe), 3.78-3.86(2H, m, 3-H 2), 
4.17-4.35(1H, m, 2-H), 5.50-5.60(1H, br d, NH); (90  MHz, CDCI3) 
28.6(OCMe3), 	52.6(OMe), 	55.7(C-2), 	63.0(C-3), 	79.9(OCMe3), 
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154.6(C=O BO,.), 1701 (O=°ester) mlz (FAB) Found: M+H, 220.11847. 
C9H 18N05 requires M+H, 220.11849. 
3.3.5.3 (4S)-3-(N-t-Butoxycarbonyl)-2,2-d imethyl-4-methoxycarbonyl-
oxazolidine (298) 
Prepared by the method of Garner and Park. 265 A solution of N-
Boc-(S)-serine methyl ester (297) (5.0 g, 22.8 mmol), 2,2-dimethoxypropane 
(4.8 g, 46.1 mmol) and p-toluenesulphonic acid (0.06 g, 0.3 mmol) in 
benzene (80 ml) was heated under ref lux for 30 mm, then distilled to collect 
69 ml of distillate. More 2,2-dimethoxypropane (1.5 ml) and benzene (32 ml) 
were added to the residue, the mixture refluxed for a further 30 min then 
distilled to collect 26 ml of distillate. The resulting residue was partitioned 
between saturated sodium hydrogen carbonate (100 ml) and ether (60 ml). 
The organic fraction was washed with saturated sodium hydrogen carbonate 
(20 ml) and brine (12 ml), dried (MgSO 4) and evaporated in vacuo to the 
crude product. Purification by dry flash chromatography (20-30% ethyl 
acetate in hexane) afforded the title compound as an oil (4.9 g, 83%); [a] - 
49.6 (c 1.11 in CHCI 3) (lit.265 [(X]21  -46.7 (C 1.3 in CHCI 3)); vm /cm 1 (neat) 
1755, 1705 (C=O); H(200  MHz, CDCI3)( doubling of peaks observed due to 
oxazolidine ring flip)b 1.34, 1.43, 1.46, 1.57, 1.60(15H, 5s, C(Me) 3, C(Me) 2), 
3.69(3H, s, OMe), 3.92-4.13(2H, m, 5-H 2), 4.31 and 4.42(1 H, 2dd, J 3.2, J 
6.9 and J2.8, J6.5, 4-H); 6(91  MHz, 25°C) 24.6, 25.2, 25.4, 26.3(C(Me) 2), 
28.45, 28.52(C(Me) 3), 52.1, 52.2(OMe), 59.0(C-4), 65.7, 66.0(C-5), 79.7, 
80.3(C(Me) 3), 93.7, 94.3(C-2), 149.8, 1 50.7(C=O,), 169.9, 170.0(COester) 
m/z (FAB) Found M+H, 260.14978. C 12HNO5 requires M+H, 260.14979. 
b This and subsequent oxazolidine containing compounds show doubling of signals in the 1 1-1 




Prepared by the method of Garner and Park. 265 DIBAL (1 M in 
hexanes, 39.4 ml, 39.4 mmol) was added slowly to a -78°C solution of the 
oxazolidine ester (298) (6 g, 23.2 mmol) in dry toluene (maintained 
temperature below -68°C throughout DIBAL addition). After stirring the 
mixture for a further 2 hr at -78°C, the reaction was quenched by slow 
addition of cold (-78°C) methanol at such a rate that the internal temperature 
did not exceed -65°C. The mixture was allowed to warm to room 
temperature, poured onto ice cold 1 M HCI (150 ml) and extracted with ethyl 
acetate (3 x 150 ml). The combined organics were washed with brine (2 x 90 
ml), dried (MgSO 4) and evaporated in vacuo to afford a yellow oil. 
Purification by distillation (60°C, 0.05mmHg) gave the title compound as a 
clear oil (4.6 g, 87%); [IR and 1 1-1 NMR data indicated partial aldehyde 
hydration, however freshly distilled aldehyde was used successfully in 
further reactions]; v m /cm' (neat) 3450w (OH), 1738vs, 1694vs (C=O); 
[()C]21 
 
-82.8 (c 0.95 in CHCI3) ( lit. 265 [x] -91.7 (c 1.34 in CHCI3)); 8H(200  MHz, 
CDCI3) (doubling of peaks observed due to oxazolidine ring flip265 ) 1.34, 
1.42, 1.46, 1.50, 1.55(15H, 5s, C(CH36 C(Me)2 ) 3.80-4.25(H, m, 4-H, 5-H 2), 
9.46 and 9.51 (1 H, 2d, J=2.5 and J=1.6, 1-H); (50 MHz, CDCI 3) 23.5, 24.4, 
25.5, 26.4(C(Me) 2), 28.0(C(Me) 3), 63.2, 63.6(0-5), 64.5(C-4), 80.8, 
81.1(C(Me) 3), 94.1, 94.8(C-2), 151.1(C=O,), 199.1(CH=O); mlz (FAB) 
Found: M+H, 230.13923. C 11 HN04 requires M+H, 230.13922. 
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3.3.5.5 (4R)-3-(N-t-Butoxycarbonyl)-2,2-dimethyl-4-vinyloxazolidine 263  
(293) 
A slurry-solution of potassium t-butoxide (7.8 g, 69.5 mmol) in dry 
THF (65 ml) was added to a stirred suspension of 
methyltriphenylphosphonium iodide (28.2 g, 69.6 mmol) in dry THE (130 ml) 
under nitrogen. The yellow suspension was stirred at room temperature for 
2 hr, then the aldehyde (153) (7.03 g, 30.7 mmol) in dry THF (100 ml) was 
added over 5 min and the resulting mixture stirred overnight at room 
temperature then at ref lux for 30 mm. The cooled solution was poured onto 
water (150 ml), concentrated in vacuo to remove THF and extracted with 
ethyl acetate (3 x 150 ml). The combined organic fraction was washed with 
brine (270 ml), dried (MgSO 4) and concentrated in vacuo to afford the crude 
alkene which was purified by flash column chromatography on silica gel (0- 
4% ether in hexane, gradient elution) to yield a clear oil (293) (4.7 g, 67%); 
vm /Cm 1  (neat) 1695 (C=O); [a] +11.9 (c 0.83 in CHCI 3), (lit. 263 [a] +14.9 
(c 2.5 in CHCI3); H(200  MHz, CDCI 3 , 55°C) 1.41, 1.47, 1.55 (15H, 3s, 
C(CH3) 2 C(CH3) 3), 3.69(1 H, dd, J4,5b 2.4,  J5a,5b  8.8, 5b-H), 3.99 (1 H, dd, J 
6.2, J5a,5b  8.8, 5a-H), 4.24-4.30 (1H, bm, 4-H), 5.05-5.17 (2H, m, CH2=CH), 
5.77 (1H, ddd, J 7.1, 10.1, 17. 1, CH 2=CI-/); 5(50 MHz, CDCI 3) 23.5, 24.6, 
26.3, 27.0(C(CH 3) 2), 28.2,(C(CH3) 3), 59.5(C-4), 67.8(0-5), 79.4(C(CH 3 ) 3), 
93.7(C-2), 1 15.6(CH 2=CH), 137.1 (CH 2=CH). 
3.3.5.6a (4R)-4-Aldoximino-3-(N-t-butoxycarbonyl)-2,2-dimethyl-
oxazolidine (299) 
A solution of freshly distilled aldehyde (153) (0.50 g, 2.2 mmol) in 
pyridine (5 ml) was added to a stirred solution of hydroxylamine 
hydrochloride (0.27 g, 3.9 mmol) in pyridine (10 ml). After stirring for 4 hr the 
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mixture was concentrated in vacuo, the residue poured onto water (20 ml) 
and extracted with ethyl acetate (3 x 40 ml). The combined organic fraction 
was dried (MgSO4 ) and concentrated in vacuo to a yellow oil. Purification by 
flash column chromatography (50% ether in hexane) afforded the title 
compound, a clear oil, as an -2:3 mixture of cis and trans isomers (299) 
(0.421 g, 79%); vm/cm1  (neat) 3380 (OH), 1690 (0=0); 6H(200  MHz, CA, 
60°C) 1.39, 1.41(9H, 2s, C(Me) 3 )
1 
 1.48, 1.59(6H, 2s, C(CH3 ) 2), 3.65-3.74(1 H, 
m, 5a-H and 5b-H), 3.80(0.4H, dd, J4,5b  3.6,  J5a,5b  9.1, 5b-H), 3.97(0.6H, dd, 
J4 , 5a 6.9, J5a,5b  9.1, 5a-H), 4.31-4.39(0.6H, m, 4-H), 4.98-5.06(0.4H, m, 4-H), 
6.76(0.4H, d, J44 5.4, CH=NOH), 7.41(0.6H, d, J4a,4 5.9,CH=NOH), 
7.41(1H, br s, OH); (90  MHz,  CA,  55°C) 24.3, 26.6(C(Me) 2), 
28.3(C(CH3 ) 3), 53.5, 56.6(0-4), 66.2, 66.9(C-5), 80.2(OC(Me) 3), 94.4(0-2), 
149.6(CH=NOH), 152.0(C=O), 153.2(CH=NOH); m/z (FAB) Found: M+H, 
245.15013. C 11 H 21 N 204 requires M+H, 245.15012. 
3.3.5.6b Alternative Synthesis of Oxime (299) 
Sodium carbonate (0.21 g, 1.98 mmol) was added in portions to a 
solution of hydroxylamine hydrochloride (0.26 g, 3.74 mmol) in water (4 ml). 
Freshly distilled aldehyde (153) (0.50 g, 2.18 mmol) in methanol (4 ml) was 
added to the stirred solution. After stirring overnight the methanol was 
evaporated in vacuo, the aqueous residue saturated with sodium chloride 
and extracted with ethyl acetate (3 x 30 ml). The combined organic fractions 
were dried (MgSO 4 ) and concentrated by rotary evaporation to a yellow oil. 
Purification by dry flash column chromatography on silica gel (50% ether in 
hexane) afforded a clear oil (299) (0.426 g, 80%) identical in every respect 
to that obtained in section 3.3.5.6a. 
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3.3.6 	Cycloaddition of Oxazolidine alkene (293) with 
Ethoxycarbonylformonitrile oxide (83) 
Alkene 	(293) 	(2.2 g, 9.7 	mmol) and 	ethyl chloro- 
(hydroxyimino)acetate (301) (2.2g, 14.5 mmol) were dissolved in ether 
(50 ml) and cooled to 000  in an ice-salt bath. A solution of triethylamine 
(1.76 g, 17.4 mmol) in ether (50 ml) was added via motorised syringe pump 
over 17 hr and the mixture stirred for a further 5 hr while warming to room 
temperature. TIc (20% ethyl acetate in hexane) indicated the incomplete 
consumption of alkene so a further portion of ethyl 
chloro(hydroxyimino)acetate (0.91 g, 6.0 mmol) in ether (20 ml) was pumped 
in as before over 16 hr. After stirring for a further 5 hr the mixture was 
filtered through celite, washed with water (3 x 20 ml), dried (MgSO 4) and 
evaporated in vacuo. The components of the resulting oil were separated by 
dry flash chromatography on silica gel (10% ether in hexane) to afford, in 
order of elution, unreacted alkene (293) (0.37 g, 17%), 3,4-
diethoxycarbonylfurazan N-oxide (225) (1.27 g, 54%) (tIc identical to 
authentic sample) and an inseparable mixture of (5R,4'S)- and (5S,4'S)-3-
ethoxycarbonyl-5 -(3'- (N -t -butoxycarbonyl)-2' ,2' -dimethyloxazolidin-4' -yf) -2-
isoxazoline (302) and (303) an oil which solidified on standing to a white 
solid (70:30 mixture by 1 H NMR) (2.70 g, 81%); v/cm -1 (neat) 1715, 1694 
(0=0); 6H(200  MHz, CDCI 3 , 63°C) 1. 18, 1.29(3H, 2t, J7.1, CH3CH20), 1.42, 
1.45, 1.51, 1.54(15H, 4s, C(CH3 ) 3 , C(Me) 2), 3.07(0.3H, dd, J 5  11.5, d4a,4b 
18.0, 4a-H), 3.10(0.7H, dd, J4a,5 17.9, 4a-H), 3.27(0.3H, dd, J4b,5 
9.2, "4a5b  18.0, 4b-H), 3.36(0.7H, J4b,5 7.7,'14a,4b 17.9, 4b-H), 3.754.15(3H, 
m, 4'-H, 5a'-H, 5b'-H), 4.27(2H, q, J 7.1, CH3CH20), 4.78(0.7H, dt, J 7.5, J 
11.1, 5-H), 5.00-5.20(0.3H, m, 5-H); 5(50 MHz, CDCI 3) 13.8(CH 3CH20), 
22.2, 23.6, 24.1, 26.3, 27.2(C(Me) 2), 28.0(C(Me) 3), 34.2, 35.8(0-4), 57.0, 
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57.3, 58.1, 58.7(C-4'), 61.7(CH 3CH20), 63.3, 64.3, 65.2(C-5'), 80.6(C(Me) 3), 
82.0, 82.4, 82.9(C-5), 94.0(C2'), 151 .9, 153.0(C-3, C=O), 160.1 (CO ester ) 
m/z (FAB) Found: M+H, 343.18693. C 16 H 27 N 206 requires M+H, 343.18690. 
3.3.7 	Preparation of (5R,4'S)- and (5S,4'S)-3-Hydroxymethyl-5-(3'-(N- 
tert-butoxycarbonyO-2',2'-dimethy!oxazoIidin.4'-y-2-
isoxazoline (306) 
Sodium borohydride (0.27 g, 7.1 mmol) was added in portions to a 
stirred solution of isoxazolines (302) and (303) (0.40 g, 1.2 mmol) in ethanol 
(16 ml). After stirring overnight the mixture was poured onto water (24 ml) 
and extracted with chloroform (3 x 16 ml). The combined organic extract 
was dried (MgSO 4) and evaporated in vacuo to a clear oil which solidified on 
standing in the freezer to a white solid, identified as an inseparable mixture 
(70:30 by 1 H NMR) of (5R,4'S)- and (5S,4'S)-3-hydroxymethyl-5-(3'-(N-tert-
butoxycarbonyl)-2' ,2' -dimethyloxazolidin-4' -yI)-2 -isoxazolines (306) (0.34 g, 
96%); Vm /Cm 1 (nujol) 3451 (OH), 1690 (C=O); 6H(360  MHz, CA,  70°C) 
1.37, 1.40, 1.43, 1.58, 1.63(15H, 5s, C(CH36 C(Me) 2), 2.42-2.68(br m, OH), 
2.60-2.68(0.3H, m, 4b-H), 2.69(0.7H, dd, J4b,5  10.5,  J4a,4b  16.9, 4b-H), 
3.03(0.3H, dd, 45 8.0, 4.4b  17.5, 4a-H), 3.11(0.7H, dd, 4a,56.6, "4a,4b 17.2, 
4a-H), 3.65(0.7H, dd, 45a  55' 5,',5b  9.2, 5a'-H), 3.69(0.3H, dd, 	6.5, 
"5a,5b 	5a'-H), 3.78(0.3H, dd, 4'5b  1.6, 5a,5b  9.8, 5b'-H), 3.903.94(0.7H, 
br m, 4'-H), 4.00(0.7H, dd, 45b  1.2, 5a,5b  9.2, 5b'-H), 4.07-4.23(2.3H, m, 4'-
H, CH20H), 4.62(0.7H, dt, J 7.3, J 10.4, 5-H), 4.96(0.3H, m, 5-H); ( 90 
MHz, CA,  70°C) 24.2, 26.9, 27.5(C(Me) 2), 28.2(C(Me) 3), 36.3, 37.7(C-4), 
57.8, 57.9(CH20H), 58.4, 59.6(C-4'), 64.1, 65.3(C-5'), 80.1, 80.9(C-5), 
80.3(C(Me) 3), 94.3(C-2'), 152.6, 153.1(C=O), 159.1, 159.3(C-3); m/z 
(FAB) Found: M+H, 301.17634. C 14 H25 N 205 requires M+H, 301.17633. 
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3.3.8 	Mesylation of 2-Isoxazoline (306) 
3.3.8.1 Attempted Mesylation of (306) using Pyridine as Base 
Methanesuiphonyl chloride (9 drops) were added to an ice-chilled 
stirred solution of alcohol (306) (68 mg, 0.23 mmol) in pyridine (0.5 ml) and 
the mixture stirred overnight while warming to room temperature. The 
mixture was concentrated in vacuo, then the residue dissolved in chloroform 
(5 ml), and washed with water (3 x 5 ml). The organic fraction was dried 
(MgSO4) and evaporated in vacuo to a yellow oil (190 mg) which by tic 
consisted of at least five components. Preparative tic on silica gel failed to 
isolate any identifiable compounds, and as a result the reaction was 
abandoned. Repetition of the reaction with work up after 4 hr also failed to 
produce any product or return starting material. 
3.3.8.2 Mesylation of (306) using Triethylamine as Base 
Methanesuiphonyl chloride (29 mg, 0.25 mmol) was added 
dropwise to an ice-chilled stirred solution of the alcohol (306) (50 mg, 0.17 
mmol) and triethylamine (27 mg, 0.27 mmol) in dry dichloromethane (2 ml) 
under argon. After stirring for 6 hr the mixture was concentrated in vacuo, 
dichloromethane (10 ml) added then washed with water (2 x 4 ml). The 
organic fraction was dried (MgSO4), evaporated in vacuo and the crude 
product purified by preparative tic on silica gel (80% ether in hexane, double 
elution) to afford a mixture of (5R,4'S)- and (5S,4'S)-3-
methanesulphonyloxymethyl-5- (3'- (te rt -butoxycarbonyl) -2' ,2'- dimethyl - 
oxazolidin-4'-yI)-2-isoxazoline (310) (43 mg, 68%); 6H(200  MHz, CDCI3) 1.45, 
1.47, 1.52(15H, 3s, C(CH3 )
31 
 C(Me) 2), 3.07(3H, 5, MeSO), 3.00-3.40(2H, m, 
4-H 2), 3.83-4.01(3H, m, 4'-H, 5'-H 2), 4.68(1H, dt, J7.3, J 10.5, 5-H), 4.94(2H, 
s, CH2OMs); 	(50  MHz, CDCI3) 24.1, 26.9, 27.5, 29.5(C(Me) 2), 
28.1(C(Me) 3), 35.5, 37.0(C-4), 37.8(MeTOS ), 57.1, 58.6(C-4'), 63.0, 63.4, 
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64.9(CH 20Ms, C-5), 80.3(C(Me) 3), 80.8, 81.5(C-5), 93.9(C(Me) 2), 153.6, 
154.0(C-3, C=O). 
3.3.9 	Reductive Hydrogenolysis of Oxazolidine Isoxazoline (306) 
Isoxazoline (306) (33mg; 0.11 mmol), boric acid (41 mg; 0.66 mmol) 
and 10% Pd-C (10mg) were stirred in methanol (5m1) and water (imi) under 
an atmosphere of hydrogen for 4 hr after which time tic analysis showed 
complete consumption of starting material. The mixture was filtered through 
celite and evaporated in vacuo to an oil. Methanol was added and 
evaporated in vacuo five times to remove the volatile trimethyl borate and 
afforded a white foam. Attempted purification by preparative thin layer 
chromatography on silica gel (100% ethyl acetate x 2) failed to afford any 
identifiable product. The experiment was repeated as follows: lsoxazoline 
(306) (58mg; 0.19 mmol), boric acid (72mg; 1.16mmol) and 10% Pd-C 
(20mg) were stirred in methanol (5m1) and water (1 ml) under an atmosphere 
of hydrogen for 4 hr. Tic analysis indicated complete consumption of the 
starting isoxazoline and the presence of a more polar material which was 
stained by Brady's solution on tic. Work-up as before but omitting the 
chromatographic purification step provided an oil. 1 C NMR analysis of this 
material indicated decomposition and no evidence of the expected new 
ketone group of compound (311). 
3.3.10 Cycloaddition of Oxazolidine Nitrile Oxide (294) and 
p-Toluenesulphonic Acid Allyl Ester (291) 
Oxime (299) (0.50 g, 2.05 mmol) in dry chloroform (10 ml) was 
added to a stirred suspension of N-chlorosuccinimide (0.27 g, 2.05 mmol) 
and pyridine (1 drop) in dry chloroform (10 ml). After stirring at room 
temperature for 2 hr the mixture was cooled in an ice-salt bath, alkene (291) 
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(0.65 g, 3.07 mmol) added and triethylamine (0.23 g, 2.28 mmol) in 
chloroform (12 ml) was pumped in over 20 hr. After a further 1 hr the mixture 
was poured onto water (50 ml), brine (50 ml), dried (MgSO 4 ) and 
concentrated by rotary evaporation. The mixture of products was separated 
by dry flash chromatography on silica gel (12% ether in hexane) to afford, in 
order of elution, unreacted alkene (291) (0.216 g, 33%), 3,4-di-(3(N-tert-
butoxycarbonyl) -2', 2' -dimethyloxazolidin-4'-yI) furoxan (337) (0.108 g, 22%) 
[m/z (FAB) Found: M+H, 485.26115. CH 37 N 408 requires M+H, 485.26112] 
and a mixture of (5R,4'R)- and (5S,4'R)-5-(p-toluenesulphonyloxymethy/)-3-
(3 (N-te rt -butoxycarbonyl) -2', 2' -dimethyloxazo/idin-4' -yl) -2- isoxazoline (335) 
and (336) respectively (0.57 g, 62% combined yield) in a ratio of 51:49. The 
diastereoisomeric isoxazolines were separated by dry flash column 
chromatography on silica gel (50% ether in hexane) (3 columns required to 
achieve complete separation) to afford, in order of elution, diastereoisomer 
(335) (0.206 g, 22%), [a] -132.6 0 (C 1.08 in CHCI3); vm/cm1  (nujol) 1700 
(C=O), 1367(Tos), 1187(Tos); 5060  MHz, CDCI 3 , 60°C) 1.58(9H, s, 
C(CH3 )3 ), 1.63, 1.73(6H, 2s, C(Me) 2), 2.47(3H, s, MeTOS), 2.94(1 H, dd, J 5 
6.2, J4a,4b  17.3, 4a-H), 3.11(1H, dd, J4b,5  10.7,  J4a,4b  17.3, 4b-H), 4.00 
4.05(1 H, br m, 5a'-H), 4.10(1 H, dd, J5,5, 4.3, 5a5a 10.8, TsOCHH), 4.14(1 H, 
dd, 45b'  6.7, 5a,5b 5b'-H), 4.79(1 H, ddt, J4.5, J6.2, J 10.7, 5-H), 4.82-
4.85(1H, m, 4'-H), 7.37(2H, d, J8.3, Ar), 7.89(2H, d, J8.3, Ar); 6(90  MHz, 
CDCI3, 60°C), 21.5(MeTOS), 23.6, 23.8, 26.4, 27.4(C(Me) 2), 28.4(C(Me) 3), 
36.8(C-4), 54.6(C-4'), 66.5(C-5'), 69.8(CH 2OTs), 77.0(C-5), 80.8(C(Me) 3), 
94.6(C-2'), 128.0, 130.1 (4xArCH), 133.1, 1 45.1(2xArC), 151 .9(C=O,j, 
158.4(C-3); m/z (FAB) Found: M+H, 455.18517. C 21 H 31 1\1 207S requires 
M+H, 455.18518; and diastereoisomer (336) (0.197 g, 21%), [a] +27.6 0 (c 
1.96 in CHCI 3); v/cm-1 (nujol) 1690 (C=O), 1359, 1174 Jos); 6H(360  MHz, 
GrRGI 
CDCI3, 60°C) 1.42(9H, s, C(CH36), 1.48, 1.57(6H, 2s, C(Me) 2), 2.40(3H, s, 
Me -l.OS), 2.81(1 H, dd, J4b,5  7.0,  J41,4b  17.3, 4a-H), 3.04(1 H, dd, J4b,5  10.6,  J4a,4b 
17.3, 4b-H), 3.91-3.94(1 H, br d, 5a'-H), 3.98(1H, dd, J5,5, 5a5a 10.6, 
TsOCHH), 4.09(1 H, dd, 4,5b'  6.8, 5a',5b'  9.4,5b'-H), 4.68-4.76(2H, m, 4'-H, 5-
H), 7.30(2H, d, J 8.3, Ar), 7.75(2H, d, J 8.0, Ar); (90  MHz,  CA,  540C), 
21 .O(MeTOS), 23.5, 26.2(C(Me) 2), 28.1 (C(Me) 3), 36.8(0-4), 54.6(0-4'), 
66.3(0-5'), 69.4(CH 2OTs), 77.3(C-5), 80.1(C(Me) 3), 94.3(C-2'), 127.9, 
129.8(4xArCH), 133.6, 144.6(2xArC), 151.6(C=O), 158.3(C-3); m/z (FAB) 
Found: M+H, 455.18517. C21 H31 N 207S requires M+H, 455.18518. (70 mg, 
8% of diastereoisomeric mixture remained to be separated.) 
3.3.11 	Hyd rogenolysis of (5R,4'R)-5-(p-to!uenesu!phonyl- 
oxymethyl)-3-[3'-(N-te rt- but oxycarbonyl)-2' ,2'- dimethyl-
oxazolldin-4'-y-2-isoxazoIine (335) 
Isoxazoline (335) (110 mg, 0.24 mmol) and boric acid (90 mg, 
1.46 mmol) were dissolved in a mixture of methanol (10 ml) and water (2 ml) 
and 10% palladium on carbon (24 mg) added. The mixture was degassed 
and hydrogen filled several times then stirred vigorously under an 
atmosphere of hydrogen overnight. Tic (50% ether in hexane) indicated 
incomplete consumption of starting material. More boric acid (45 mg, 0.73 
mmol) and 10% palladium on carbon (24 mg) were added and the mixture 
stirred, as before, for a further 7 hr. The mixture was filtered through celite 
and evaporated in vacuo. Excess boric acid was removed by repeated 
methanol addition and evaporation. The residue was diluted with chloroform 
(5 ml), washed with water (2 x 2 ml), dried (MgSO 4) and purified by 
preparative tic on silica gel (100% ether) to afford (3R,4'S)-3-hydroxy-1-[3'- 
(N -te rt -butoxycarbonyl)-2' , 2' -dimethyloxazolidin-4' -yIJ-4 - (p -toluenesulphonyl- 
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oxy)butan-1 -one (338) (72 mg, 65%); v/cm -1 (neat) 3471 (OH), 1730 
(0=0), 1696 (0=0), 1368, 1175 (Tos); 6H(360 MHz, CDCI 3). (Doubling of 
peaks due to oxazolidine ring flipping led to considerable overlapping of 
peaks and hence to complex multiplets from which coupling constants could 
not be determined. A higher temperature NMR spectrum was not obtained 
as the 1 H NMR spectrum showed evidence of sample decomposition even at 
room temperature). 1.38, 1.46, 1.48, 1.50, 1.63, 1.67(4S, C(Me)3 , C(Me) 2), 
2.44(3H, 5, MeTOS ), 2.65 and 2.77(2H, 2dd, J 16.4, and J2b,3  8.5, 
J, 16.4, 2a-H and 2b-H), 3.91(1H, dd, J3.2, J9.5, 4-H or 5'-H), 4.00-4.03, 
4.07-4.15, 4.24-4.29, 4.44-4.47(6H, 4m, 5'-H 2 , 4'-H, 3-H, 4-H, OH or 5'-H, 4'-
H, 3-H, 4'-H 2, OH), 7.34(2H, d, J 7.9, Ar), 7.78(2H, d, 8.3, Ar); 6(90  MHz, 
ODd 3) 21.5(MeTOS), 23.4, 24.7, 25.3, 25.8(C(Me) 2), 28.1 (C(Me) 3), 41.0, 
42.4(0-2), 64.6, 65.1(C-5'), 65.3, 65.5, 65.8(0-4', 0-3), 71.9, 72.2(0-4), 80.8, 
81.4(C(Me) 3), 94.6, 95.2(0-2'), 127.8, 129.8(4xArCH), 132.5, 144.9(2xArC), 
151.5, 152.5(C=O 0 ), 207.2, 207.7(0-1); m/z (FAB) Found: M+H, 
458.18487. C21 H 32 N08S requires M+H, 458.18485. 
C 
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Crystal Type 2 
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Angles(degrees) with standard deviations 
0(1) - 	 C(1) - 	 0(2) 108.3( 9) 0(31) -0(31) -C(32) 107.9( 	9) 
0(1) - 	 C(1) - 	 0(4) 114.7( 9) 0(31) - 0(31) -0(34) 113.3( 9) 
C(2) - 	 C(1) - 	 0(4) 105.0( 8) C(32) -0(31) -0(34) 104.1( 9) 
C(1) - 	 0(1) -0(12) 113.4( 9) 0(31) -0(31) -0(42) 113.6( 9) 
C(1) - 	 C(2) - 	 0(2) 111.8( 9) 0(31) -C(32) -0(32) 108.5( 9) 
C(1) - 	 C(2) - 	 C(3) 105.2( 9) 0(31) -C(32) -C(33) 104.6( 8) 
0(2) - 	 C(2) - 	 C(3) 102.9( 8) 0(32) -C(32) -0(33) 102.2( 8) 
C(2) - 	 0(2) -0(13) 109.8( 8) C(32) -0(32) -C(43) 108.7( 8) 
0(2) - C(3) - 	 0(3) 104.3( 7) C(32) -0(33) -0(33) 105.3( 7) 
0(2) - 	 C(3) - 	 C(4) 102.1( 8) C(32) -0(33) -0(34) 103.6( 8) 
0(3) - 	 0(3) - 	 0(4) 112.1( 7) 0(33) -0(33) -0(34) 113.0( 8) 
C(3) - 	 0(3) -C(13) 110.9( 7) C(33) -0(33) -0(43) 109.4( 7) 
C(3) - 	 C(4) - 	 0(4) 106.6( 7) C(33 ) -C(34) -0(34) 106.2( 8) 
C(3) - 	 C(4) - 	 C(5) 115.5( 8) C(33) -C(34) -C(35) 114.9( 8) 
0(4) - 	 C(4) - 	 C(5) 107.7( 7) 0(34) -C(34) -0(35) 108.5( 8) 
C(1) - 	 0(4) - 	 C(4) 106.4( 7) 0(31) -0(34) -0(34) 107.2( 8) 
C(4) - 	 C(5) - 	 0(5) 107.7( 8) 0(34) -0(35) -0(35) 107.6( 8) 
C(4) - 	 C(5) - 	 C(6) 115.4( 8) 0(34) -C(35) -0(36) 114.7( 6) 
0(5) - 	 0(5) - 	 0(6) 105.0( 8) 0(35) -0(35) -0(36) 104.5( 7) 
0(5) - 	 0(5) - 	 N(7) 110.3( 7) 0(35) -0(35) -N(37) 108.2( 7) 
0(5) - 	 C(6) - 	 0(7) 101.5( 8) 0(35) -0(36) -0(37) 101.7( 8) 
C(6) - C(7) - 	 N(7) 113.9( 8) C(36) -0(37) -N(37) 114.4( 9) 
C(6) - 	 C(7) - 	 C(8) 127.3( 8) 0(36) -C(37) -0(38) 126.5( 8) 
N(7) - 	 0(7) - 	 C(8) 118.7( 9) N(37) -0(37) -0(38) 119.1( 8) 
0(5) - 	 N(7) - 	 C(7) 109.2( 8) 0(35) -N(37) -C(37) 110.1( 8) 
C(7) - 	 C(8) - 	 0(8) 108.7( 7) C(37) -C(38) -0(38) 107.3( 7) 
C(7) - 	 C(8) - C(9) 114.1( 7) C(37) -C(38) -C(39) 113.7( 7) 
0(8) - 	 0(8) - C(9) 104.5( 7) 0(38) -0(38) -C(39) 103.6( 7) 
0(8) - 	 0(8) -C(16) 108.6( 7) C(38) -0(38) -0(46) 105.2( 7) 
C(8) - 	 C(9) - 0(9) 100.5( 6) 0(38) -C(39) -0(39) 103.5( 7) 
C(8) - 	 C(9) -C(10) 116.2( 7) C(38) -C(39) -0(40) 113.9( 7) 
0(9) - 	 C(9) -C(10) 108.3( 7) 0(39) -0(39) -C(40) 108.9( 7) 
0(9) - 	 0(9) -C(16) 107.8( 7) 0(39) -0(39) -0(46) 108.9( 7) 
C(9) -0(10) -0(10) 106.2( 7) 0(39) -0(40) -0(40) 107.8( 7) 
C(9) -C(10) -0(11) 114.8( 7) 0(39) -0(40) -C(41) 115.3( 8) 
0(10) -C(10) -C(11) 104.2( 7) 0(40) -0(40) -C(41) 104.1( 7) 
C(10) -0(10) -C(19) 106.8( 7) C(40) -0(40) -C(49) 110.4( 7) 
0(10) -C(11) -0(11) 104.9( 7) C(40) -0(41) -0(41) 103.4( 7) 
0(11) -0(11) -C(19) 109.4( 8) C(41) -0(41) -C(49) 105.9( 7) 
0(2) -C(13) - 0(3) 104.5( 8) 0(32) -C(43) -0(33) 104.9( 8) 
0(2) -C(13) -C(14) 113.7( 9) 0(32) -0(43) -C(44) 112.4( 9) 
0(2) -C(13)- -C(15) 109.3( 9) 0(32) -C(43) -C(45) 108.6( 9) 
0(3) -C(13) -C(14) 109.5( 8) 0(33) -C(43) -0(44) 110.3( 8) 
0(3) -C(13) -C(15) 106.5( 8) 0(33) -C(43) -C(45) 108.7( 8) 
0(14) -C(13) -C(15) 112.7( 9) C(44) -0(43) -C(45) 111.6( 9) 
0(8) -C(16 - 0(9) 107.1( 7) 0(38) -C(46) -0(39) 108.0( 8) 
0(8) -C(16 -C(17) 107.3( 8) 0(38) -0(46) -C(47) 110.3( 9) 
0(8) -C(16) -C(18) 108.5( 8) 0(38) -C(46) -C(48) 108.4( 9) 
0(9) -C(16 -C(17) 112.3( 8) 0(39) -C(46) -C(47) 110.9( 9) 
0(9) -C(1 -C(18) 109.6( 8) 0(39) -C(46) -C(48) 107.5( 9) 
C(17) -C(16 ) -C(),8) 112.0( 9) C(47) -C(46) -C(48) 111.6(10) 
0(10) -C(19$ -0(11) 103.2( 8) 0(40) -C(49) -0(41) 104.7( 7) 
0(10) -C(191 -C(20) 109.3( 8) 0(40) -C(49) -C(50) 110.7( 8) 
0(10) -C(19 -C(21) 107.8( 8) 0(40) -C(49) -C(51) 110.7( 8) 
0(11) -C(19 -C(20) 113.6( 9) 0(41) -C(49) -C(50) 110.0( 8) 
0(11) -C(19 -C(21) 110.4( 8) 0(41) -C(49) -0(51) 106.5( 8) 
C(20) -Cr19 -C(2) 112.0( 9) C(50) -C(49) -0(51) 113.8( 9) 
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Bond Lengths(A) with standard deviations 
0(1) - 	 0(1) 1.368(13) 0(31) -0(31) 1.373(14) 
C(1) - 	 C(2) 1.487(16) 0(31) -0(32) 1.524(16) 
C(l) - 	 0(4) 1.410(12) 0(31) -0(34) 1.414 (13) 
0(1) -C(12) 1.405(14) 0(31) -0(42) 1.412(16) 
C(2) - 	 0(2) 1.416(14) C(32) -0(32) 1.436(13) 
C(2) - 	 0(3) 1.562(15) 0(32) -0(33) 1.531(14) 
0(2) -C(13) 1.408(13) 0(32) -C(43) 1.382(13) 
0(3) - 	 0(3) 1.404(11) C(33) -0(33) 1.405(11) 
0(3) - 	 C(4) 1.532(13) 0(33) -C(34) 1.527(14) 
0(3) -C(13) 1.423(12) 0(33) -C(43) 1.425(12) 
C(4) - 	 0(4) 1.449(11) 0(34) -0(34) 1.418(12) 
0(4) - 	 C(5) 1.504 (13) 0(34) -C(35) 1.519 (14) 
C(5) - 	 0(5) 1.444 (12) C(35) -0(35) 1.476 (12) 
C(5) - 	 0(6) 1.526(14) C(35) -0(36) 1.518(14) 
0(5) - 	 N(7) 1.409(11) 0(35) -N(37) 1.416(11) 
0(6) - 	 C(7) 1.496(14) 0(36) -0(37) 1.484(14) 
0(7) - 	 N(7) 1.286(13) 0(37) -N(37) 1.267 (13) 
C(7) - 	 C(8) 1.486(13) 0(37) -C(38) 1.498(13) 
0(8) - 	 0(8) 1.414(11) C(38) -0(38) 1.432(11) 
0(8) - 	 0(9) 1.537(12) 0(38) -C(39) 1.521(12) 
0(8) -C(16) 1.426(12) 0(38) -0(46) 1.419 (13) 
0(9) - 	 0(9) 1.437 (10) C(39) -0(39) 1.431 (11) 
0(9) -C(10) 1.488(12) C(39) -0(40) 1.500(13) 
0(9) -C(16) 1.396(12) 0(39) -0(46) 1.410(13) 
C(10) -0(10) 1.429(11) 0(40) -0(40) 1.426(12) 
0(10) -C(11) 1.513(13) 0(40) -0(41) 1.514 (14) 
0(10) -C(19) 1.438 (12) 0(40) -C(49) 1.413 (12) 
0(11) -0(11) 1.401(12) C(41) -0(41) 1.424(12) 
0(11) -C(19) 1.397 (13) 0(41) -C(49) 1.454 (12) 
C(13) -C(14) 1.491 (15) 0(43) -C(44) 1.495 (15) 
0(13) -0(15) 1.521 (16) 0(43) -0(45) 1.493 (16) 
C(16)  1.503 (15) C(46) -0(47) 1.448 (16) 
0(16)  1.519(14) 0(46) -0(48) 1.527 (16) 
0(19) -C(20) 1.487 (15) C(49) -0(50) 1.497 (15) 
0(19) -C(21) 1.479(14) 0(49) -0(51) 1.502 (14) 
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Torsion angles(degrees) with standard deviations 
C(2) - 	 0)1) - 	 0(1) -0(12) .76.1 ( 	 9) 0)32) -0(31> -0(31) -C)42) -175.8) 	9) 
0(4) - 	 0(1) - 	0(1) -C(12) 65.0(11) 0(34) -0(31) -0)31) -0(42) 69.5(12) 
0(1) - 	C(1) - 	0(2) - 	0(2) 156.9( 	9) 0(31) -0)31) -0(32) -0(32) 158.4) 	8) 
C(1) - 	C(1) - 	C(2) - 	C(3) -92.1(10) 0 (31 ) -0(31) -0(32) -0(33) -93.2(10) 
0(4) - 	 0(1) - 	 '1 (2) - 	0(2) -80.1 (13) 0(34) -0(31) -0(32) -0(32) -80.9)10) 
0(4) - 	C(1) -0(2) -0(3) 30.9(10) 0(34) -0(31) -0(32) -C(33) 27.5(10) 
0(1) - 	C(1) -0(4) -C(4) 78.9(10) 0(31) -C(31) -0(34) -C(34) 77.9(10) 
0(2) -C(1) -0(4) -C(4) -39.8(10) 0(32) -0(31) -0(34) -C(34) -39.0(10) 
0(1) - 	C(2) - 	 0(2) -C (13) 136.7) 	9) C(31) -0(32) -0(32) -C (43) 137.9) 	9) 
C (3) - 	C (2) - 	 0(2) -C(13) 24.3(10) C (33) -C (32) -0(32) -C (43) 27.9(10) 
0(1) - 	C(2) - 	 0(3) - 	0(3) -127.6) 	8) 0(31)   -0(33) -126.0) 	8) 
0)1) - 	C(2) - 	 0)3) - 	C(4) -10.8(10) C(31) -C(32) -0(33) -C(31) -7.1(10) 
0(2) - 	 0(2) - 	0(3) - 	 0(3) -10.4(10) 0(32) -C(32) -C (3 3) -0(33) -12.9) 	9) 
0(2) - 	 0(2) - 	C(3) - 	C(4) 106.4) 	8) 0(32) -0(32) -0(33) -0(34) 105.9) 	8) 
C(2) - 	 0(2) -C(13) - 	 0(3) -28.8(1C) C(32) -0(32) -C(43) -0(33) -32.0(10) 
C (2) - 	 0(2) -0(13) -0(14) 90.6(10) C (32) -0(32) -C (4 3) -0(44) 87.8(10) 
0(2) - 	0(2) -0(13) -C(15) -142.5) 	9) 0(32) -0(32) -0(43) -C (45) -148.2) 	9) 
0)2) - 	C (3) - 	 0(3) -C(13) -6. 6(10) C (32) -C(33) -0(33) -C (43) -5.6(10) 
C(4) - 	C(3) - 	 0(3) -0(13) -116.3) 	8) C(34) -C(33) -0(33) -C(43) -117.9) 	9) 
0(2) - 	C(3) - 	C(4) - 	0)4) -12.3) 	9) C(32) -0(33) -0(34) -0(34)  
0(2) - 	 0(3) - 	 0(4) - 	C(5) -131.8) 	8) 0(32) -0(33) -C(34) -0(35) -135.5) 	9) 
0(3) - 	 0(3) - 	 0(4) - 	 0(4) 98.8) 	8) 0(33) -C(33) -0)34) -0(34) 97.8) 	9) 
0)3) - 	 0(3) - 	 0(4) - 	 0(5) -20.7(11) 0(33) -0(33) -0(34) -0(35) -22.1 (11) 
0(3) - 	 0(3) -0(13) - 	 0(2) 21.4(10) 0(33) -0)33) -0(43) -0(32) 22.9(10) 
0)3) - 	 0(3) -C(13) -C(14) -100.8) 	9) C(33) -0)33) -0(43) -C(44) -98.4) 	9) 
0(3) - 	0(3) -C(13) -0)15) 137.1) 	8) C(33) -0(33) -C)43) -0)45) 138.9) 	8) 
0(3) - 	0(4) - 	 0(4) - 	C(1) 32.7) 	9) C(33) -C)34) -0(34) -0(31) 34.7(10) 
C(S) - 	0(4) - 	 0(4) - 	C(1) 157.2) 	8) C(35) -0(34) -0)34) -0)31) 158.7) 	8) 
0(3) - 	C(4( - 	 0(5) - 	 0(5) -63.9)10) C(33) -0(34) -C(35) -0(35) -65.6)10) 
0(3) - 	C)4) - 	C(S) - 	 0(6) 179.3) 	8) 0(33) -0)34) -0(35) -0(36) 178.7) 	8) 
0(4) - 	 0(1) - 	C(5) - 	 0(5) 177.2) 	7) 0(34) -0)34) -0)35) -0(35) 175.8) 	7) 
0)4) - 	 0(4) - 	 0(5) - 	 0(6) 60.4(10) 0(34) -0(34) -C)35) -C(36) 60.0)11) 
0(4) - 	C(S) - 	0(5) - 	N(7) -120.1) 	8) C(34( -0)35) -0(35) -N(37) -112.0) 	8) 
0)6) - 	C(S) - 	 0(5) - 	N)7) 3.3(10) 0(36) -0(35) -0(35) -N(37) 10.3) 	9) 
C(4) - 	C)5) - 	 0)6) - 	 0(7) 116.1) 	9) 0(34) -C(35) -C(36) -0(37) 108.0) 	9) 
0(5) - 	0(5) - 	 0(6) - 	 0(7) -2.2) 	9) 0(35) -C(35) -0(36) -C(37) -9.5) 	9) 
C(S) - 	0(5) - 	N(7) - 	C(7) -3.1(10) C(35) -0(35) -N (37) -C (37) -7.0 (10) 
C(S) - 	0(6) - 	 0(7) - 	N(7) 0.5(11) 0(35) -0(36) -0(37) -N)37) 6.1(11) 
C(S) - 	C(6) - 	C)7) - 	C(8) -175.9) 	9) C(35) -0(36) -0(37) -C(38) -174.4) 	9) 
C(6) - 	 0(7) - 	N(7) - 	 0(5) 1.5(11) 0(36) -0(37) -N(37) -0(35) 0.3(11) 
0(8) - 	C(7) - 	N (7) - 	0(5) 178.3) 	8) C (38) -C(37) -N (37) -0(35) -179.2) 	7) 
0)6) - 	C (7) - 	C (8) - 	 0(8) 70.3(11) 0(36) -0(37) -C(38) -0(38) 60.2(11) 
C(6) - 	C (7) - 	 0(8) - 	C(9) -46.0(13) 0(36) -0(37) -C(38) -C (39) -53.8 (12) 
N)7) - 	C (7) - 	C(8) - 	 0(8) -106.0(10) N(37) -C(37) -0(38) -0(38) -120.3) 	9) 
N(7) - 	C(7) - 	 0(8) - 	C(9) 137.7) 	9) N(37) -C(37) -0(38) -0(39) 125.7) 	9) 
0(7) - 	0(8) - 	 0(8) -0(16) -137.5) 	8) C (37) -0(38) -0(38) -0(46) -153.7) 	7) 
0(9) - 	C(8) - 	 0(8) -0(16) -15.2) 	9) 0(39) -C (38) -0(38) -C (4 6) -33.2) 	8) 
C(7) - 	0(8) - 	0(9) - 	 0(9) 148.1) 	7) C(37)  -0(39) -0(39) 143.5( 	7) 
C (7) - 	0(8) - 	C (9) -C (10) -95.3 ( 	9) C (37) -C (38)  -C (40) -98.4) 	9) 
0(8) - 	 0(8) - 	C(9) - 	 0(9) 29.4) 	8) 0(38) -C (38) -0(39) -0(39) 27.4) 	8) 
0(8) - 	0(8) - 	C(9) -0(10) 146.0) 	7) 0(38) -C(38) -0(39) -0(40) 145.5) 	7) 
0(8) - 	0(8) -C (16) - 	 0(9) -5.6( 	9) 0(38) -0(38) -C (4 6) -0(39) 27.0) 	9) 
0(8) - 	0(8) -0(16) -C(17) 115.2) 	8) 0(38) -0(38) -C(46) -C(47) 148.4) 	8) 
C(8) - 	 0(8) -0(16) -0(18) -123.7) 	8) 0(38) -0(38) -0(46) -0(48) -89.1) 	9) 
0)8) - 	0(9) - 	 0(9) -0(16) -33.8) 	8) 0(38) -0)39) -0(39) -C(46) -11.5) 	9) 
C(10) - 	0(9) - 	 0(9) -C(16) -156.1) 	7) 0(40) -C(39) -0(39) -0(46) -133.0) 	8) 
0(8) - 	C(9) -0(10) -0(10) 69.5( 	9) 0(38) -C(39) -0(40) -0(40) 59.6) 	9) 
C(8) - 	0(9) -0(10) -0(11) -176.0) 	7) C(38) -0(39) -C(40) -C(41) 175.1) 	8) 
0(9) - 	0(9) -C(10) -0(10) -178.3( 	6) 0(39) -0(39) -0(40) -0(40) 174.5) 	7) 
0(9) - 	C(9) -0(10) -0)11) -63.8) 	9) 0(39) -0(39) -0(40) -C(41) -69.7(10) 
0(9) - 	0(9) -0(16) - 	 0(8) 26.0) 	9) 0(39) -0(39) -0(46) -0(38) -9.0(10) 
0(9) - 	0(9) -0(16) -0(17) -91.5) 	9) 0(39) -0(39) -0(46) -0(47) -130.0( 	9) 
0(9) - 	0(9) -0(16) -C(18) 143.5( 	8) C(39) -0(39) -C(46) -C(48) 107.7) 	9) 
C(9) -C(10) -0(10) -0(19) 143.6) 	7) 0(39) -0(40) -0(40) -C(49) 128.8) 	8) 
C(li) -0(10) -0(10) -0(19) 22.0( 	9) 0(41) -0(40) -0(40) -C(49) 5.9) 	9) 
C(9) -C(10) -0(11) -0(11) -118.2( 	8) 0(39) -0(40) -0(41) -0(41) -142.4) 	8) 
0(10) -C(10) -0(11) -0(11) -2.5) 	9) 0(40) -C(40) -0(41) -0(41) -24.5) 	9) 
0(10) -0(10) -0(19) -0(11) -33.5) 	9) 0(40) -0(40) -C(49) -0(41) 14.7) 	9) 
C(10) -0(10) -C(19) -C(20) 87.7) 	9) 0(40) -0(40) -C(49) -0(50) -103.8( 	9) 
0(10) -0(10) -C(19) -0(21) -150.3) 	8) 0(40) -0(40) -C(49) -C(51) 129.1( 	8) 
0(10) -0(11) -0(11) -0(19) -18.8(lo) 0(40) -0(41) -0(41) -0(49) 34.0) 	9) 
C(li) -0(11) -C(19) -0(10) 32.5) 	9) 0(41) -0(41) -C(49) -0(40) -30.8) 	9) 
C(11) -0(11) -C(19) -0(20) -85.8(10) 0(41) -0(41) -C(49) -C(50) 88.1) 	9) 
C(11) -0(11) -C(19) -C(21) 147.5) 	8) 0(41) -0(41) -C(49) -0(51) -148.1) 	8) 
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Selected torsion angles(degrees) involving H atoms 
H(1) - 	 C(l) - 	 0(1) -C(12) -58.7 H (31) -C(31) -0(31) -C (42) -55.0 
H(1) - 	 C(1.) -C(2) - 	 H(2) -89.4 H(31) -C(31) -C(32) -H(32) -89.6 
H(1) - 	 C(l) - C(2) - 	 0(2) 37.5 H(31) -0(31) -0(32) -0(32) 37.6 
H (1) - 	 C (1) - 	 C(2) - 	 C(3) 148.4 H (31) -C(31) -C (32) -0(33) 146.1 
0(1) - 	 C(1) - 	 C(2) - 	 H(2) 30.0 0(31) -C(31) -C(32) -H(32) 31.2 
0(4) - 	 C(1) - 	 0(2) - 	 H(2) 153.0 0(34) -C(31) -C(32) -H(32) 151.8 
H(1) - 	 C(1) - 	 0(4) - 	 C(4) -157.4 H(31) -C(31) -0(34) -C(34) -157.6 
H(2) - 	 C(2) - 	 0(2) -C(13) -96.4 H(32)  -0(32) -0(43) -94.8 
C(1) - 	 C(2) - 	 C(3) - 	 H(3) 110.1 C(31) -0(32)  -H (33) 112.9 
H(2) - 	 C(2) - 	 C(3) - 	 H(3) -12.0 H(32) -0(32) -C(33) -H (33) -11.4 
H(2) - 	 C(2) - 	 C(3) - 	 0(3) 110.3 H(32) -C(32) -C(33) -0(33) 109.7 
H(2) - 	 C(2) - 	 0(3) - 	 0(4) -132.9 H(32) -C(32) -0(33) -C(34) -131.4 
0(2) - 	 0(2) - 	 0(3) - 	 H (3) -132.7 0(32) -0(32) -0(33) -H (33) -134.0 
H (3) - 	 0(3) - 	 0(3) -C (13) 115.6 H (33) -C(33) -0(33) -0(43) 115.5 
0(2) - 	 C(3) - 	 0(4) - 	 H(4) 105.2 0(32) -0(33) -C(34) -H(34) 101.8 
H(3) - 	 0(3) - 	 0(4) - 	 H(4) -15.7 H (33) -0(33) -0(34) -H (34) -18.3 
H(3) - 	 0(3) - 	 C(4) - 	 0(4) -133.2 H (33) -0(33) -0(34) -0(34) -135.7 
H(3) - 	 0(3) - 	 0(4) - 	 0(5) 107.3 H(33) -0(33) -0(34) -0(35) 104.4 
0(3) - 	 C(3) - 	 C(4) - 	 H(4) -143.7 0(33) -0(33) -0(34) -H (34) -144.8 
H(4) - 	 0(4) - 	 0(4) - 	 0(1) -84.8 H (34) -0(34) -0(34) -0(31) -82.7 
C (3) - 	 0(4) - 	 0(5) - 	 H (5) 55.1 0(33) -0(34) -0(35) -H (35) 54.1 
H(4) - 	 0(4) - 	 C(S) - 	 H(S) 178.1 H(34) -0(34) -C(35) -11(35) 176.9 
Fl (4) - 	 C (4) - 	 C(S) - 	 0(5) 59.1 H (34) -0(34) -0(35) -0(35) 57.1 
H(4) - 	 0(4) - 	 0(5) - 	 0(6) -57.7 H (34) -0(34) -0(35) -0(36) -58.6 
0(4) - 	 0(4) - 	 0(5) - 	 H(5) -63.8 0(34) -0(34) -0(35) -H(35) -64.5 
H (5) - 	 0(5) - 	 0(5) - 	 N(7) 120.8 H(35) -C(3S) -0(35) -N(37) 128.3 
0(4) - 	 C(S) - 	 0(6) -Fl (61) -125.2 0(34) -0(35) -0(36) -H(361)-133.1 
0(4) - 	 C(S) - 	 0(6) -H(62) -2.7 0(34) -0(35) -0(36) -H(362) -10.8 
H(S) - 	 0(5) - 	 C(6) -H(61) -1.0 H(35) -0(35) -0(36) -H(361) -8.6 
H(S) - 	 C(5) - 	 0(6) -H(62) 121.4 H(35) -0(35) -0(36) -H(362) 113.7 
H(5) - 	 C(S) - 	 C(6) - 	 0(7) -119.8 H(35) -0(35) -C(36) -0(37) -127.4 
0(5) - 	 0(5) - 	 C(6) -H(61) 116.5 0(35) -C(35) -C(36) -H(361) 109.4 
0(5) - 	 C(S) - 	 C(6) -H(62) -121.0 0(35) -0(35) -0(36) -H(362) -128.3 
H(61) - 	 0(6) - 	 0(7) - 	 N(7) -118.2 H(361)-C(36) -0(37) -N(37) -112.8 
H(61) - 	 0(6) - 	 C(7) - 	 C(8) 65.3 H(361)-C(36) -C(37) -0(38) 66.8 
H(62) - 	 C(6) - 	 C(7) - 	 N(7) 119.3 H(362)-C(36) -0(37) -N(37) 124.9 
H(62) - 	 0(6) - 	 C(7) - 	 C(8) -57.1 H(362)-C(36) -0(37) -0(38) -55.6 
0(6) - 	 C(7) - 	 0(8) - 	 H(8) -169.6 0(36) -0(37) -0(38) -H(38) -179.0 
N(7) - 	 C(7) - 0(8) - 	 H(8) 14.1 N(37) -0(37) -C(38) -H(38) 0.5 
H(8) - 	 C(8) - 	 0(8) -0(16) 102.4 H(38) -0(38) -0(38) -0(46) 85.5 
C(7) - 	 C(S) - 	 C(9) - 	 H(9) 31.4 0(37) -C(38) -0(39) -H(39) 25.8 
H(8) - 	 0(8) - 	 0(9) - 	 H(9) 155.1 H(38) -0(38) -0(39) -H(39) 151.1 
H(8) - 	 0(8) - 	 0(9) - 	 0(9) -88.3 H(38) -0(38) -0(39) -0(39) -91.2 
H(8) - 	 C(8) - 	 C(9) -0(10) 28.4 H(38) -C(38) -C(39) -0(40) 26.8 
0(8) - 	 0(8) - 	 C(9) - 	 H(9) -87.2 0(38) -C(38) -0(39) -H(39) -90.3 
H(9) - 0(9) - 	 0(9) -0(16) 82.9 H(39) -0(39) -0(39) -0(46) 106.2 
0(8) - 	 C(9) -0(10) -H(10) -50.3 C(38) -C(39) -0(40) -H(40) -60.0 
H(9) - C(9) -0(10) -H(10) -177.0 H(39) -0(39) -0(40) -H(40) 175.7 
H(9) - 	 0(9) -C(10) -0(10) -57.2 H(39) -0(39) -0(40) -0(40) -64.7 
H(9) - 	 C(9) -C(10) -0(11) 57.3 H(39) -0(39) -C(40) -0(41) 51.1 
0(9) - 	 C(9) -0(10) -H(10) 61.9 0(39) -0(39) -C(40) -H(40) 54.9 
H(10) -0(10) -0(10) -0(19) -96.6 H(40) -0(40) -0(40) -C(49) -111.6 
0(9) -C(10) -0(11) -H(111) 1.4 0(39) -0(40) -0(41) -H(411) -23.2 
0(9) -0(10) -0(11) -H(112) 122.3 C(39) -0(40) -0(41) -H(412) 98.4 
H(10) -C(10) -0(11) -H(111) -124.3 11(40) -C(40) -C(41) -H(411)-147.8 
H(10) -C(10) -0(11) -H(112) -3.4 11(40) -C(40) -C(41) -H(412) -26.2 
H(10) -C(10) -C(11) -0(11) 116.1 H(40) -0(40) -0(41) -0(41) 93.0 
0(10) -0(10) -0(11) -d(111) 117.1 0(40) -0(40) -C(41) -H(411) 	94.7 
0(10) -0(10) -C(11) -H(11.2)-122.0 0(40) -0(40) -0(41) -H(412)-143.8 
H(111)-C(11) -0(11) -C(19) -138.4 H(411)-C(41) -0(41) -0(49) -85.2 
H(112) -C(11) -0(11) -0(19) 100.7 H(412)-C(41) -0(41) -C(49) 153.2 
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